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Abstract 
 
 
Increasing Access to Pre-Exposure Prophylaxis (Prep) among Transgender Women 
and Trans Feminine Non-Binary Individuals in New York City  
by 
  Augustus Klein 
 
 
 
 
Advisor: Professor SJ Dodd 
 
 
 In the United States, transgender women (i.e., individuals born male whose gender 
identity is on the feminine spectrum) are a highly vulnerable and marginalized population at high 
risk for HIV. Substance use, survival sex work, depression, unstable housing, and high levels of 
victimization and violence are commonly reported by transgender women and trans feminine 
individuals, indicating the potential for multiple concurrent HIV risks and underlying 
vulnerabilities. Structural forms of discrimination may contribute to these risk factors, possibly 
leading to poor outcomes such as unemployment or underemployment, homelessness, and lack 
of access to gender affirming health care. Given this context, a biomedical intervention such as 
pre-exposure prophylaxis (PrEP), which can address risks from multiple types of exposure (i.e. 
sexual or parenteral) and be used effectively without negotiation between sexual partners, may 
be critical for effective HIV prevention packages that meet the needs of transgender women and 
trans feminine individuals.  This dissertation was designed to identify the facilitators and barriers 
to PrEP access, uptake, and adherence among transgender women and trans feminine individuals 
at risk for HIV.   
 Thirty in-depth semi-structured interviews were conducted with two groups: a) 
transgender women and trans feminine individuals on PrEP (n=15) and b) transgender women 
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and trans feminine individuals not on PrEP.  Participants were recruited throughout New York 
City using flyers, online social media postings, targeted emails to community-based 
organizations, and word of mouth.   All interviews contained a core set of questions regarding 
factors at the individual, community, and systems level that might influence PrEP adoption, 
adherence, access, and willingness to use future biomedical PrEP interventions.  Interviews were 
transcribed verbatim and coded thematically using Dedoose Qualitative Software. 
 The results of this dissertation suggest that to increase PrEP access, uptake, and 
adherence there is a need for the development and design of strategies and programs that 
contextualize HIV risk among transgender and non-binary women (TGNBW) as a social and 
psychological process rather than solely a byproduct of behavior. Situating HIV risk as a social 
and psychological process acknowledges that for TGNBW, risk factors are associated with 
multiple levels of social oppression (i.e., racism, transphobia, and sexism) (Sevelius, 2013; 
2016). By recognizing that HIV risk is driven by social oppression, we begin to reframe the HIV 
prevention discussion to focus on the intersection of the structural, interpersonal, and individual 
level factors contributing to HIV risk, rather than focusing solely on individual behaviors. To do 
otherwise may contribute to the alarming rates of HIV infection among this community by 
creating barriers to PrEP.   
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CHAPTER 1: INTRODUCTION 
 
Problem Formulation 
 
Transgender, trans, non-binary or gender non-conforming are a terms individuals use to 
describe a gender identity or expression that is different from their sex assigned at birth 
(Bornstein & Bergman, 2010; Lombardi, 2010; Namaste, 2000; NCTE, 2016). In the United 
States transgender women (i.e., individuals born male whose gender identity is on the feminine 
spectrum) are a highly vulnerable and marginalized population at high risk for HIV (Baral et al., 
2013; Herbst et al., 2008). Despite a high prevalence of HIV, transgender women have 
historically been included under the behavioral risk group men who have sex with men (MSM), 
erasing their unique HIV risk and prevention needs and impeding understanding of accurate HIV 
prevalence and incidence rates (Sevelius et al., 2016). In HIV surveillance data and research, if 
included at all, transgender women represent a small number of individuals and are commonly 
referred to using the phrase ‘MSM and transgender women.' When presenting results or 
implication of study findings, researchers do so without disaggregating transgender women from 
MSM. Thus, offering an inaccurate representation of the HIV prevalence and incidence among 
both groups.    
In the early 1990’s, the introduction of the MSM category within HIV research aimed to 
describe behaviors rather than a complex set of sexual identities in an effort to acknowledge that 
behaviors, not identities placed people are risk for HIV infection (Young & Meyer, 2005). 
However, MSM as a behavioral risk category has been criticized for failing to account for 
sociocultural differences within this population that are seen as crucial to promoting sexual 
health and preventing HIV (Boellstroff, 2011; Young & Meyer, 2005). Universally applying the 
term MSM to a group of people may undermine the identities of sexual minorities, disregard 
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social meanings of sexuality, and ultimately fail in their aim to describe sexual behavior (Young 
& Meyer, 2005). The implication that MSM are a heterogeneous group is not devoid of cultural 
meaning. Young & Meyer (2005) assert that the way in which public health counts and 
categorizes people in research not only reveals a great deal about cultural attitudes and social 
constructions, it also shapes and perpetuates these attitudes and constructions. By incorporating 
transgender women within the category of MSM researchers convey several beliefs, including: 
1) that transgender women are in fact men, 2) gender identity is not important in understanding 
sexual health and preventing HIV, and 3) transgender women's sexual practices and experiences 
are fundamentally the same as the men who are included in this category (Fiereck, 2015; 
Sevelius et al., 2016). While there is currently no literature on transgender women’s sexual 
health to support these beliefs, it is possible that devaluing and ignoring self-determined gender 
identity (by emphasizing biologically driven sexual behavior) within HIV research may 
exacerbate the HIV disparities experienced by transgender women (Sevelius et al., 2016). For 
example, research has demonstrated that gender affirmation (i.e., social and/or medical 
affirmation of one's gender identity) is a significant factor in both sexual risk-taking and health 
care seeking behaviors among transgender women (Colton-Meier, Fitzgerald, Pardo, & Babcock, 
2011; Nuttbrock, Rosenblum, & Blumenstein, 2002; Nuttbrock et al., 2009; Sevelius, 2013; 
Sevelius et al., 2016).  To fully characterize the disparities experienced by transgender women it 
is imperative to understand the psychosocial differences between transgender women and MSM. 
However, this cannot be explained from current research, which aggregates MSM and 
transgender women, privileging one group over the other (Fiereck, 2013; Sevelius et al., 2016). 
Although transgender people are excluded from national data collection, research has 
consistently demonstrated that HIV disproportionately affects transgender women (Baral et al., 
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2013; Herbst et al., 2008). A 2013 meta-analysis found that internationally transgender women 
have 49 times the odds of HIV infection compared to the general adult population (Baral et al., 
2013). In the United States, transgender women have been identified as the group with the 
highest rates of new HIV diagnoses (2.1%) compared to cisgender men (1.2%) and cisgender 
women (0.4%) (CDC, 2013). Due to higher HIV rates among transgender women compared to 
MSM, it is possible that transgender women may increase perceived prevalence among MSM in 
studies that aggregate transgender women with MSM (Deutsch et al., 2015; Sevelius et al., 
2016). Based on these aggregated HIV rates, funding for HIV prevention efforts are made 
available, yet the program and prevention strategies developed are designed solely for those who 
were assigned male at birth. Transgender women's unique social, emotional, sexual, and physical 
health needs and contexts of risk are not considered or addressed in prevention programming for 
MSM.  For example, while some MSM do engage in sex work, research has consistently 
documented that due to pervasive economic disenfranchisement transgender women, in 
particular, those living in urban areas have higher rates of lifetime engagement in transactional 
sex (Nadal, Davidoff, & Fujii-Doe, 2014; Sevelius et al., 2016).  Furthermore, transgender 
women sex workers have higher rates of HIV than cisgender male sex workers (Operario, Soma, 
& Underhill, 2008). Thus, it is imperative that HIV prevention programming for transgender 
women address sex work. 
  Substantial attention has been paid to pre-exposure prophylaxis (PrEP), the newest and 
most promising biomedical HIV prevention intervention to be developed and tested (Grant et al.; 
2010; Golub et al., 2013; Liu et al., 2014). The first clinical trial of PrEP (the Chemoprophylaxis 
for HIV Prevention in Men (iPrex), which included high-risk MSM and transgender women 
found that PrEP reduced the risk of HIV acquisition by 44% (Grant et al., 2010). Although a 
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subanalysis of the iPrex data found no efficacy among the small subgroup of transgender women 
in the study (Mascolini, 2011). Further analysis of the transgender women in iPrex found 
unequal drug levels between MSM and transgender women, where lower levels of uptake and 
adherence were reported among transgender women, which most likely contributed to the 
disparate rates of efficacy (Deustsch et al., 2015).  However, researchers and clinicians state that 
interactions between PrEP and hormones cannot be ruled out due to a lack of pharmacokinetic 
studies (Deutsch et al., 2015). Lastly, of the seven clinical trials of PrEP for HIV prevention, 
iPrex is the only study with a confirmed enrollment of transgender women (Escudero et al., 
2014).     
There are currently no guidelines for PrEP that provide specific considerations for PrEP 
dissemination to transgender women (Escudero, et al., 2014; Sevelius, et al., 2016). PrEP 
guidelines from the World Health Organization mentions transgender women yet does not 
specifically address their needs (World Health Organization, 2012). Furthermore, in the Centers 
for Disease Control's clinical PrEP guidelines, transgender women are not included at all (CDC, 
2011). To date, PrEP demonstration projects have reported low or unclear levels of enrollment of 
transgender women (Liu et al., 2014). Inaccurate data collection and tracking of transgender 
individuals allows for miscategorization of participants who may identify as transgender, non-
binary, or gender non-conforming. In addition, transgender women face barriers to study 
participation such as, fear of stigma and marginalization associated with gender diversity, lack of 
cultural competency training for research staff, fear of participation due to lack of scientific 
knowledge regarding medication interaction with hormones, mistrust of the scientific 
community, and discomfort with visitor IDs and complications related to name change (Women 
& PrEP Working Group, 2015).  Furthermore, a recently published study examined levels of 
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knowledge, indications, and willingness to take PrEP among a sample of 233 transgender women 
in San Francisco (Wilson, Jin, Liu, & Raymond, 2015). Only 13.7% of participants had heard of 
PrEP, despite the fact that San Francisco was a participating site in the three-city PrEP 
demonstration project (Wilson, Jin, Liu, & Raymond, 2015).  Given the lack of trans-specific 
recruitment and retention strategies or data to guide trans-inclusive PrEP implementation this 
finding is not surprising. Results from this study underscore the fact that transgender women are 
not reached by the same information and social networks as MSM and do not benefit from HIV 
prevention programming designed for MSM (Sevelius et al., 2016). The lack of attention to both 
the barriers to PrEP uptake and adherence among transgender women and the sociocultural 
contexts that contribute to HIV risk, highlights how privileging sex assigned at birth over 
contextual factors of sexual risk in HIV prevention strategies perpetuates HIV related disparities 
(Fiereck, 2013; Sevelius et al., 2016).    
The invisibility of transgender women in studies of MSM has significant consequences 
for informing the policy, programming, and access to PrEP.  HIV prevention and treatment 
research has consistently demonstrated that transgender women have been left behind (Baral et 
al., 2013; Herbst et al., 2008; Poteat, Reisner, & Radix, 2014; Sevelius, Keatley, & Guitierrez-
Mock, 2011), with higher rates of HIV than any group as well as higher rates of morbidity and 
mortality (Baral et al., 2013; CDC, 2008; Feldman, et al., 2016; Herbst et al., 2008). To date, 
PrEP research continues to repeat this pattern.    
Statement of Research 
 PrEP researchers have called for trans-specific research on PrEP knowledge and 
acceptability (Escudero et al., 2014; Golub et al., 2013; Sevelius et al., 2016). To date, there have 
been two studies examining the specific facilitators and barriers to PrEP uptake among 
 6 
transgender women (Sevelius et al., 2016; Wilson, Jin, Liu, & Raymond, 2015). However, we 
still need to know more about the specific facilitators and barriers to PrEP adoption, adherence, 
and access among transgender women at risk for HIV acquisition. This dissertation is designed 
to answer the following four research questions: 
1. What are the structural, interpersonal, and individual level factors impacting 
transgender women’s willingness to utilize PrEP as an HIV prevention tool?  
2. To what extent do these factors impede the integration of PrEP into the lives of 
transgender women?  
3. What are best practices for integrating PrEP into health care for transgender women?  
4. To what extent does need for and access to gender affirmation influence engagement 
in HIV risk behaviors among transgender women?    
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CHAPTER 2:  CONTEXTUALIZING TRANSGENDER IDENTITIES 
Introduction 
Little historical information on transgender individuals exists outside of the medical and 
psychological literature. During the late nineteenth and early twentieth century, writing on 
transgender identities first appeared in Europe. In the United States, doctors and scientists did not 
begin to address transgender issues until the late 1940's (Meyerowitz, 2002; Stryker, 2007). 
Echoed throughout the literature is the debate as to whether sex and gender are essential and 
biologically based or socially constructed. Predominant theories on transgender individuals 
throughout much of the twentieth century were predicated on the belief that to be transgender 
was a form of mental illness or medical disorder (Benjamin, 1953; Cauldwell, 1949; Hirschfeld, 
1910; Money & Schwartz, 1969; Stoller, 1964; 1968). In opposition to these ideas, new 
theoretical perspectives on transgender identities emerged during the late twentieth century 
influenced by community activism, academia, and the belief that to be transgender was not a 
mental illness or physical condition (Feinberg, 1992; Stone, 1991; Whilcins, 1997). The 
historical perspectives on transgender identities are linked to the current structural, interpersonal, 
and individual level factors that may influence transgender women's HIV risk and willingness to 
adopt and adhere to PrEP. This chapter will present historical and contemporary ideologies on 
transgender identities. 
Historical Perspectives on Transgender Identities  
Early European Medical Perspectives 
In the late nineteenth and early twentieth century, beliefs about sexuality and gender 
identity were rooted in biological essentialism (DeCecco, Elia, 1993; Meyerowitz, 2002; Stryker, 
2007).  Sex not only signified female and male, but the traits, attitudes, and behaviors associated 
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with masculinity and femininity (DeCecco, Elia, 1993). Sex and gender were anchored in 
anatomy, physiology, and the belief that "nature" intended gender and sexuality as a biological 
imperative for reproduction. 
Because sex and gender were believed to be interconnected, same-sex attraction was 
associated with femininity in men and masculinity in women. In turn, cross-gender identification 
was thought to be a form of homosexuality (Krafft-Ebing, 1877; Meyerowitz, 2002; Stryker, 
2007). Within the medical literature, cross-gender identification first appeared in the landmark 
study, Psychopathia Sexualis (Krafft-Ebing, 1877). Krafft-Ebing (1877) proposed that 
individuals who actively identified as members of the opposite sex were profoundly disturbed 
and that the desire to physically alter one’s body was a form of psychosis.   
In 1910, physician Magnus Hirschfeld an early advocate for transgender individuals 
challenged the notion that cross-gender identification was a form of homosexuality and 
psychopathy (Hirschfeld, 1910; Meyerowitz, 2002; Stryker, 2006; Stryker, 2007). He proposed 
that cross-gender identification was a complex phenomenon independent from homosexuality. 
Hirschfeld (1910) coined the term transvestites (trans=cross over; vesti=dress) to describe 
individuals who identified with and dressed as the opposite sex. He believed that sex was rooted 
in biology and promoted a theory of sexual intermediaries, which was the idea that biologically, 
men and women embodied a unique combination of male and female sex characteristics, traits, 
attitudes, and desires (Hirschfeld, 1910). 
At the same time Hirschfeld (1910) promoted his theory of sexual intermediaries, two significant 
medical advances occurred. First, the new field of endocrinology discovered and created a 
chemical test to measure female and male sex hormones (Hausman, 1995).  This discovery 
transformed the study of sex differentiation, which was previously solely reliant on the external 
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genitalia and reproductive organs. Sex hormones helped to explain sexual development, 
contributing to a new vision of sex that believed no individual was one hundred percent man or 
woman (Benjamin, 1945). Second, European scientists began to undertake experiments, first to 
transform the sex of animals and then humans (Meyerowitz, 2002). In Austria, physiologist 
Eugen Steinach took the lead in changing the sex of animals (Steinach, 1940). In Germany, 
during the 1920s and early 1930s, doctors working with Hirschfeld began to perform and 
publicize sex change surgeries on persons labeled transvestites (Meyerowitz, 2002; Stryker, 
2007).  The practice of sex-change surgery coupled with the discovery of sex hormones provided 
scientific evidence to promote the idea that male and female were not mutually exclusive 
categories. 
The Emergence of the Transsexual 
In the United States, the issue of cross-gender identification first appeared in the medical 
literature during the mid-twentieth century (Benjamin, 1953; Cauldwell, 1949).  In 1949, 
physician David O. Cauldwell wrote Psychopathia Transexualis published in the Journal of 
Sexology. Psychopathia Transexualis (1949) is considered the first scholarly paper to use the 
term transsexual to describe individuals wishing to become the opposite sex (Meyerowitz, 2002; 
Stryker, 2006; Stryker, 2007). According to Cauldwell (1949), transsexuality was a 
psychological disorder caused by a genetic predisposition, an unfavorable childhood, and 
overbearing parents. Echoing the earlier writing of Krafft-Ebbing (1877), Cauldwell (1949) 
believed that individuals afflicted with wanting to live as the opposite sex were severely mentally 
disturbed. He promoted the belief that masculinity and femininity were social and psychological 
attributing gender differences to social factors (Cauldwell, 1950, 1951). While he acknowledged 
that sex change operations were possible, he strongly opposed physicians performing such 
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medical interventions, considering it a crime to remove healthy tissue and glands. He professed 
that treatment must focus on rehabilitation through social re-education by discouraging cross-
gender behaviors (Cauldwell, 1949).   Cauldwell's theory on the origins of and treatment to 
correct cross-gender identification was the foundation for the pathologization of the transsexual.    
In stark contrast to Cauldwell, endocrinologist Harry Benjamin emerged as a proponent 
of the use of hormones to treat individuals wishing to change their sex. Benjamin (1953; 1966) 
challenged the emerging psychological and psychoanalytic cures, stating that hormone treatment 
rather than psychological care was more appropriate for treating individuals who wished to 
change their sex. While he did not discount the psychological origins of transsexualism, 
Benjamin (1953; 1966) believed that transsexuality was primarily a physical condition 
influenced by hormones and genetics. Given the physical nature of transsexualism, he posited 
that attempts to discourage transsexuality through psychotherapeutic interventions were useless 
and would not alleviate a person's desire to change their sex. Benjamin (1966) supported the 
theory of universal bisexuality popularized in Europe during the early twentieth century, which 
suggested that no individual was exclusively male or female and that each person was both parts 
male and female. Benjamin's clinical practice, scholarly publications, and advocacy for the rights 
of transsexuals determined much of the modern medical approach for transgender individuals. 
Early Psychological Perspectives on Transsexuality 
Following World War II, psychiatrists and psychologists gained legitimacy as an 
authority within American medicine and society (Hale, 1995; Starr, 1982). Because the field 
played a crucial role in screening recruits for military service during the war and providing 
treatment to soldiers in distress, the federal government acknowledged their growing influence 
by passing the Mental Health Act of 1946, which established the National Institute of Mental 
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Health (Hale, 1995). As their authority grew, psychiatrists and psychologists increasingly 
supported environmental causes to psychological conditions, rejecting biological explanations. It 
was in this context that psychologists and psychiatrists began to promote that transsexuality was 
psychological and not a medical condition. During much of the 1950's and 1960's, the 
recommended treatment for transsexuals was psychoanalysis and other forms of 
psychotherapeutic treatment that tried to eliminate the desire to live as the opposite sex 
(Meyerowitz, 2002).     
  In the 1960's, psychoanalyst Robert Stoller (1964; 1968) developed an influential model 
distinguishing biological sex from gender, gender identity and gender role. Although a proponent 
of the psychological etiology of transsexuality, he did not discount the influences biology had on 
the psychological development of a person's sex. Stoller's model (1964) attempted to bridge the 
gap between the biological and environmental "causes" of cross-gender identification. He 
proposed that biological sex, which was determined by physical conditions, such as 
chromosomes, external and internal genitalia, hormones, and secondary sex characteristics, was 
separate from the psychological and cultural process of gender (Stoller, 1964). Gender referred 
to the amount of masculinity or femininity found in a person, where sex was termed male and 
female, gender was masculine and feminine. While Stoller (1964) believed that a "normal" male 
was mostly masculine and a "normal" female mostly feminine, gender identity was the subjective 
sense of being a particular sex, which over time might develop in opposition to biological sex. 
Gender role was defined as the display of overt behaviors that helped others determine a person's 
gender.  Stoller's work remains influential and to a large extent responsible for the expanded 
sex/gender distinction underlying much of the research on transgender individuals. 
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  The field of psychology used this new conceptualization of sex and gender to further the 
belief that cross-gender identification could be changed through therapeutic interventions that 
discouraged cross-gender behaviors. By applying the concept of gender identity, psychologists 
and psychiatrists professed that appropriate treatment of transsexuality was to monitor gender in 
early childhood (Stoller, 1967).  Since early cross-gender behaviors were seen as a symptom of 
transsexualism, a preventative intervention was needed to treat this process before gender 
identification was complete (Burke, 1996). If gender did not necessarily come from biological 
sex, then training was required to ensure that transsexuality did not occur. To further the 
preventative model of treatment, Stoller and his colleagues at UCLA established a Gender 
Identity Research Clinic (Meyerowitz, 2002), which allowed for research on the development of 
gender identity with the explicit goal of preventing transsexuality in adults (Stoller, 1966). This 
preventative model urged the preservation of societal gender norms built on the heteronormative 
assumption that men and women exist solely to reproduce to ensure the continuation of the 
production of labor (Stoller, 1966). 
Legitimizing Treatment for Transsexuality 
In the 1950's and 1960's as doctors and scientists debated the meanings of sex and 
gender, individuals armed with growing information from the medical literature on transsexuality 
contacted doctors to inquire about sex-change treatment (Meyerowitz, 2002). As they urged their 
doctors to engage in this new form of medical treatment, most experienced barriers related to 
unwillingness on the part of the physician, prohibitive costs, and limits of technology. In the 
history of transsexuality, few doctors emerged as pioneers willing to assist patients determined to 
change their bodies and lives.     
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In the United States, Dr. Harry Benjamin emerged as an expert on transsexualism during 
this period. After the publication of his seminal work, The Transsexual Phenomenon (1966), his 
notoriety increased and would be patients traveled to his offices in New York City and San 
Francisco (Meyerowitz, 2002). Patients introduced their friends and acquaintances to Benjamin 
as he became known as both a pioneer and advocate for the medical treatment of transsexuality 
(Meyerowitz, 2002; Stryker & Whittle, 2006; Stryker, 2007). In their initial consultations with 
Benjamin, patients conveyed a sense of hopelessness and despair (Benjamin, 1966). Previous 
attempts to seek medical treatment for sex change were often met with offers for psychotherapy, 
shock treatments, lobotomies, or commitment to a mental institution (Stryker & Whittle, 2006). 
Some individuals had spent years in psychoanalysis or institutions to rid themselves of their 
desire to live as the opposite sex (Benjamin, 1966). Additionally, stories of arrests for cross-
dressing, loss of employment or fear of being found out to be an imposter were common 
(Benjamin, 1966). Medical treatment was not just a strategy for self-protection, but an active 
form of self-expression where the desire to change sex reflected the assertion of an inner self.     
In the mid-1960's, the Erickson Educational Foundation (EEF) a non-profit organization, 
began to fund medical research outside of the mainstream (Erickson Educational Foundation, 
1970). Reed Erickson, its founder, was a female to male transsexual who after undergoing sex-
change surgery and hormone therapy, felt compelled to further research on and services for 
transsexuality by providing grants to the doctors who helped him (Devor, 2002; Erickson, 1969; 
Meyerowitz, 2002). Benjamin and John Hopkins Hospital were two of EEF's funding recipients 
(Devor, 2002; Meyerowitz, 2002). The support EEF provided for research, treatment, and 
advocacy helped transform transsexuality into an acknowledged medical specialty and social 
issue (Meyerowitz, 2002).    
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During the late 1960s, the first clinic to perform sex reassignment surgery (SRS) was 
started at John Hopkins Hospital in Baltimore, which solidified a professional legitimacy to the 
practice of SRS (Money & Schwartz, 1969).  The program at John Hopkins also cleared the way 
for other medical centers to start similar clinics (Meyerowitz, 2002). At the same time, Harry 
Benjamin began to move towards creating a formal program with a network of psychologists and 
doctors willing to recommend and arrange surgery, forming the Harry Benjamin Foundation 
(Meyerowitz, 2002). With support from the EEF, an anthology on transsexualism entitled 
Transsexualism and Sex Reassignment (1969) was published, of the thirty-two articles published 
more than half came from researchers affiliated with Johns Hopkins Gender Identity Clinic, the 
Harry Benjamin Foundation, and the UCLA Gender Identity Research Clinic (Green and Money, 
1969; Meyerowitz, 2002).  The anthology served as a handbook for doctors who chose to treat 
transsexual patients, providing a detailed outline of how to treat patients with hormones and 
surgery (Green and Money, 1969).    
As sex reassignment surgery received institutional backing and gained more legitimacy 
doctors began to formulate criteria for assessing patients that were appropriate for hormone 
therapy and surgery (Green, 1969). Individuals wishing to live as the opposite sex were first 
required to undergo a psychological evaluation to determine whether they had a longstanding 
cross-gender identification and no severe mental illness. Before undergoing surgery, doctors 
expected patients to live as the opposite sex and take hormones for several months and in some 
cases years, all at the discretion of the physician (Baker & Green, 1970; Edgerton, Knorr, & 
Callison, 1970; Hunt & Hampson, 1980). Physicians were careful to choose patients with the 
capacity to understand what treatment would and would not do (Benjamin, 1966; Pauly, 1969).  
This group of physicians, psychiatrists, and researchers that endorsed medical intervention set up 
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a gatekeeping system that allowed them to control access to treatment based on their subjective 
belief as to who was worthy and a "true" transsexual.   Preference was given to individuals 
whom the doctor believed could "pass" as the opposite sex. It was important that these 
individuals both looked and behaved like conventional women or men (Benjamin, 1966; Green 
& Money, 1969). In some cases, doctors required training in traditional gender stereotypes 
(Meyerowitz, 2002). Additionally, doctors expected their patients to live as heterosexuals, and if 
possible marry after surgery.  A male to female individual who had sex with women before 
treatment would not qualify for treatment as readily as a male to female person who had sex with 
men (Meyerowitz, 2002). Doctors rejected candidates who after treatment would not conform to 
the dominant standards of gender and sexuality.     
In the 1970's, to further legitimate doctor's authority in this growing medical field, a new 
diagnostic category was adopted, gender identity disorder was an umbrella term covering a broad 
range of cross-gender behaviors deemed appropriate for medical intervention (Meyerowitz, 
2002). During the International Symposium on Gender Identity at Stanford University in 1975, a 
committee was appointed to draft guidelines to serve as medical standards for the diagnosis and 
treatment of transsexuals (Meyerowitz, 2002). At the next conference in 1977, the guidelines 
were approved. In 1979, professional recognition of transsexualism and guidelines for its 
treatment had culminated in the formation of the Harry Benjamin International Gender 
Dysphoria Association (HBIGDA) (Meyerowitz, 2002). The international organization further 
standardized criteria for diagnosis and treatment, which authorized medical treatment under 
certain conditions, but disavowed surgery on demand, and required recommendations from two 
licensed psychologists or psychiatrists before medical intervention (SOC, HBIGDA, 1981).     
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 At the same time, HBIGDA formed, psychiatrist Richard Green began to draft a section on 
transsexualism for the American Psychiatric Association's Diagnostic and Statistical Manual of 
Mental Disorders (Meyerowitz, 2002). In 1980, transsexualism first appeared in the Diagnostic 
and Statistical Manual of Mental Disorders (DSM, 1980), and was officially recognized as a 
gender identity disorder. The inclusion of transsexualism provided further legitimation and 
medical authority to doctors providing medical and surgical treatment to transsexuals, however, 
it unearthed a growing divide between doctors and the individuals who needed them.  
Building on the legitimacy provided by university-based clinics offering transsexual 
surgeries, private psychologists, psychiatrists, and physicians began to treat transsexual patients 
(Meyerowitz, 2002). Additionally, starting in the 1970s, the privatization of medical treatment 
began to play an integral role in the practice of transsexual surgery, as doctors in private practice 
discovered the lucrativeness of offering transsexual surgery (EEF, 1972). The privatization of 
transsexual surgery created access to those individuals who had the money to afford such 
treatment. For individuals who could pay for access to care, they no longer had to settle for any 
doctor they could find. Furthermore, private psychologists and psychiatrists began to recommend 
surgery for individuals who would not have met the surgical criteria required at the more 
restrictive university research and treatment programs. By the 1980's and 1990's, transsexuals 
increasingly turned to private doctors for sex reassignment surgery (Stryker, 1998). The original 
doctors who had led the field of transsexual medicine were no longer at the forefront. A new 
group of doctors began to fill this role coupled with a growing transgender movement that 
emerged in the 1990's. 
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The Building of a Movement 
In the early 1990's, a wave of transgender activist organizations emerged, including 
Transgender Nation, Transsexual Menace, and the American Educational Gender Information 
Services (AEGIS) (Wilchins, 1997).  These activists pressured the HBIGDA to revise its 
standards of care and include transsexuals in its deliberation process, as well as convince non-
profit organizations fighting for gay rights (such as the National Gay and Lesbian Taskforce) to 
fight for the rights of transgender people in their political efforts (Meyerowitz, 2002). They 
brought attention to the violence and brutality targeted towards the transgender community 
advocating for the inclusion of the rights of transsexuals and transgender people into anti-
discrimination legislation (Meyerowitz, 2002; Stryker, 2007).   
To build community and disseminate information magazines, newsletters, and 
conferences for and by transgender individuals began to emerge calling for free expression of 
gender variance. For example, this included magazines and newsletters such as TransSisters: The 
Journal of Transsexual Feminism, Transsexual News Telegraph, Gender Euphoria (Meyerowitz, 
2002). The creation of the Internet provided a new opportunity to organize, and connect with 
people who were otherwise isolated, join public protests, and find a community of peers that they 
could connect with, without leaving their home (Wilchins, 1997).     
The new movement addressed the ongoing issue of redefining sex, gender, and sexuality 
(Stone, 1991; Meyerowitz, 2002; Stryker, 2006; Stryker, 2007). In 1991, The Empire Strikes 
Back: A Posttranssexual Manifesto (Stone, 1991), helped launch a new transgender scholarship. 
Stone (1991) advocated for transsexuals to live openly, to stop hiding their past and building 
their histories around doctor's expectations of who was a "true" and appropriate transsexual 
(Stone, 1991). Stone argued against the binary model of gender identification, by acknowledging 
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that identities and desires were diverse and complex (Stone, 1991). Stone's (1991) manifesto 
ushered in a renewed interest in redefining gender, which came from a new movement of 
transsexual scholars and activists seeking to contribute to a discourse that had been previously 
dominated by the medical field.    
 In 1992, Leslie Feinberg published Transgender Liberation: A Movement Whose Time 
Has Come (Feinberg, 1992). Feinberg's book was a call to action for social, political, and 
economic justice, bringing together all individuals who were marginalized and oppressed for a 
gender expression that was different from societal gender norms. Feinberg's (1992) definition of 
transgender encompassed transsexuals, drag queens, butches, cross-dressers, masculine women, 
effeminate men, and anyone else not accounted for by the dominant binary sex/gender 
dichotomy. Feinberg's call to arms was a catalyst for the transgender liberation movement, 
mobilizing a community of individuals who began to fight for civil and human rights for 
transgender people, which continues to fuel the current public debate on transgender issues 
(Feinberg, 1992; Stryker, 2006). For example, during the 1990's some states began to recognize 
the legal change of sex on birth certificates, change of name and gender on driver's licenses, and 
the rights of postoperative transsexuals to marry in their preferred gender (Stryker, 2007).    
 As Feinberg (1992) called for a political revolution, scholars such as Judith Butler (1990) 
influenced by Michel Foucault began to publish new theoretical perspectives on gender and 
sexuality.     
In Gender Trouble: Feminism and the Subversion of Identity (Butler, 1990), Butler 
proposed a concept of gender performativity, which became central to the understanding of a 
predominantly White and well-educated group regarding their gender expression and transgender 
identity (Namaste, 2000). For transgender people who were the targets of violence, 
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discrimination and rejection for actualizing their transgender identity the idea that gender was a 
game, where one could put on and take off one's gender identity at will was infuriating 
(Wilchins, 2004; Namaste, 2000). Butler extends her arguments on gender in Bodies That 
Matter: On the Discursive Limits of Sex (1993), embracing the social constructionist views of 
biological sex, gender, gender identity, and gender role which were popularized in psychiatry 
and psychology during the 1950's and 1960's. Butler (1993) proposes a "new" theoretical 
framework, which suggests that sociocultural contexts influence how we understand and 
"perform" gender. For scholars within the new transgender movement, Butler's explanations 
provided a new understanding of the transgender experience. 
A National Transgender Movement  
The visibility of the transgender community grew exponentially during the 1990's, 
however much of this growth was situated in large cities such as San Francisco, New York, and 
the District of Columbia (Stryker, 2007). In 1991, the expulsion of a transwoman from the 
Michigan Womyn's Music Festival sparked off the debate of policies within queer women-only 
spaces as to whether transwomen were welcomed because they were not born women (Strkyer, 
2007). In direct response, transgender activists and allies organized a "Camp Trans" near the 
festival protesting the anti-trans policy and providing educational outreach, community 
discussions and action to combat transphobia (Meyerowitz, 2002, Styker, 2007). Another 
milestone in transgender activism also occurred in 1991, when the first transgender conference, 
Southern Comfort took place in Atlanta (Stryker, 2007), which included guest speakers, 
workshops, support/discussion groups, entertainment, and socializing.  Southern Comfort is still 
one of the largest gatherings of transgender individuals.     
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In 1994, activist Riki Wilchins launched the political action group Transsexual Menace, 
which was known by their trademark image of the group's name in blood-dripping red letters on 
the backdrop of a black t-shirt. Wilchins and Transsexual Menace gained national media 
coverage by sponsoring vigils outside of courthouses where cases involving anti-transgender 
crimes were being held, most notably was their ongoing protests during the trial of the 1993 rape 
and murder of Brandon Teena in Nebraska (Stryker, 2007).  In 1995, Wilchins went on to form 
the first national political organization (Gender Public Advocacy Coalition) devoted to and 
representing the rights of the transgender community (Wilchins, 1997).  GenderPac was 
instrumental in bringing Congress’ attention to transgender issues, specifically those related to 
individual, community, and structural levels of violence and discrimination (Wilchins, 1997).   
GenderPac, closed in 2009, citing the growth of several organizations working to further the 
rights of the transgender community. 
 In San Francisco, transgender activists worked with the city’s Human Rights Commission 
in 1993 and 1994 to create a landmark report documenting the unprecedented levels of human 
rights abuses against the transgender community (Green, 1994).  The report provided the 
framework for San Francisco's 1995 transgender anti-discrimination ordinance (Stryker, 2007).  
Over the next decade, San Francisco built upon this foundation by offering transgender 
individuals greater legal protections against discrimination and becoming the first city to offer its 
transgender employee’s health care benefits that covered the cost of their gender transition 
(Stryker, 2007).    
The Transgender Day of Remembrance was started by Gwendolyn Ann Smith in 1999 to 
honor those who have lost their lives to violence (https://tdor.info/) and to highlight the 
disproportionately high rates of anti-transgender violence and murder cases. The event started as 
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a small candlelight vigil in San Francisco and has grown to an International day of remembrance 
held each November, to raise public awareness of the hate crimes against transgender people 
through honoring all transgender individuals who have lost their lives.    
 Lastly, as the Internet became more accessible to the masses in the late 1990’s, it 
provided an additional avenue for the growing transgender movement.   The Internet helped 
connect transgender people nationally and internationally and provided fertile ground for the 
expansion of the transgender movement into the twenty-first century. The transgender activism 
of the 1990's built communities brought awareness to transgender-related violence and 
discrimination and created a transgender narrative separate from the dominant medical and 
psychological paradigm.   
Contemporary Perspectives on Transgender Identities 
 The twenty-first century has seen a rise in visibility among the transgender and gender 
non-conforming communities.  An estimated .03% percent of adults in the US, or almost 700,000 
people between the ages of 18 and 64, identify as transgender (Gates, 2011).  However, the total 
number is unknown, due in part to a lack of data collection on gender identity in population-
based surveys (e.g., US Census and the National Health and Nutrition Examination Survey; 
NHANES). The following presents, current medical, psychological, social, and political 
perspectives on transgender identities to contextualize the environment transgender and non-
binary individuals navigate to exist in the world. 
Current Medical and Psychological Perspectives 
 Given the nascent field of transgender health, current medical and psychological 
perspectives are continually evolving. No scientific evidence exists as to the etiology of the 
transgender phenomena. Current guidelines and recommendations for the medical and 
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psychological treatment of transgender individuals contain the same core recommendations from 
the 1979 initial recommendations (Berger, Green, Laub et al., 1979), which were based solely on 
anecdotal experiences of the pioneers in the field not scientific evidence.   No studies have been 
conducted to test the current criteria's impact on post-treatment satisfaction outcomes, or 
complications (Deutsch, 2016).  Transgender and gender non-conforming individuals must fulfill 
certain procedure specific criteria as described by the current guidelines in order to receive 
gender affirming care, including hormone therapy and surgery.   Yet, there is no consensus as to 
who is a “qualified” candidate and no formal training exists (Deutsch, 2016).  This leaves 
transgender and gender non-conforming individuals in a powerless position, whose care lies 
solely on the subjective expertise of medical and mental health practitioners who determine who 
is “deserving” or “worthy” enough for treatment. Furthermore, this dynamic shifts the focus of 
the doctor/patient relationship to gatekeeper rather than health care partner.  
 To address the barriers to transgender affirming care, LGBT specific medical and mental 
health providers are developing new models of care (Callen-Lorde Community Health Clinic, 
2012; Reisner et al., 2015). However, none of these models have been evaluated or tested. The 
most common practice addressed in these new models regards access to cross-sex hormone 
where an informed consent model is being adopted, which removes the need for prolonged 
mental health evaluations and “real life tests” (i.e., living full-time in one’s self-identified 
gender) to obtain hormone therapy.  For example, in this model, individuals wishing to initiate 
hormones would meet with medical staff first who would discuss the medical effects of cross-sex 
hormones, present the risks and benefits, as well as inform patients based on clinical knowledge 
and limited research the types of physical changes that will occur. Referrals for counseling are 
offered to provide support for navigating the psychological and social impact of transitioning.   
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By addressing the medical aspects first, the hope is to depathologize the transitioning experience 
for transgender and gender non-conforming individuals. These practitioners view gender 
affirming care as a holistic practice one that should not start off by forcing transgender and 
gender non-conforming individuals to prove that their biological sex and internal sense of gender 
are different.     
Gender Dysphoria 
 During the preparation of the 5th edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-V), a contentious debate arose as to whether the new edition should 
continue to include and categorize gender identity disorder (GID) as a mental illness (Vance et 
al., 2010).  Before this new edition, the core indicators of GID were the combination of 
identification with the other gender, and a sense of inappropriateness, or outright rejection, of 
one’s sex assigned at birth (American Psychiatric Association, 1994).     
 Some scholars have drawn similar parallels between the debates of GID and the DSM 
and those, which led to the removal of homosexuality from the DSM in 1973 (Meyer-Bahlburg, 
2010). Before the DSM-III, homosexuality was believed to be a pervasive mental illness (Bayer, 
1981). The lack of scientific evidence for homosexuality as psychopathology launched a protest 
movement against its classification as a mental disorder (Meyer-Bahlburg, 2010). Psychiatrists 
declared that homosexuality was a “normal variant” of sexual identity and that individuals who 
were gay or lesbian were both high functioning and satisfied with their sexual orientation (Bayer, 
1981).   Given that "impairment" and "distress" were defining features of a "mental disorder," 
these insights provided the foundation for resolution approved by the American Psychiatric 
Association to remove homosexuality from the DSM in December 1973 (Bayer, 1981).   
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 Historically, cross-gender identification has been seen as a pervasive mental illness 
(Siomopoulos, 1974).  Over the past twenty years, there has been growing recognition that 
transgender individuals are not mentally ill (Meyer-Bahlburg, 2010). A prominent activist 
movement has emerged, which includes a growing school of mental health professionals (some 
of whom are transgender) who view gender as fluid and do not consider cross-gender 
identification a form of mental illness (Brill & Pepper, 2008; Hill et al., 2007; Lev, 2005; Moser 
& Kleinplatz, 2005; Perrin, 2002). Also, recognition that lesbian, gay, bisexual, transgender and 
gender non-conforming individuals experience extensive societal stigma, which in many cases 
may increase psychological distress (Alanko, et al., 2009; Lombardi, Whilchins, Priesing, & 
Malouf, 2001; Meyer & Northridge,2007; Nuttbrock et al., 2009; Ryan, Huebner, Diaz & 
Sanchez, 2009; Winter, 2009) has helped to contextual the social, emotional, and cultural factors 
impacting this community’s mental health.    
 Unlike individuals who are gay, lesbian, or bisexual, transgender and gender non-
conforming individuals may wish to change their legal gender status to the other desired gender, 
as well as align their body with their desired gender by the use of cross-gender hormones or 
surgery. In the United States, legal regulation for government action and insurance coverage 
require the recognition of a clinical or psychopathological condition that is attested to by a 
professional specialist (Currah, Juang, & Minter, 2006; Currah, Green, & Stryker, 2009; Khan, 
2011). In the arguments for and against the inclusion of GID some key issues came to light, 
including 1) whether or not gender variance is a pathological condition or "natural" variation? 2) 
how are the criteria for GID as a mental disorder defined? 3) is the psychological distress 
associated with gender variance primarily a function of social stigma or is it inherent to gender 
variance itself? 4) does the label of mental disorder serve as an additional source of stigma? 5) is 
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the use of hormones and surgery a psychiatric treatment? 6) how can gender affirming mental 
health and medical care be justified if “GID” is removed from the DSM and gender non-
conformity considered a normal variation? (American Psychological Association Task Force on 
Gender Identity and Gender Variance, 2008; Ault & Brzuzy, 2009; Meyer-Bahlburg, 2010).  
These questions address essential areas for researchers, clinicians, and policy advocates 
investigate with the goal of enhancing access to health care for transgender and gender non-
conforming individuals as well as reducing the pervasive impact of stigma and discrimination.   
 While, GID was removed from the DSM-V (American Psychiatric Association, 2013) it 
was replaced by Gender Dysphoria. The American Psychiatric Association (2013), stated that 
while the DSM is used to define and diagnosis mental disorders, it also impacts how people see 
themselves and others.  Furthermore, while diagnostic terms facilitate care and access to 
insurance coverage that supports mental health, the APA (2013) also acknowledged how terms 
have a stigmatizing effect.  The hope in replacing the term disorder with dysphoria was to also 
remove the stigma associated with being disordered. What is clear from the APA’s statement is 
that the decision to include gender dysphoria was for the need to protect transgender individuals 
access to care, given that many treatment options including cross-sex hormones, gender 
reassignment surgery, and social and legal transition to one’s desired gender are currently 
contingent on obtaining a diagnosis.    
Models of Transgender Identity Development  
 Scholars attempting to articulate a coherent model of transgender and/or transsexual 
identity development almost exclusively draw from literature on the gay and lesbian “coming 
out” process (Coleman, 1982; Cass, 1979, 1990, 1996; Troiden, 1988, 1989). Within these 
models an assumption is made that transgender and/or transsexual identities are formed through 
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a predetermined series of stages that begin in adolescence or early adulthood and culminate in a 
healthy and integrated transgender/transsexual identity (Eliason & Schope, 2007 & Devor, 2004; 
Nuttbrock et al., 2002). Although no developmental model applies to every individual, most 
stage models of transgender identity development aim to explain transgender identity 
development of all or most transgender individuals (Devor, 2004; Eliason & Schope, 2007; 
Gagne, Tewksbury, & McGaughey, 1997). Most stage models include at least three broad stages: 
1) awareness and confusion about gender identity, 2) exploration and testing, and 3) integration 
of transgender and/or transsexual identity (‘coming out’) (Bockting & Coleman, 2007).  
According to these models, transgender individuals should be able to transition successfully to 
the opposite gender, most often via medical intervention, ‘come out’ to family and friends, and 
integrate their “new” gender identity with other aspects of their identities (Bockting & Coleman, 
2007; Devor, 2004).  These outcomes are considered markers of a successful gender transition 
and, once they are achieved, the resulting identity is largely resistant to change. Although stage 
models provide important insights they cannot account for differences in transgender identity 
development across race, ethnicity, age, social class and gender. The reliance on a linear 
sequential account of a developmental process that can be fluid does not attend to the 
development of intersecting identities that may be inseparable from one’s transgender identity.   
 There is a small but growing body of research and theory development offering 
alternative understandings of transgender identity based on the claim that this developmental 
process has no universal endpoint, interacts with, and is influenced by contextual factors.  For 
example, Bilodeau and Renn (2005) in a study of transgender identity formation among college 
students adapt D’Augelli’s (1994) lifespan approach to sexual identity development, which 
suggests that sexual orientation can be fluid at certain times in the lifespan or more fixed at 
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others. Suggesting that human growth is intimately connected to and shaped by environmental 
and biological factors. Another conceptual model developed by Denny et al. (2004) attempts to 
deemphasize the rigid gender binary that characterizes conventional models of gender identity 
development, and instead presumes the existence of parallel gender continuums inclusive of 
male and female dimensions. According to this model, individuals can strongly identify with 
both male and female dimensions or with neither (Denny et al., 2004). In addition, rather than 
positing a single modal developmental pathway, it posits the existence of multiple, 
individualized trajectories. A third approach emphasizes the fluidity and malleability of 
transgender identity (Diamond, Pardo, Butterworth, 2011). The researchers propose applying 
dynamic systems theory (Thelen & Smith, 1994) to transgender identity development which is 
characterized by non-linear changes and view identity development as a process which is 
continually constructed and reconstructed over time, rather than achieved with an absolute 
finality (Diamond, Pardo, Butterworth, 2011). These recent additions to conceptualizing 
transgender identity development have attempted to improve upon traditional stage models.  
However, they ignore how transgender identity development intersects with other aspects of 
social and developmental experience such as culture, race, ethnicity, sexuality, and 
socioeconomic status.  These contextual factors are important to understanding the sociocultural 
lives of transgender women and in particular, transgender women of color.   
Cisgenderism 
 The term cisgender was first used as a descriptive category to distinguish non-transgender 
people from transgender and gender non-conforming individuals (Edelman, 2009; Serano, 2007).  
More recently, a new conceptualization of cisgender termed cisgenderism has emerged.  
Cisgenderism (Ansara and Hegarty, 2012; Ansara and Hegarty, 2014; Lennon and Mistler, 2014) 
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refers to the cultural and institutional ideologies that deny, pathologize, or delegitimize gender 
variance by refusing to acknowledge or accept that natal sex can differ from one’s social and 
psychological gender. Thus, cisgenderism endorses and perpetuates the belief and practice that 
people’s biological sex, psychological, social, and legal genders are connected and binary, and 
that any deviation from this is abnormal (Lennon & Mistler, 2014; Lombardi, 2007). For 
example, sex segregation by sex assigned at birth within the prison or shelter system is a form of 
cisgenderism, which prioritizes natal sex over self-identified gender identity. The very nature of 
cisgenderism is to create systems that contribute to the erasure of transgender identities and 
bodies. By systematically rendering transgender and non-binary individuals invisible, they not 
only do not exist, but are unable to access basic life necessities (e.g., access to public bathrooms, 
housing, employment, education) cisgender individuals take for granted.        
 Transgender-Related Stigma and Discrimination   
 A growing body of evidence points to the multitude of challenges affecting the quality of 
life of gender minority populations, including poverty, violence, incarceration and routine 
discrimination in housing, employment, educational, health care and social service settings 
(Grant et al., 2011; Khan, 2011; Lombardi, Wilchins, Priesing, & Malouf, 2001; Nemoto, 
Bödeker, & Iwamoto, 2011; Reisner, Bailey, & Sevelius, 2014; Testa et al., 2012). For example, 
the National Transgender Discrimination Survey (Grant et al., 2011), the first comprehensive 
survey in the US examining the pervasiveness of transgender discrimination found that sixty-
three percent (63%; N=6,456) of respondents reported experiencing a severe act of 
discrimination, which was defined as an event that would have a significant impact on a person's 
quality of life and ability to sustain themselves financially or emotionally.  Examples of 
discrimination included loss of job due to bias, eviction due to bias, school bullying/harassment, 
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teacher bullying, physical and sexual assault due to bias, homelessness because of gender 
identity/expression, and loss of relationship with a partner or child due to gender 
identity/expression. Furthermore, twenty-three percent (23%) of participants stated that they had 
experienced at least three of the major life events in their lifetime.  While pervasive 
discrimination was reported throughout the sample, particularly devastating were the combined 
effects of anti-transgender bias and structural racism.  People of color, reported higher rates of 
discrimination compared to White participants, with African-American respondents experiencing 
the highest incidents of discrimination.     
Research has demonstrated that many risks to the physical, emotional, and social health 
of transgender and gender non-conforming individuals are related to social stigma and negative 
societal response towards gender non-conformity (Bradford, Reisner, Honnold, & Xavier, 2013; 
Clements-Nolle, Marx, Guzman, & Katz, 2001; Clements-Nolle, Marx, & Katz, 2006; Grant et 
al., 2011; Herbst et al., 2008; Nuttbrock et al., 2012; Testa et al., 2012; Wilson et al., 2009; 
Xavier, Bobbin, Singer, & Budd, 2008).  Much of this research has focused on stigma and 
discrimination at the structural level (i.e., policies, social norms and behaviors within institutions 
and social structures that are unjust towards transgender people). For example, several studies 
have documented stigma and discrimination against transgender individuals in healthcare 
settings, and its impact on the community's ability to access safe and supportive health services 
(Bradford, Reisner, Honnold, & Xavier, 2013; Goldblum et al., 2012; Grant et al., 2011; 
Operario, Yang, Reisner, Iwamoto, & Nemoto, 2014; Testa et al., 2012).    
Data consistently suggests that transgender and gender non-conforming individuals are at 
unusually high risk for a host of adverse health outcomes, including HIV infection, substance 
misuse, depression, and suicide (Baral et al., 2013; Benotsch et al., 2013; Clements-Nolle, Marx, 
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Guzman, & Katz, 2001; Clements-Nolle, Marx, & Katz, 2006; Goldblum et al., 2012; Haas & 
Rodgers, 2014; Herbst et al., 2008; Neilands, & Sevelius, 2013; Keuroghlian, Reisner, White, & 
Weiss, 2015; Reisner, Gamarel, Nemoto, & Operario, 2014; Resiner, Pardo, Gameral, Pardee, 
Keo-Meier, 2015). For example, in the general population, the rate of suicide is between 1-6% 
(Kessler, Borges, & Walters, 1999; Nock & Kessler, 2006; Nock et al., 2008).  These rates are 
higher among lesbian, gay, and bisexual (10-20%) individuals (Paul et al., 2002). Increased risk 
for suicide among the LGB community has been linked to the social stigma, prejudice, and 
discrimination associated with being a sexual minority (Haas et al., 2011; Suicide Prevention 
Resource Center, 2008). LGB persons commonly experience discrimination at both the 
individual-level (e.g., interpersonal rejection, including family rejection, harassment, and 
physical violence) (Meyer, 2003; Meyer et al., 2007; Ryan, Huebner, Diaz, & Sanchez, 2009) 
and the institutional-level (e.g., laws and public policies that create inequities or fail to provide 
protections for sexual minorities) (Buchmueller & Carpenter, 2010; Hatzenbuehler, 2010; Heck, 
Sell, & Gorin, 2006; Ponce, Cochran, Pizer, & Mays, 2010). 
Among transgender populations, these rates of suicide are even higher, estimated to be 
between 25% and 43%) (Clements-Nolle et al., 2006; Goldblum et al., 2012; J. L. Haas & 
Rodgers, 2014b; Moody & Smith, 2013; Xavier et al., 2008). Clements-Nolle, Marx, and Katz 
(2006) conducted a study of a non-random sample of transgender-identified individuals living in 
San Francisco. The study assessed whether the discrimination and victimization transgender 
individuals experience were independently associated with attempted suicide after controlling for 
known risk factors such as substance abuse, physical and sexual abuse, and depression.  Thirty-
two percent (32%) of participants reported having ever attempted suicide, with equal rates 
between MTF and FTM respondents. The study found that younger age, unemployment, 
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depression, substance abuse, and a history of forced sex were individual risk factors significantly 
associated with suicide (Clements-Nolle et al., 2006). Additionally, societal risk factors such as 
gender-based discrimination and victimization were independently associated with attempted 
suicide. 
Goldblum and colleagues (2012) examined the relationship between gender-based 
victimization and suicide attempts among a sample of transgender individuals in Virginia. Of the 
total sample (N=290), 28.5% reported a history of suicide attempts. Among these respondents, 
32.5% reported having made one attempt, 28.6% reported a history of two attempts, and 39% 
reported having made three or more attempts.  Transgender men reported the highest rates of 
suicide attempts (32.1%), while transgender women reported a suicide attempt rate of 26.5%.  
Additionally, 33% of participants under the age of 45 reported a history of suicide attempt, 
compared to older respondents who reported significantly lower rates (19%; 45-54 and 6.9% 55 
and older). Furthermore, of the total sample, those who reported experiencing gender-based 
discrimination or violence (44.8%) were almost four times as likely to endorse making a suicide 
attempt as those who had not experience gender-based discrimination or violence.   
Lastly, a needs assessment of transgender people of color living in Washington D.C., 
conducted by Xavier, Bobbin, Singer, and Budd (2008) highlighted how transgender people of 
color are at increased risk for suicidality, substance abuse, and HIV risk behaviors. Of the total 
sample (N=248), 38% reported suicidal ideation, and 16% had made a suicide attempt (Xavier et 
al., 2008).  Among those reporting suicidal ideation, 63% of these individuals attributed it to 
their transgender status (Xavier et al., 2008). Although transgender men were more likely to 
report suicidal ideation, transgender women were more likely to attribute suicidal ideation to 
their gender identity (Xavier et al., 2008). 
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Furthermore, the few existing studies demonstrate that transgender people have a 
significantly elevated prevalence of alcohol and illicit drug use compared to the general 
population, and that misuse is associated with experiences of gender-based violence and 
discrimination (Benotsch et al., 2013; Testa et al., 2012).  Benotsch and colleagues (2013) 
recruited 155 transgender individuals from a transgender health clinic in Virginia. Overall, 
26.5% of the sample reported lifetime non-medical prescription drug use, including opiate 
painkillers (23.9%), benzodiazepines (17.4%), stimulants (13.5%), and sleeping aids, such as 
Ambien (8.4%) (Benotsch et al., 2013). Participants who reported lifetime non-medical 
prescription drug use were significantly more likely to report recent use of recreational drugs, 
including alcohol (72.5%), marijuana (62.5%), poppers (15.4%), ecstasy (20.5%), cocaine 
(15.4%), methamphetamine (10.3%), and heroin (10.3%). Additionally, participants who 
reported experiencing transgender-related discrimination were significantly more likely to report 
non-medical prescription drug use (Benotsch et al., 2013). 
 Testa and colleagues (2012), examined whether there was a relationship between 
exposure to physical and sexual violence and substance abuse in a sample of transgender 
individuals. Participants were recruited through transgender service organizations and over the 
Internet. Overall, a substantial portion of the sample reported being victims of past physical 
(38%) or sexual (26.6%) violence.  The study found that a history of experiencing sexual 
violence was associated with a history of alcohol abuse in transgender women and transgender 
men. Additionally, transgender women who experienced sexual violence were significantly more 
likely to report past illicit substance use as compared to those who had not experienced past 
violence.   
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Lastly, studies have linked minority stress theory (Meyer, Schwartz, & Frost, 2008; 
Meyer, 2003) with adverse health - related outcomes in transgender and gender non-conforming 
adults, including HIV infection, suicide (Clements-Nolle et al., 2006; Goldblum et al., 2012; 
Haas & Rodgers, 2014; Moody & Smith, 2013; Testa, Jimenez, & Rankin, 2014), substance 
misuse (Keuroghlian,Reisner, White, & Weiss, 2015; Operario et al., 2014; Reisner, Gamarel, 
Nemoto, & Operario, 2014; Xavier et al., 2008), depression, and experiencing transgender-
related violence (Bauer et al., 2009; Grant et al., 2011; Khan, 2011; Lombardi, 2007, 2009; 
Lombardi, Wilchins, Priesing, & Malouf, 2001; L. Nuttbrock et al., 2012; Reisner, Bailey, et al., 
2014). The most commonly documented experiences of gender minority related stress for 
transgender and gender non-conforming individuals surround external events that occur in the 
person’s environment and are related to either knowledge or perception of their transgender or 
gender non-conforming status (Testa et al., 2012). Surveys have consistently documented that 
transgender individuals report high levels of both physical and sexual violence related to 
transphobia, with 43% to 60% of transgender individuals having experienced physical violence 
and between 43% and 46% reporting having experienced sexual violence (Clements-Nolle, 
Marx, & Katz, 2006; Kenagy & Bostwick, 2005; Lombardi, Wilchins, Priesing, & Malouf, 2001; 
Xavier, Bobbin, Singer, & Budd, 2005).  
Transgender as a Social Problem 
Criminalization of Transgender Identities  
Until the mid-1970’s and 1980’s, policing gender took the form of enforcement of laws, 
which required individuals to wear at least three articles of clothing associated with their sex 
assigned at birth or risk incarceration for impersonating the opposite gender (Craig, 2007).   
During the late nineteenth century, municipalities in the United States began enacting cross-
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dressing laws (Capers,2008; Franke, 1995; Stryker, 2007). However, little historical research 
exists surrounding the origins of such laws. Scholars have drawn parallels between the 
formations of the gay and lesbian community, which emerged with the rise of industrialization 
and the migration of mostly single men to cities where an industrial economy had created wage-
paying jobs (D' Emilio, 1998; Meyerwitz, 2002; Stryker, 2007).   The anonymity of city living 
coupled with an independence from one’s family provided the social environment for gay 
communities to develop (Stryker, 2007).  At a time when sexual orientation and gender variance 
fell under the same broad category, cities might have been prompted to create laws to regulate 
and control gender and sexual deviance (Capers, 2007; Mogul, Ritchie, & Whitlock, 2011). 
Cross-dressing laws did not just affect effeminate men and masculine women, it signaled to 
everyone the type of dress and behavior that was appropriate. Men and women must both behave 
and dress in a manner that was congruent to their biological sex. The division between men and 
women must be readily visible and maintained.   
 In the United States, crossdressing laws were overturned beginning in the 1970’s through 
the 1980’s (Meyerwitz, 2002; Mogul, Ritchie, & Whitlock, 2011; Stryker, 2007).   However, 
these laws have contributed to the lasting image that transgender and gender transgressive 
individuals are inherently criminal (Capers, 2007). Individuals whose appearance, dress, or 
behavior conflicts with cisgender expectations of sex and gender continue to be punished by law 
enforcement under a set of unwritten laws which when violated, signal disorder or fraud (Mogul, 
Ritchie & Whitlock, 2011).  Today, gender is often policed by arbitrary and violent arrests of 
transgender and gender non-conforming people for using the "wrong" restroom.  Most recently, 
anti-transgender bathroom legislation has either been passed (North Carolina, Mississippi, 
Kansas) or proposed (Michigan, Washington, Texas), these laws would or do make it illegal for 
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transgender and gender non-conforming people to use a bathroom that is different from their sex 
assigned at birth (NCTE, 2016). These laws are punishable by imprisonment if an individual is 
presumed to be transgender or gender non-conforming. 
From Individual Problem to Public Issue  
Due to increased media coverage on transgender issues, including the public transition of 
several prominent celebrities, the success of the television show Transparent, and most recently 
the political and economic response to the anti-transgender bathroom laws, there has been a shift 
in the public discourse as to whether or not the social, psychological, health, and economic issues 
transgender and gender non-conforming individuals face are a significant issue in need of 
government response. Without political and social capital, transgender communities are often not 
in the position to garner support for themselves, which is particularly true for transgender and 
non-binary people of color, and those dealing with multiple levels of oppression.  The current 
political climate regarding transgender issues provides a real-time example of how a social 
problem moves from personal trouble to a public issue (Wright Mills, 1959).  Manning (1987) 
states that when an individual problem becomes a typical experience for many, it moves into the 
realm of a public problem rather than solely an issue located within the person.  Simply put, 
everyone can relate to needing to use the restroom, and this is precisely why the "bathroom 
issue" has resonated with the American public.     
Size and responsibility are at the heart of any discussion on social problems, the use of 
the word “social” implies something larger than individual experience (Manning, 1987).  While 
the current discourse on bathrooms is important, the movement towards “transgender” as a social 
issue rather than an individual problem is evident in the historical and contemporary perspectives 
discussed above. From the dominant medical and psychological theories on cross-gender 
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identification, which viewed gender variance as an individual problem that was either 
biologically based or a result of one’s inability to conform to societal gender norms.  To the 
increased medical authority and power to regulate who is truly deserving of changing their sex; 
the criminalization of gender non-conformity, which sought to uncover those who were 
masquerading or worse deceiving unknowing “normal” individuals into believing they were a 
gender they were not; and to the rise of the politicized and visible transgender movement of late 
twentieth century, which not only challenged the predominant medical and psychological 
theories but brought attention to the social, emotional, and economic issues faced by this 
community. These combined efforts contribute to the national attention transgender, and gender 
non-conforming people are receiving today. 
Furthermore, increased visibility has raised awareness to the persistent and often severe 
forms of discrimination and violence the transgender and gender non-conforming community 
face on the individual, community, and structural level.  Public discourse for and against 
transgender rights has grown exponentially, due in part to the creation of federal, state, and local 
anti-discrimination legislation that attempt to address the social, emotional, physical, and 
economic needs of the transgender and gender non-conforming community (Transgender Law 
Center, 2016). While there is currently no federal comprehensive civil rights bill protecting 
transgender and gender non-conforming community, anti-discrimination policies are being 
enacted to protect transgender individuals in employment settings, when accessing public 
accommodations, identification documents, health care, housing, credit, education, and federally 
funded programs (Transgender Law Center, 2016). These policies seek to address, the economic 
loss associated with a lack of job protection, the psychological effects of being a stigmatized and 
marginalized community living without equal rights, and the health of transgender and non-
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binary individuals who are more likely to be uninsured or underinsured due to discriminatory 
policies and practice in the health care system (NCTE, 2016). Current government response has 
legitimated transgender and gender non-conforming people as deserving of equal protection.  
Despite, a growing anti-transgender social, economic, and political movement that wishes to 
uphold conventional ideas about gender and sex.   
Conclusion 
 The historical ideologies on cross-gender identification continue to influence 
contemporary beliefs regarding the transgender and gender non-conforming community.   
Current societal beliefs still view biological sex and gender as connected, binary, and immutable.  
A person is either male or female, and individuals whose gender identity is different from their 
biological sex or those whose gender representation does not align with societal gender norms 
are often punished for failing to present their gender in a socially appropriate manner.   Those 
who fall outside or between the gender binary, are expected to conform or risk being stigmatized, 
ostracized, and socially rejected. Within this context, transgender and gender non-conforming 
individuals must navigate significant obstacles to live. The rise of a transgender movement has 
propelled the social, emotional, economic, and political needs of this community forward. While 
the magnitude of the transgender community is unknown, the experiences of violence and 
discrimination are well documented, and national public discourse has begun to discuss how to 
best address these issues. Contextualizing the historical and contemporary perspectives on 
transgender identities situates the facilitators and barriers to PrEP among transgender women at 
risk for HIV within a broader context.  The following chapter presents the theoretical concepts 
guiding the design of this dissertation. 
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CHAPTER 3: THEORETICAL CONCEPTS OF STIGMA AND DISCRIMINATION 
AND GENDER AFFIRMATION 
Introduction  
 This dissertation integrates theories of stigma and discrimination (Link and Phelan, 2001) 
and the Gender Affirmation Framework (Sevelius, 2013) to examine the facilitators and barriers 
to pre-exposure prophylaxis (PrEP) access, adoption, and adherence among transgender women 
at risk for HIV acquisition. First, I apply theories of stigma and discrimination to a socio-
ecological model (Baral et al., 2013; Link and Phelan, 2001), which conceptualizes structural, 
interpersonal, and individual level barriers to health care access and utilization among 
transgender and gender non-conforming individuals as an outcome of transgender-related stigma 
and discrimination. This model posits that access to gender-affirming health care, which includes 
PrEP is necessary to facilitate PrEP access, adoption and adherence among transgender women.  
Second, I utilize the gender affirmation framework to contextualize HIV risk as a social and 
psychological process rather than solely a byproduct of behavior. The gender affirmation 
framework (Sevelius, 2013) proposes that HIV risk among transgender women is a consequence 
of social oppression, whereby transgender women find themselves in high-risk contexts where 
HIV risk increases due to the social and emotional impact of stigma and discrimination at the 
individual, community, and institutional level. To understand potential facilitators and barriers to 
PrEP for transgender women it is imperative to examine the contextual factors that contribute to 
HIV risk for this community. 
Stigma and Discrimination  
 Stigma refers to the negative regard, inferior status, and relative powerlessness that 
society collectively assigns to individuals and groups that are associated with various conditions, 
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statuses, and attributes (Link & Phelan, 2001).  As discussed above, transgender and gender non-
binary people routinely face stigma and discrimination due in part to their gender non-
conformity and these experiences are associated with adverse health outcomes.  Due to stigma 
and discrimination at the structural, interpersonal, and individual level, transgender and non-
binary individuals experience barriers to health care - whether they seek preventive routine, or 
emergency care, mental health and social services; or transition-related care (Bauer et al., 2009; 
Feinberg, 2001; Grant et. al, 2011; Lombardi, 2007, 2011 ). Transgender and non-binary people 
are regularly denied access to health care and social services and must navigate serious obstacles 
when accessing care (Bauer et al., 2009; Clements-Nolle et al., 2001; GLBT Health Access, 
2000; Kenagy, 2005; Lombardi, 2001, 2011; Grant et al., 2011; Shipherd et al., 2010; Snelgrove, 
Jasudavisius, Rowe, Head, & Bauer, 2012). For example, transgender and gender non-binary 
individuals report experiences of discrimination from staff and medical providers, including 
misgendering, refusal to use or even ask a person's gender pronoun or name, insurance practices 
which do not cover transition-related care, and a lack of providers who are willing and competent 
to provide services to this community.  While, many of these barriers can be traced to 
transgender-based stigma, for individuals who claim multiple identities experiences of stigma 
and discrimination due to race/ethnicity, socioeconomic status, age, and immigration status 
create additional barriers to accessing vital health care services. Additionally, a lack of research 
on provider side barriers to transgender care fails to view health care providers as integral to the 
success of creating a safe and inclusive health care system. 
Structural Stigma 
 Structural or institutional stigma is the manifestation of stigma within the institutions of 
society (Link & Phelan, 2001). Within the healthcare system structural stigma against 
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transgender and gender non-conforming individual’s manifests as cisgenderism (Ansara and 
Hegarty, 2012; Ansara and Hegarty, 2014; Lennon and Mistler, 2014), which is the cultural 
ideology embedded in institutional practices that refuse to acknowledge self-identified gender 
identity. It is important to note that structural stigma can occur in the absence of individual 
prejudice or discrimination(Link & Phelan, 2001). The healthcare system justifies and 
perpetuates cisgenderism in two ways. First, is the assumption that gender and biological sex are 
connected, binary, and immutable. We are either male or female. One's sex (gender) 
determination is based on external genitalia. This belief renders transgender and non-binary 
people invisible within a two-gender healthcare system. When gender nonconformity becomes 
visible, transgender and non-binary people are often labeled or diagnosed with a psychological or 
psychiatric disorder. Within a health care system predicated on cisgenderism, structural barriers 
include: health insurance practices that limit the types of care covered for transgender and gender 
non-conforming individuals (e.g., insurance companies view gender reassignment surgery as 
cosmetic will often not cover it); the cost of gender confirming procedures (e.g. gender 
reassignment surgery, hormones); lack of training for providers in transgender health; and 
institutional policies and practices that create unsafe environments for transgender and gender 
non-conforming individuals to receive care (Bauer et al., 2009; Lombardi, 2001, 2007; Snelgrove 
et al., 2012).  
Informational Systems 
A lack of consistent information on the social, emotional, and physical health needs of 
transgender and non-binary individuals dramatically affects the community’s access to health 
care services (Bauer et al., 2009; GLBT Health Access, 2000; Kenagy, 2005;  Lombardi, 2001, 
2007, 2011).  When information is produced, it is often not incorporated into textbooks and 
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educational curricula for individuals in the medical and psychology field (Bauer et al., 2009; 
Lombardi, 2001, 2007, 2011; Snelgrove et al., 2012).  Furthermore, the specific needs of 
transgender people are often omitted or incorrectly equated with the needs of the lesbian, gay, 
and bisexual community (Bauer et al., 2009; Lombardi, 2001, 2007).  For example, research on 
PrEP has consistently lumped transgender women and cisgender men who have sex with 
cisgender men (MSM) together (Sevelius et al., 2016).  This process not only contributes to the 
erasure of the social, emotional, physical and sexual health needs of transgender women it 
conflates gender identity with sexual orientation. 
Locating a knowledgeable provider. Finding a health care provider who is 
knowledgeable of the psychosocial and health care needs of the transgender and gender non-
conforming community is the most commonly reported barrier to care (GLBT Health Access, 
2000; Kenagy, 2005; Lombardi, 2001, 2007, 2011; Grant et al., 2011; Sanchez et al., 2009). 
Once an individual locates a provider, they often find themselves in the role of the educator 
(Bauer et al., 2009; GLBT Health Access, 2000; Kenagy, 2005; Lombardi, 2001, 2007).  A 
limited number of providers are able and willing to treat transgender and gender non-conforming 
people, which makes it difficult to secure appointments for both transition-related and routine 
medical care. Studies have found that gender affirming providers are located primarily within 
urban areas, which creates an enormous barrier to care for individuals living in rural areas (Bauer 
et al., 2009; GLBT Health Access, 2000; Kenagy, 2005; Lombardi, 2007; Snelgrove et al., 
2012).  Due to geographic location, individuals may need to travel far distances to find an 
accommodating provider.  Further, due to a scarcity of providers, transgender and gender non-
binary people are limited in the number of providers to choose from (Bauer et al., 2009; GLBT 
Health Access, 2000; Kenagy, 2005; Khan, 2013; Lombardi, 2001, 2007; Snelgrove et al., 2012).   
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The lack of trained healthcare providers is due in part to the failure of most medical schools and 
health care institutions to prepare their students and staff on transgender care (Makadon, 2008; 
Obedin-Maliver et al.; Solursh et al., 2003).  For example, Obedin-Maliver, et al. (2011), 
distributed an internet-based survey to administrators of medical education at 148 allopathic 
medical schools (17 Canada, 131 United States) and all 28 osteopathic medical schools in the 
United States to assess the number of hours of LGBT – related content hours in the medical 
curricula. Of the 176 medical schools, 132 (75%) completed the entire questionnaire. The 
median number of curriculum hours dedicated to LGBT related care was five.       
Physician barriers. The absence of transgender-related medical education is the barrier 
most often cited by providers who report that insufficient training and exposure to transgender 
patients impacts their ability to provide appropriate medical care to transgender individuals 
(Lurie, 2005; Poteat et al., 2013; Snelgrove et al., 2012).  Despite internationally recognized 
standards of care published by the World Professional Association for Transgender Health 
(WPATH), providers are often not aware of available and reliable sources to assist them in 
providing care.  Snelgrove et al. (2012) found that providers reported a need for readily 
accessible information whether through the Internet, academic journals, Internet sites endorsed 
by a professional medical organization, and Continuing Medical Education (CME) conferences.   
Finding “trans-friendly” colleagues for referral outside of one’s scope of practice is also difficult 
for many providers (Snelgrove et al., 2012), and, if a provider is located, there are concerns 
about a colleague’s lack of knowledge, sensitivity, and availability.  The lack of qualified and 
affirming medical care is particularly evident for gender-affirming surgeries given the highly 
specialized skill set required for these procedures.  For example, studies have found that 
depending on the specific procedure; a significant barrier exists when trying to locate a surgeon 
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capable of performing gender-affirming surgeries within a specific geographic location (Poteat, 
2013; Snelgrove et al., 2012).  
Institutional Barriers 
 Institutional barriers to health care are policies and procedures that do not accommodate 
and acknowledge transgender identities and bodies. Studies have posited that health care barriers 
at the structural level are an outcome of a two-gender medical system (Lombardi, 2009; Poteat, 
2013; Snelgrove, 2012; White, Reisner, & Pachankis, 2015). At the institutional level these 
barriers manifest as systemic failures in recognizing and accommodating the health care needs of 
transgender patients. Sex-specific eligibility criteria for certain procedures, screening tests, or 
therapies often prevent adequate healthcare for transgender patients. Health system level barriers 
occur when providers are unable to order a test or offer treatment to a patient because of sex-
specific eligibility criteria (Snelgrove, 2012). Additionally, billing systems and health insurance 
providers will only allow sex-specific procedures to be paid when an individual is designated 
that sex (GLBT Health Access, 2000; Khan, 2011; Sanchez et al., 2009; Snelgrove et al., 2012, 
White-Hughto, Reisner, & Pachankis, 2015).  Examples include the inability to bill for a 
hysterectomy for a male patient or a prostate related procedure for a female patient.  
Health Insurance. Lack of health insurance is a major structural barrier to healthcare for 
many Americans and for transgender and gender non-conforming people in particular. The 
National Transgender Discrimination Study (2011) found that study participants were less likely 
than the general population to have health insurance or be insured by an employer and more 
likely to be covered by public programs such as Medicare or Medicaid. Economic 
disenfranchisement, employment discrimination, underemployment, and non-recognition of 
marriages result in a disproportionate number of transgender and gender non-conforming people 
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who are uninsured (Conron et al., 2012; Grant et al., 2011; Lombardi, 2011). If an individual is 
insured, most are denied insurance coverage for transgender-specific health care, such as 
hormone therapy or gender reassignment surgery (Bauer et al., 2009; GLBT Health Access, 
2000; Kenagy, 2005; Khan, 2011).  Most private and public insurance plans contain explicit 
exclusions for transgender-related care (Khan, 2011).  Additionally, in the event that an 
insurance company is aware of a person’s transgender identity, non-transition related care has 
been denied and attributed to a symptom of their gender transition (GLBT Health Access, 2000; 
Khan, 2011; Lombardi, 2007, 2011). Transgender and gender non-conforming individuals who 
do not have access to insurance are forced to pay out of pocket for gender-affirming procedures, 
which are often cost prohibitive (Khan, 2011). From the perspective of the insurer, transgender 
and gender non-conforming individuals do not have an insurable interest (Khan, 2011).  
Transgender and non-binary individuals are often seeking coverage for what is termed "a pre-
existing" condition that is believed to be expensive to treat. Since gender non-conformity or 
transgender individuals have historically have little social and political power, health care for 
transgender individuals does not provoke the popular sympathy or support that common medical 
conditions garner. Insurers can deem gender-affirming care as medically unnecessary without 
experiencing public or political backlash (Khan, 2011). Within this context, transgender and non-
binary individuals unable to afford medically necessary care, resort to the use of street hormones 
or illegal silicone injections, acquired through friends or online (Grossman & D'augelli, 2006; 
Sanchez et al., 2009). Due to a lack of regulation, there is little known information as to the 
contaminants that are found in street hormones (Coleman et al.,2012; Nemoto, et al., 1999; 
Williamson, 2010). Furthermore, the use of street hormones can pose a serious health risk if 
taken in excess of the recommended dose or if clean syringes are not used. 
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Interpersonal and Individual Stigma 
Interpersonal and individual level barriers reflect the attitudes, beliefs, and behaviors of 
both providers and patients within the health care system (IOM, 2010). Indirect and direct forms 
of transgender-based stigma create substantial barriers when attempting to access health care. 
Three essential expressions of stigma will be discussed to understand the interpersonal and 
individual manifestation of gender-based stigma, enacted, felt, and internalized stigma (Herek, 
2007; Scambler & Hopkins, 1986).   
Enacted stigma 
Societal norms and beliefs of gender often translate into enacted stigma at the 
interpersonal level. Enacted stigma are instances of discrimination against individuals on the 
grounds of their perceived unacceptability or inferiority (Scambler & Hopkins, 1986). Enacted 
transgender based stigma refers to overt acts of transphobia, through slurs, rejection, ostracism, 
or explicit forms of discrimination and violence. An example of enacted transgender based 
stigma is evident in a qualitative study (n=40) conducted in Boston, Massachusetts, which 
uncovered that transgender and gender non-conforming individuals encountered significant 
barriers when accessing health care (GLBT Health Care Access, 2000). Comprised of four focus 
groups (MTF adults, FTM adults, MTF youth, and FTM youth) the study addressed several areas 
related to health care access.  Focus group participants were recruited from local community 
organizations serving the transgender community and by transgender identified outreach workers 
who approached community members they felt might be willing to participate. The group 
members provided examples of discrimination ranging, from outright refusal by health care 
providers to treat them, to the refusal to use an individual's correct pronoun or name, to providers 
showing shock or disbelief when a person disclosed their transgender or gender non-conforming 
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status. Additionally, several participants raised the issue that a health care experience included 
interactions with both one's provider and the other medical and office staff, leaving the potential 
for enacted stigma to occur at several points during a visit. 
The National Transgender Discrimination Survey (N=6,456) (2011) was the first large-
scale national survey of transgender and gender non-conforming individuals. In 2008, The 
National Center for Transgender Equality (NCTE) and the National Gay and Lesbian Taskforce 
(NGLTF) partnered to conduct a cross-sectional survey of transgender discrimination. The 
NTDS used convenience sampling methods, including community/venue based and snowball 
sampling to recruit participants. To ensure broad participation in the survey, ‘‘transgender'' was 
defined to include individuals who have transitioned or are transitioning from one gender to 
another, whether medically, socially, and/or legally, as well as individuals who cross-dress, 
identify as genderqueer or androgynous, or whose gender nonconformity is a part of their 
identity. Individuals from all 50 states, as well as the District of Columbia, Puerto Rico, Guam, 
and the U.S. Virgin Islands, were included in the sample. The overall sample was predominantly 
White (76%), identified along the transfeminine spectrum (60%), had some college or more 
(88%), reported a salary <$20,000 (74%), and were currently in the workforce (82%). 
When asked to report on experiences of discrimination within the health care system, 
respondents reported being denied equal treatment in doctor's offices and hospitals (24%), 
emergency rooms (13%), mental health clinics (11%), by EMTs (5%) and in drug treatment 
programs (3%) (Grant et al., 2011).  Furthermore, female to male respondents reported higher 
rates of unequal treatment than male to female respondents. Latinx participants reported the 
highest rate of unequal treatment (32% by a doctor or hospital and 19% in both emergency 
rooms and mental health clinics). When participants were asked if they have been denied service 
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altogether by doctors and other providers, 19% reported being refused treatment because of their 
transgender or gender non-conforming status. Twenty-eight percent (28%) of respondents 
experienced harassment in medical settings, and 2% were subjected to violence in a doctor's 
office. Twenty-four percent (24%) of transgender women and 20% of transgender men reported 
having been refused treatment altogether.   
The findings of this survey make a powerful statement. However, it leaves many 
questions unanswered. To understand how stigma and discrimination are enacted within the 
health care system more information is needed to place these findings within a broader context. 
The authors of the survey acknowledge that this analysis is only a first step and encourage 
researchers to utilize this data for further investigation. One area that is addressed in the NTDS is 
how resilient transgender and gender non-conforming people are despite encountering stigma 
and discrimination in every major life area.   
Felt Stigma 
 Felt stigma is the fear of enacted stigma, in addition to the feelings of shame associated 
with being transgender or gender non-conforming (Scambler & Hopkins, 1986).  Because people 
wish to avoid being targets of enacted stigma, felt stigma often affects behavior. Transgender and 
gender non-conforming individuals may modify or adapt their behavior in a variety of ways to 
avoid stigma in various aspects of their lives, including healthcare settings.  For example, a 
person may choose not to disclose their transgender or gender non-conforming status to their 
medical provider. They may even change their appearance to match their biological sex.  To this 
extent, felt stigma can be adaptive because it protects an individual from enacted stigma (Cruz, 
2014; Dewey, 2008; Mizock and Mueser, 2014). However, fear of stigmatization or previous 
negative experiences within the health care system may lead transgender and gender non-
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conforming individuals to postpone or forgo care altogether.  The National Transgender 
Discrimination Survey (2011) found that 28% of respondents delayed medical care when they 
were sick or injured due to discrimination.  Other studies have found that participants did not 
have to experience direct discrimination from a provider to postpone or not get care. Reports of 
discrimination from other communities members were enough to encourage them to stay away 
from health providers (GLBT Health Access, 2000). 
Internalized stigma 
  The third way an individual manifests stigma is by accepting the legitimacy of society’s 
negative regard for the stigmatized group.  The individual manifestation of stigma and 
discrimination towards transgender and non-binary individuals are referred to as transphobia or 
the acceptance that those who transgress societal gender norms need to be feared and shunned 
(Herek, 2007).  Transphobia on the part of healthcare providers often underlies enactments of 
stigma. There is a lack of literature examining provider attitudes towards transgender and gender 
non-conforming individuals.    
 Internalized stigma, internalized transphobia, or self-stigma may cause transgender and 
gender non-conforming individuals to feel that they do not deserve respect from their health care 
provider.  They may not feel that they deserve access to health care as those who are cisgender 
(IOM, 2011).  As a result, they may not disclose key information to their provider, may avoid 
seeking treatment, or refrain from challenging discrimination and other forms of enacted stigma. 
Dewey (2008) conducted a qualitative study with 22 self-identified transgender people. 
Participants were recruited through three transgender organizations in a large Midwestern city in 
the US.  All participants were White with a mean age of 48. Through participant observation and 
interviews the researcher observed that in order to ensure quality care, maintain credibility and 
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receive particular treatments, each subject spent considerable energy deciding how they would 
approach a doctor.  Patients chose what to disclose to doctors, depending on the type of medical 
treatment they needed and what they believed was the best way to receive these services (Dewey, 
2008). Some participants were careful with what they revealed to their doctor, because they 
feared being denied quality medical attention for “cisgender” medical issues.  While others, 
either because they had already fully transitioned or because they did not want treatments related 
to transitioning, chose to conceal their transgender identity, because they wanted to be seen as 
real men or women.  Those who were gender non-conforming would attempt to keep their 
identity protected by lying to their doctors (Dewey, 2008).  
 Dewey (2008) asserts that concealment of a person's transgender identity may be a 
protective factor used to prevent conflict within a relationship where the doctor, as a gatekeeper, 
has considerable power.  Furthermore, participants wanted to be seen as authentic in their 
representation and thus deserving of appropriate treatment.  The qualitative observation and the 
author's presentations of the findings provide concrete examples of how some transgender and 
non-binary individuals approach health care interactions with the goal of minimizing stigma and 
discrimination. Whether these actions affect, a person's health care experience needs further 
examination.  
  While enacted stigma refers to acts that are done to someone, the distinction between felt 
and internalized stigma is less clear. Many of how transgender and gender non-conforming 
individuals attempt to minimize the effects of stigma and discrimination can be protective. 
However, having to plan out every step for fear of potential discrimination may impact the 
physical, psychological, and social health of transgender and gender non-conforming individuals 
over time. Further research in is needed to identify protective factors and interventions that seek 
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to reduce adverse healthcare experiences associated with experiences of stigma and 
discrimination.  
Gender Affirmation Framework  
Gender affirmation refers to the social process by which individuals are recognized and 
supported in their gender identity and expression (Bockting et al. 2006; Melendez and Pinto, 
2007; Nuttbrock et al., 2009; Sevelius, 2013).   The need for gender affirmation is not unique to 
transgender individuals.  However, due to their gender minority status, gender affirmation may 
take on a more prominent role in the lives of transgender, and non-binary individuals.  Even 
cisgender people whose gender identity and expression align with their sex assigned at birth may 
find themselves at odds with societal pressures to conform to rigid notions of masculinity and 
femininity, which are pervasive and often unattainable for many (Sevelius, Keatley, and 
Gutierrez-Mock, 2011). For transgender individuals, gender affirmation is a vital component of 
their sense of self, a validation of their gender identity and expression.   Gender affirmation can 
include the use of one's correct name and pronoun, to the active acceptance of the range of 
gender expressions transgender and gender non-conforming individuals claim.   Studies have 
observed the importance of and need for gender affirmation among transgender individuals 
specifically related to the process of disclosing one's transgender identity (Melendez and Pinto, 
2007; Nuttbrock et al., 2009).  Despite the importance of gender affirmation in the lives of 
transgender individuals, the relationship between the need for gender affirmation and high-risk 
behavior has not been thoroughly investigated (Reisner et al., 2015; Sevelius, 2013). 
The Gender Affirmation Framework (Sevelius, 2013) was developed from an 
intersectional perspective (Warner, 2008) and integrates objectification theory (Fredrickson and 
Roberts, 1997; Moradi and Huang, 2008) and the Identity Threat Model of Stigma (Major and 
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O'Brien, 2005). Fundamental to an intersectional approach is understanding that identity is 
informed by institutional, political, and societal structures (Warner, 2008). Objectification theory 
proposes that experiences associated with gender socialization and sexual objectification may 
create environments where women's bodies and appearance are both defined by others as well as 
themselves (Moradi, 2010). The second theory that informs the gender affirmation framework is 
the Identity Threat Model of Stigma, a social psychological theory which suggests that when 
persons with a stigmatized identity perceives a threat to one's identity and that person lacks the 
necessary coping skills to address such a threat, the individual will either attempt to decrease 
their exposure to the threat or increase one's coping skills and ability (Major and O'Brien, 2005). 
Lastly, the gender affirmation framework draws from HIV related research with Latino gay and 
bisexual men, which examines sexual risk and psychological distress as outcomes of social 
oppression (Diaz et al., 2001, 2004).    
 
 
 
 
 
 
 
 
Figure 1. Gender affirmation framework for conceptualizing risk behavior among transgender women 
(Sevelius, 2013) 
 
Sevelius (2013) suggests that for transgender women of color the intersection of multiple 
oppressions (i.e., racism, transphobia and sexism) results in extreme marginalization where a 
high need for gender affirmation often goes unmet.  Transgender women of color often report 
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early childhood experiences of harassment (Mallon and De Crescenzo, 2006) and family 
rejection (Koken et al., 2009) due to gender non-conformity. Research has found that transgender 
women often receive affirmation for their gender identity and expression from friends rather than 
family (Nuttbrock et al., 2009).  For transgender women rejection from family members at a 
young age has been associated with homelessness, school dropout, and unemployment, often 
leading to a cycle of sex work, substance misuse, incarceration, and poverty (Cochran et al., 
2002; Koken, et al., 2009; Reisner et al., 2015; Wilson, et al., 2009).  This cycle is intensified for 
transgender women of color, in particular, African-American transgender women (Lombardi, 
2009; Reisner et al., 2015), highlighting the relationship between racism, transphobia, poverty, 
and violence (Sevelius, 2013).   Furthermore, studies have demonstrated a relationship between 
experiences of transphobia and self-reported depression, anxiety, and low self-esteem 
(Lombardi, 2009; Melendez and Pinto, 2007; Nuttbrock et al. 2010). 
Research has found that transgender women also report experiences of sexual 
objectification starting at a young age (Garofalo et al 2006).  Sevelius (2013) posits that for 
transgender women experiences of sexual objectification may represent an environment in which 
they receive some form of gender affirmation; this is particularly salient within the context of sex 
work where gender affirmation is often perceived as readily accessible.  Sexual objectification 
refers to experiences that reduce women to their appearance or the function of their body/body 
parts (Fredrickson and Roberts 1997).  This includes experiences of objectifying stares from 
men, public evaluations of a woman’s appearance (i.e., catcalls), and other sexual gestures and 
comments, all of which are commonly reported by transgender women (Sevelius, 2013).   
Objectification theory also proposes that experiences of sexual objectification may lead to self-
objectification, which is defined as a process in which women internalize themselves as sexual 
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objects, which may cause them to consistently monitor and measure their bodies against the 
dominant societal standards of beauty (Moradi, 2010).   The self-objectification process can lead 
to body shame and increased anxiety, which has been commonly reported among transgender 
women (Algars et al., 2010; Kraemer et al., 2008; Moradi, 2010).    
Self-objectification and body shame have been associated with lower body esteem, lower 
self-esteem, and less health-promoting behaviors (Bockting et al., 1998; Lowery et al., 2005; 
Sevelius, 2013).   McKinley and Hyde (1996) propose that body control beliefs are associated 
with self-objectification and body shame.  These beliefs perpetuate the idea that one's physical 
appearance can and should be controlled to comply with cultural standards of beauty and 
attractiveness (i.e., through medical intervention).  Body control beliefs represent an 
internalization of societal expectations of beauty and may be associated with both a sense of 
agency over a person's health and risky body modification behaviors (McKinley and Hyde, 
1996).  For transgender and non-binary women, body control may be a protective factor and 
include seeing a doctor for feminizing hormones and gender-affirming health care. However, it 
may also result in the unsafe practice of using feminizing hormones obtained on the street or 
taking additional doses of hormones than prescribed by a physician in hopes that they will 
produce feminizing results quicker (Sevelius, 2013). 
The Identity Threat Model of Stigma states that anxiety and maladaptive coping 
strategies can result from stigma-related stressors that threaten one's identity and exceed one's 
coping skills (Major and O'Brien, 2005). Thus, when the need for gender affirmation is high (due 
to psychological distress), and access to gender affirmation is low (due to social oppression), 
identity threat may result. For transgender women, stigma, social rejection, and body shame 
create a high need for gender affirmation while stigma and discrimination can prevent access to 
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gender affirmation (Sevelius, 2013). This discrepancy creates identity threat, resulting in anxiety 
and depression in addition to attempts to reduce the threat. For example, transgender women may 
attempt to reduce identity threat by either attempting to increase their access to gender 
affirmation or decrease their need for gender affirmation. Evidence suggests that transgender 
women may seek to fulfill unmet needs for gender affirmation in ways that increase risk for HIV 
and other negative health outcomes (i.e., engaging in sex work, pursuing dangerous silicone 
injections, having sex to obtain gender affirmation) (Bockting, et al., 1998; Glynn et al., 2016; 
Sausa et al., 2007; Sevelius, 2013; Weiessing et al., 1999). According to the identity threat model 
of stigma, those with the highest need for and the lowest access to gender affirmation will be at 
the highest risk for negative health outcomes (Sevelius, 2013).    
Research with Latino men who have sex with men has found that self-reported 
experiences of discrimination were highly associated with psychological distress and risky sex 
practices (Diaz, 1998; Diaz et al., 2004). Diaz (2004) proposed a framework for understanding 
how oppression may influence sexual risk behaviors among marginalized populations. He 
proposed that the psychological distress (i.e., anxiety, depression) associated with stigma and 
discrimination may increase engagement in high-risk contexts, such as sex under the influence of 
drugs or alcohol. Moreover, it is within these contexts that HIV risk increases (Diaz et al., 2004). 
Transgender women consistently report condomless receptive anal sex with multiple 
partners and sex under the influence of drugs and alcohol (Kenagy, 2002; Nemoto et al., 2004; 
Operario et al., 2011; Sausa et al., 2007). Studies have also shown that experiences of stigma and 
discrimination increase transgender women's need for gender affirmation from their male sexual 
partners. The need for gender affirmation has been associated with a willingness to engage in 
risky sexual behavior, the inability to negotiate condom use and substance use during sex 
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(Bockting et al., 1998; Melendez and Pinto, 2007; Reisner et al., 2009; Rodriguez-Madera and 
Toro-Alfonso, 2005; Sausa et al., 2007; Sevelius, 2013; Sugano et al., 2006).  One meta-analysis 
found that 44% of transgender women reported unprotected receptive anal sex, with the highest 
rates being reported with sex work clients (39%) and primary partners (37%) (Herbst et al., 
2008). Further, sex under the influence of drugs or alcohol is one of the most commonly cited 
sexual risk factors associated with condomless sex among transgender women and is often used 
as a way of coping with stigma, loneliness, or the demands of sex work (Nemoto et al., 2004; 
Xavier et al., 2005). 
Conclusion 
The theories presented in this chapter situate HIV risk and the facilitators and barriers to 
PrEP among transgender women on a macro, mezzo, and micro level. If the structural barriers to 
health care prevent transgender women from both awareness of and access to PrEP, uptake, and 
adherence cannot occur. By contextualizing HIV risk as a social and psychological process that 
is driven by social oppression, we begin to reframe the HIV prevention discussion to focus on 
the intersection of the structural, interpersonal, and individual level factors, which contribute to 
HIV risk, rather than focusing solely on individual behaviors. Research has examined the 
contextual factors that contribute to the increased rates of HIV among this group. The following 
chapter presents a review of research on HIV risk among transgender women.    
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CHAPTER 4: LITERATURE REVIEW  
Introduction  
 Historically, research on transgender communities has predominantly focused on HIV 
risk among transgender women. The literature review below presents a historical overview of the 
recognition of HIV risk among transgender women, the emergence of transgender women as an 
HIV risk category, current HIV burden and vulnerabilities, and available HIV prevention 
strategies. 
HIV and Transgender Women 
Recognition of HIV Risk among Transgender Women 
 During the late 1980's, early 1990's a small body of research began to emerge on HIV 
risk among transsexual and transvestite female sex workers (Boles and Elfison, 1994, Castello-
Branco, et al., 1988, Elfison, et al., 1993, Gattari, et al., 1991, Gattari, et al., 1992, Modan et al., 
1992, Tirelli, et al., 1991).  It is not clear from these studies whether participants were asked 
about their gender identification or sexual orientation. Thus, it is possible that participants did 
not identify with the group they were assigned by researchers. Transsexual and transvestite 
female sex workers were identified as a specific subgroup of sex workers, often found living in 
major urban cities.  Studies found, when compared to cisgender female and male sex workers, 
transsexual and transvestite females had higher HIV prevalence rates (Boles and Elifson, 1993, 
1994; Modan et al., 1992). Several factors were identified as increasing risk for HIV among this 
population, including, multiple sexual partners, sexual behavior (frequent receptive anal sex), 
illicit drug use, and the interaction between sexual and drug using/injecting behavior (Boles & 
Elifson, 1994; Elifson et al., 1993; Galli et al., 1991; Gattari et al., 1991; 1992; Modan et al., 
1992; Tirelli et al, 1988; 1991).  The research found that condom use was more frequent with 
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partners who paid for sex than with non-paying partners (Boles & Elifson, 1994; Elifson et al., 
1993; Tirelli et al., 1991). One study (Modan et al., 1992) found that ‘male to female transsexual' 
sex workers had an HIV prevalence rate of 11.1% compared to cisgender female sex workers 
(1.1%). Another study demonstrated that 68% of the sample were HIV-positive and that HIV 
seroprevalence rates were higher among ‘transvestites' who engaged in receptive anal sex and 
used crack than those who did not (Elifson et al., 1993). Furthermore, Boles & Elifson (1994) 
found that a strong commitment to transvestism, defined as using female names, wearing 
feminine clothing, and identifying as female, was associated with social and/or physical 
isolation, experiences of discrimination, feelings of hopelessness, participation in risky sexual 
behavior, and higher rates of HIV infection. 
Emergence of a Risk Category  
 A 2008 meta-analysis found that in the United States a small number (N=29) of studies 
on transgender women and HIV risk took place from 1996-2003 (Herbst et al., 2008). The 
majority of these studies were conducted in urban areas such as, San Francisco (Clements-Nolle 
et al., 2001a; Clements-Nolle, 2001b; Kellogg et al., 2001; Nemoto et al., 1999; Nemoto et al., 
2004, 2006; Operario and Nemoto, 2005; Sugano et al., 2006; Weinberg et al., 1999), New York 
City (Lombardi et al., 2001; McGowan, 1999; Wilchins et al., 1997), Philadelphia (Kenagy, 
2002; Kenagy, 2005; Kenagy and Hsieh, 2005) and Los Angeles (Reback et al., 2001; Reback et 
al., 2004, 2005; Simon et al., 2000).   Unlike earlier studies, a definition of "transgender," as well 
as specific eligibility criteria for recruitment and enrollment of transgender individuals, began to 
emerge, with several standard gender identity markers used across each study. Of the twenty-
nine research studies, sample size ranged from 19 – 515, with nearly half of the samples having 
100 participants or less (Herbst et al., 2008). Seventy-two (72%) percent of the studies were 
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comprised of predominantly transgender women of color (Herbst et al., 2008). Transgender 
women were found to engage in risk behaviors, such as drug use, having multiple sex partners, 
condomless sex, and participating in sex work ( Kenagy, 2002; Kenagy, 2005; Nemoto et al., 
2006; Reback & Simon, 2004; Simon, Reback, & Bemis, 2000).   In addition to sexual risk 
behaviors, individual (e.g., substance use, suicidality, depression, and anxiety), interpersonal 
(e.g., physical and sexual violence, discomfort in public settings), and structural (e.g., 
discrimination in employment, housing, and social services, incarceration, lack of transgender 
specific health care) level factors commonly reported by transgender women (Lombardi, 1999; 
Lombardi & van Servellen, 2000; Lombardi et al., 2001; Nemoto, et al., 1999; Nemoto, et al., 
2004).  
HIV Burden  
  The Center for Disease Control (CDC) identifies transgender women as a group at high 
risk for HIV infection, but for whom no efficacious interventions exist (CDC, 2013). It is unclear 
as to when the CDC officially designated transgender women as a group at high risk for HIV, 
which is due in large part to the lack of uniform HIV surveillance data on transgender individuals 
collected at the federal level, state, and local level. While data on HIV prevalence and incidence 
among transgender women remain unreliable and underestimated, research indicates high HIV 
rates. HIV prevalence among transgender women is estimated at 27.7% among transgender 
women, higher than the 19% prevalence among men who have sex with men and STI prevalence 
among transgender women is estimated at 21%, with a range of 12-79% (Herbst et al., 2008). 
The highest HIV prevalence is found among African American transgender women, averaging 
56.3%.(Herbst et al., 2008). Additionally, findings from a 2013 meta-analysis indicate that 
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transgender women had more than 49 times the odds of HIV infection compared to cisgender 
adults (Baral et al., 2013).  
 Research has demonstrated that transgender women engage in a variety of HIV risk 
behaviors. For example, on average, 44.1% of transgender women report unprotected receptive 
anal sex, 27.4% unprotected insertive anal sex, and 39.3% sex while under the influence of drugs 
and alcohol (Herbst et al., 2008). Increased sexual risk behaviors are associated with sex work 
among transgender women (Clements-Nolle et al., 2001; Clements-Nolle et al., 2006; Poteat, 
Reisner, & Radix, 2014; Sevelius, 2013) On average, 41.5% of transgender women report sex 
work, and the highest rates of unprotected sex are with clients (Herbst et al., 2008). Studies have 
found that transgender women who exchanged sex for money, drugs, housing, and other services 
were a population at high risk for HIV acquisition and transmission (Baral, et al., 2013; 
Clements-Nolle et al., 2001; Clements-Nolle et al., 2006; Herbst, et al., 2008; Poteat, Reisner, & 
Radix, 2014; Sevelius, 2009; 2013). Inconsistent condom use, often coupled with offers of more 
money for condomless sex (Herbst et al., 2008; Sevelius, 2009; 2013) is commonly reported 
among this population. In one study, a majority of participants reported engaging in unprotected 
anal sex with transactional male sex partners whose HIV status was either unknown or different 
serostatus in the past 12 months (Sevelius et al., 2009). Studies have found that financial need, 
gender-based discrimination, lack of access to education and jobs, drug/alcohol misuse were 
central reasons for transgender women to engage in sex work (Clements-Nolle et al., 2001; 
Herbst et al., 2008; Sevelius et al., 2009; 2013). Lastly, research has found that transgender 
women significantly underestimate their level of HIV risk; on average 71.6% of transgender 
women perceived low or no chance of being HIV+, and 83.9% felt they had little or no chance of 
becoming HIV+ (Herbst et al., 2008). 
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HIV Vulnerability  
 A body of research examining the relationship between individual, interpersonal, and 
structural level factors and HIV risk has emerged, acknowledging that sexual risk behaviors are 
not the sole indicator for HIV risk (Operario et al., 2014; Sevelius, Reznick, Hart, & Schwarcz, 
2009). These syndemic factors contribute to increased HIV risk for transgender women. A 
syndemic represents multiple co-occurring health and social problems that contribute to the 
exacerbation of additional health problems within disadvantaged communities.(Singer & Clair, 
2003).  Research demonstrates that experiences of stigma and discrimination towards one's 
gender identity and gender expression are associated with severe health disparities, including 
HIV (Operario et al., 2014; Sevelius et al., 2009; Bradford et al., 2013; Sevelius, 2013). 
Transgender women experience pervasive discrimination and stigmatization, including high rates 
of violence and sexual assault (Lombardi et al., 2001; Nemoto et al., 2011; Testa et al., 2012). 
Herbst et al. (2008) found that of transgender women 42.9% reported physical abuse, 20.6% 
sexual assault, and 57.9% partner violence. Research has demonstrated that transgender women 
reporting sexual violence had triple the odds of inconsistent condom use (Clements-Nolle et al., 
2001; Herbst et al., 2008). A prospective study in New York City found that transgender-related 
discrimination and violence was associated with sexual risk behavior and HIV and STI incidence 
among young transgender women (Nuttbrock et al., 2013). Lack of parental support has also 
been associated with HIV risk. A study among young transgender women in Los Angeles and 
Chicago found that sex without condoms was reported by individuals without parental support 
while having at least one supportive parent was associated with consistent condom use (Wilson 
et al., 2012). 
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Studies have found the accumulative effects of low self-esteem, depression, anxiety, 
substance use, and victimization related to one's transgender identity, and intimate partner 
violence has been associated with HIV infection and sexual risk (Brennan et al., 2012; Jefferson 
et al., 2013; Nuttbrock et al., 2009; Operario et al., 2014; Sevelius et al., 2009; Sevelius, 2013). 
Kenagy & Bostwick (2005) found that transgender women reporting low self-esteem had triple 
the odds of inconsistent condom use. Rates of depression among transgender women are high, 
exceeding 61% (Clements-Nolle et al., 2001; Jefferson et al., 2013; Nuttbrock et al., 2012; 
Nuttbrock et al., 2010).   Suicidal ideation and attempts are common among transgender women 
(Clements-Nolle et al., 2006; Goldblum et al., 2012; Grant et al., 2011; Klein & Golub, 2016; 
Xavier et al., 2008); on average 53.8% report suicidal thoughts (Clements-Nolle et al., 2006; 
Goldblum et al., 2012; Grant et al., 2011) and 31.4%-48% report suicide attempts (Clements-
Nolle et al., 2006; Goldblum et al., 2012; Grant et al., 2011; Klein & Golub, 2016; Xavier et al., 
2008). 
Transgender women often report substance use as a way to cope with the stigma and 
discrimination associated with gender non-conformity (Benotsch et al., 2013; Grant et al., 2011; 
Keuroghlian et al., 2015; Klein & Golub, 2016; Xavier et al., 2008).  Studies have demonstrated 
that substance use among transgender women is associated with unprotected sex (Nemoto et al., 
2011; Operario et al., 2014) and that unprotected sex under the influence of polysubstance is 
common (Nemoto, et al., 2004; Operario, et al., 2014; Risser, et al., 2005), thus magnifying the 
risk for HIV and other STIs.  Furthermore, discrimination in housing, employment, and 
healthcare settings are identified as factors that may increase transgender women’s risk for HIV 
infection (Bradford et al., 2013; Grant et al., 2011; Khan, 2011; Nemoto et al., 2011; Sevelius et 
al., 2009; Sevelius, 2013; Strousma, 2014).  
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Evidenced in current studies are the multilevel vulnerabilities contributing to HIV risk 
among transgender women. Stigma and discrimination, including the intersection of multiple 
stigmatized identities, lack of social and legal recognition of self-identified gender identity, and 
lack of employment and educational opportunities are well documented as central drivers of HIV 
risk in transgender women (Baral et al., 2013; Poteat, Reisner, & Radix, 2013; Sevelius, et al., 
2009; Sevelius, 2013). Studies have identified that barriers to health care access, including 
stigma and discrimination, and a lack of trans-specific and trans-sensitive health care providers 
contribute to low HIV testing rates among transgender women (Bradford et al., 2013; Baral et 
al., 2013; Grant et al., 2011; Poteat, Reisner, & Radix, 2013). Furthermore, lack of access to 
gender-affirming health care may also influence the development of and access to transgender-
specific HIV prevention and treatment services.  
HIV Prevention for Transgender Women 
Despite the existing body of research on HIV risk among transgender women, no 
efficacious interventions exist (Garofalo et al., 2012; Poteat, Reisner, & Radix, 2013; Reisner et 
al., 2016). Interventions sensitive to the numerous vulnerabilities faced by transgender women 
are needed, not just for alleviating HIV burden, but also because the marginalization of 
transgender women leads to a variety of adverse health and psychosocial outcomes (Sevelius et 
al., 2009). For many transgender women, HIV prevention may become an afterthought given the 
day-to-day necessities of food, shelter, and safety. Data suggest that programs that integrate HIV 
prevention into broader concerns of vulnerable groups are more acceptable and more likely to 
retain participants and have better outcomes (Garofalo et al., 2012; Melendez & Pinto, 2009; 
Poteat, Reisner, & Radix, 2013; Sevelius et al., 2009; Sevelius, 2013). Melendez and Pinto 
(2009) found that building HIV prevention services into existing gender affirming (i.e., hormone 
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therapy) care at a community – based health clinic increased HIV/STI screening and engagement 
in HIV treatment among a sample of transgender women in New York City. Leveraging the 
experience of community settings in identifying community health needs and implementing 
context specific and culturally appropriate health promotion and HIV prevention is paramount. 
Given this context, a biomedical intervention such as pre-exposure prophylaxis (PrEP), may be 
critical for effective HIV prevention packages that meet the unique needs of transgender women 
(Escudero et al., 2015). 
Pre-exposure prophylaxis (PrEP) refers to a daily or intermittent oral administration of 
antiretroviral drugs designed to protect high-risk HIV-negative individuals from infection (CDC, 
2015). PrEP has been found to be efficacious in preventing HIV acquisition among several high-
risk populations, including men who have sex with men (MSM) (Grant et al., 2010), 
serodiscordant heterosexual couples (Baeten, et al., 2012) and people who inject drugs 
(Choopanya et al., 2013). Although, results from clinical trials have spurred recommendations 
for PrEP among these high-risk groups, (CDC, 2011; CDC, 2012; CDC, 2015) research 
involving (and specific recommendations for) transgender women have mostly been absent, 
despite the substantially elevated risk for HIV within this community. To date, few studies 
include transgender people and those that do often conflate transgender women with MSM 
(Buchbinder et al., 2014; Liu et al., 2014; Grant et al., 2014). Additionally, inaccurate data 
collection and tracking of transgender individuals allows for miscategorization of participants 
who may identify as transgender or gender non-conforming. Transgender women face barriers to 
study participation such as, fear of stigma and marginalization associated with gender non-
conformity, lack of cultural competency training for research staff, fear of participation due to 
lack of scientific knowledge regarding medication interaction with hormones, mistrust of the 
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scientific community, and discomfort with visitor IDs and complications related to name change 
(U.S. Women & PrEP Working Group, 2015). A 2015 meta-analysis, found that of the seven 
trials that analyzed the efficacy of oral PrEP for HIV prevention, only one (iPrex) confirmed 
enrollment of transgender women (Escudero et al., 2015). Of the 2,499 participants enrolled in 
this trial, 29 (1.2%) self-identified as transgender at baseline (Escudero et al., 2015).  
 Deutsch et al. (2015) conducted a subgroup analysis of the iPrex clinical trial, which 
initially reported the participation of 29 transgender women. This secondary analysis of the iPrex 
study is the first study to disaggregate transgender women from MSM, thus providing valuable 
information regarding the efficacy of PrEP as an HIV prevention intervention for this population. 
Of the 2499 enrolled participants, 296 (12%) identified as transgender and 29 (1%) as a woman. 
An additional 14 (1%) male-identified participants reported female hormone use. The total 
number of combined participants from each of the three groups was 339 (14%). This analysis 
found that the distribution of transgender women participants including those with sub-identities 
did not differ between the intervention and placebo group. Compared with MSM, transgender 
women were more likely to report transactional sex, receptive anal intercourse without a 
condom, or 5 or more partners in the past three months. Among transgender women in the study, 
there were 11 HIV infections in the PrEP group and ten in the placebo group. In the PrEP group, 
no drug was detected in any of the transgender women who seroconverted. The findings suggest 
that PrEP appears to be effective in preventing HIV acquisition in transgender women when 
taken, of the women in the PrEP group who became infected none had detectable drug levels at 
the time of seroconversion. The lack of protection from PrEP seems to be primarily a result of 
low adherence leading to low drug exposure, yet due to a lack of studies on drug interactions 
between PrEP and hormones, this factor cannot be ruled out.  
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 Lastly, a recent study (Sevelius et al., 2016), examined trans-specific barriers and 
facilitators to PrEP acceptability among transgender women in San Francisco. The study 
conducted three focus groups and nine individual interviews (N=30). Participants ranged in age 
from 21 to 51, with a mean age of 36. The majority of (n=22, 74%) self-identified as a person of 
color (Sevelius et al., 2016). Sevelius et al. (2016) found that knowledge of PrEP was low, yet 
once participants were given information regarding PrEP interest was relatively high. 
Participants expressed that due to past negative experiences with health care providers, the need 
for trans-competent providers was an essential component to PrEP uptake and adherence. 
Additionally, participants felt that PrEP could be used to promote self-efficacy and 
empowerment in sexual situations where transgender women encountered reduced power to 
negotiate condom use, especially within the context of sex work. Lastly, trans-specific barriers 
included lack of trans-inclusive social marketing campaigns of PrEP, overall prioritization of 
hormone use over taking a medication that little information is known about with regards to 
hormone interactions, and general medical mistrust due to experiences of transphobia (Sevelius 
et al., 2016).  
Conclusion 
Despite decades of research, HIV surveillance and monitoring of transgender women at 
the federal, state, and local level has not been required. A lack of research and HIV surveillance 
and monitoring are due in large part because the Centers for Disease Control (CDC), does not 
collect nor require that specific data on an individual’s current gender identity and sex assigned 
at birth be collected. A lack of governmental response to the HIV crisis among transgender 
women has created a situation in which researchers and clinicians must continually fight to 
receive funding for research and HIV prevention and treatment programs that are trans-specific. 
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Until population-based data is collected at the federal level funding will continue to be funneled 
to the groups for which there is data that is viewed as legitimate. The next chapter will present 
the research design and methodology for this dissertation. 
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CHAPTER 5: RESEARCH DESIGN AND METHODOLOGY 
Introduction 
 The purpose of this dissertation was to identify the facilitators and barriers to pre-
exposure prophylaxis (PrEP) adoption, adherence, and access to transgender women. This study 
was designed to answer the following four research questions: 1) what are the structural, 
interpersonal, and individual level factors impacting transgender women's willingness to utilize 
PrEP as an HIV prevention tool? 2) to what extent do these factors impede the integration of 
PrEP into the lives of transgender women? 3) what are best practices for integrating PrEP into 
health care for transgender women? 4) to what extent does need for and access to gender 
affirmation influence engagement in HIV risk behaviors among transgender women? 
Research Design and Methodology 
Identification of Facilitators and Barriers to PrEP Adoption, Adherence, and Access 
 Utilizing qualitative research methodology (i.e., in-depth semi-structured interviews) this 
dissertation:  a) identified social and behavioral factors that are likely to influence PrEP 
acceptance, uptake and adherence among transgender women in New York City, including 
factors at the structural, interpersonal, and individual level; and b) examined social and 
behavioral factors associated with disparities in access to gender-affirming - transgender-
sensitive prevention and care services among transgender women in NYC that might directly 
impact PrEP adoption and adherence.   
 Sampling and Recruitment. A series of in-depth semi-structured interviews were 
conducted with a total of thirty participants from the following two groups: a) transgender 
women currently taking PrEP (n=15), and b) transgender women currently not using PrEP 
(n=15). To be eligible for participation individuals had to meet the following criteria: 1) 18 years 
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of age or older; 2) assigned male at birth; 3) identify with a gender different from sex assigned at 
birth; 4) in the past six months had receptive anal or vaginal sex with a cisgender man or 
transgender woman or meet at least one criteria for PrEP eligibility; 5) live in the NY tri-state 
area; and 6) self-report a negative HIV status. Also, to be eligible for the PrEP group, individuals 
had to self-report current PrEP use. People of color were oversampled to facilitate understanding 
of specific issues related to disparities in access and acceptability among this group deemed at 
high risk for HIV acquisition. Sample size was chosen based on recommendations for similar 
qualitative inquiries to ensure thematic saturation (Reisner, Perkovich, & Mimiaga, 2010; 
Sevelius, 2009; Sevelius, 2013; Sevelius et al., 2016) as well as feasibility concerns.  
Recruitment flyers were posted at the following community-based health centers, which provide 
medical and social services to transgender women in New York City:   Callen-Lorde Community 
Health Center, APICHA Community Health Center, CKLife at Bronx Lebanon Hospital, and 
Community Health Network. Emails were sent to transgender community leaders and advocates 
throughout New York City to assist with recruitment through their social networks. Lastly, 
online recruitment consisted of online flyers and text postings via Facebook, Twitter, and 
transgender-inclusive and specific listservs. 
 Procedures. Potential participants contacted the Hunter HIV/AIDS Research Team 
(HART) via telephone to be screened for eligibility. If eligible, participants were scheduled for 
an in-person semi-structured interview that took place at the HART office at Hunter College at 
68th Street and Lexington Ave. Trained research staff took participants through the informed 
consent process, including the audio recording of the interview. Interviews lasted between an 
hour to an hour, and a half and participants were compensated $40 for their time. Interviews 
were transcribed by members of the study's research team and a transcription service (Transcript 
 69 
Divas). Any identifying information was redacted immediately from the transcripts to ensure the 
confidentiality of interview participants. Interviews contained a core set of questions regarding 
factors at the structural, interpersonal, and individual level that might influence PrEP adoption, 
adherence, access, and willingness to use future biomedical PrEP interventions. 
Interview Topics (see appendix - interview guide). Participants on PrEP were asked to 
discuss any contributing factors that led to their PrEP use and any benefits and challenges 
experienced since initiating PrEP, including issues around access and adherence. Participants 
not on PrEP were asked to discuss their knowledge of and attitudes towards PrEP, and any 
factors that contributed to their decision-making around whether to take PrEP. Participants in 
both groups were asked to discuss factors that would be most important to facilitate broad 
interest and participation in PrEP. Input was also solicited on intervention components that 
would ensure cultural competence and acceptability. 
Qualitative Data Analysis 
After interviews were transcribed and verified for accuracy, thematic coding was used, 
following procedures outlined by Miles and Huberman and Patton (Miles & Huberman, 1994; 
Patton, 1999). For thematic analyses, data were indexed and coded using open and axial 
coding(Patton, 1999). Axial coding procedures allowed the data to be coded to address research 
questions 1-4. Open coding procedures were used to identify emerging themes and factors 
associated with each research question. Following the development of the codebook, data were 
coded in Dedoose qualitative software. Reliability was maintained through the use of multiple 
coders, including two research assistants and the principal investigator. Inconsistent application 
of codes was discussed and revised until coders maintained 90% agreement. Once the coding 
scheme captured the themes arising from the transcripts, the synthetic and analytic features of 
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Dedoose were used to facilitate theory building by permitting the examination of overlap 
between codes to conceptualize and assess hypotheses about the co-occurrence of themes.  
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CHAPTER 6: RESULTS  
  
Introduction 
 
The purpose of this dissertation is to identify the facilitators and barriers to pre-exposure 
prophylaxis (PrEP) adoption, adherence, and access among transgender and non-binary women 
(TGNBW). The following chapter presents results from thirty semi-structured interviews with 
two groups: 1) TGNBW not on PrEP (n=15) and 2) TGNBW on PrEP (n=15). Each interview 
contained a series of open-ended questions addressing the study’s four main research questions: 
1) what are the structural, interpersonal, and individual level factors impacting TGNBW’s 
willingness to utilize PrEP as an HIV prevention tool? 2) To what extent do these factors impede 
the integration of PrEP into the lives of TGNBW? 3) What are best practices for integrating PrEP 
into health care for TGNBW? And, 4) to what extent does need for and access to gender 
affirmation influence HIV risk among TGNBW? 
Description of Study Sample  
Demographic Characteristics  
In New York City (NYC) between 2012-2016, transgender people represented 2% of 
individuals newly diagnosed with HIV (NYC DOHMH, 2017). Among transgender people 
newly diagnosed with HIV in NYC the majority were transgender women (99%) between the 
ages of 20-29 (60%), who were either Black (44%) or Latinx (48%) (NYC DOHMH, 2017). As 
such, the overall sample for this dissertation is comprised of thirty transgender and non-binary 
women (TGNBW) living in (NYC) who reflect these demographics and are disproportionately at 
risk for HIV. Participants represent a cross section of the NYC TGNBW community for whom 
PrEP has the potential to greatly reduce the disparate rates of HIV infection.  
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Presented in Table 1, the vast majority of the sample were under the age of 30 (60%, 
n=18) (M=28.00, SD=6.91; age range 21-49), identified as a person of color (73%, n=22), 
claimed a binary gender identity (i.e., identified as female, woman, or trans woman) (93%, 
n=23), identified as heterosexual/straight (57%, n=17), reported an income of less than $12,000 
(87%, n=26), were currently not in the workforce (90%, n=27), and were publically insured 
(87%, n=26).  
Overall, 60% (n=18) of the total sample represented individuals under the age of 30. 
Participants under 30 were more likely to be on PrEP (73%, n=11) compared to non-PrEP users 
(47%, n=7). Far fewer non-PrEP users identified as white (13%, n=2) compared to PrEP-users 
40% (n=6). Sixty-seven (67%, n=10) percent of non-PrEP users identified as 
heterosexual/straight compared to 47% (n=7) of participants on PrEP who identified as 
heterosexual/straight. Finally, all participants not on PrEP (n=15) reported an annual income of 
less than $12,000, were currently not in the workforce, and were publically insured compared to 
participants on PrEP (73%, 80%, and 73%, respectively).  
PrEP Eligibility and Indications    
 
 Table 2 presents PrEP eligibility criteria and indications by group. Overall, the majority 
of participants met at least one of the following PrEP eligibility criteria (CDC, 2014): a) 
condomless anal sex in the past 6 months (93%, n=28), b) STI diagnosis in the past 6 months 
(3%, n=1), and/or c) have an HIV-positive sex partner (20%, n=6). Among PrEP-users, 100% 
(n=15) reported condomless anal sex in the past 6 months compared to 87% (n=12) of 
participants not on PrEP. Participants on PrEP were more likely to report having an HIV-positive 
sex partner in the past 6 months (27%, n=4) compared to 13% (n=2) of non-PrEP users.  
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In addition to meeting PrEP eligibility criteria, participants also reported three key factors 
that increased risk for HIV infection where PrEP use would be beneficial, including engaging in 
sexual activity with a) multiple sex partners (33%, n=10), b) a partner with multiple sex partners 
(30%, n=9), and c) a partner whose HIV status is unknown (53%, n=16). Among the total 
sample, PrEP users were more likely to report at least one of the three indicators: a) multiple sex 
partners (40%, n=6), b) a partner with multiple sex partners (40%, n=6), and c) a partner whose 
HIV status is unknown (60%, n=9) compared to non-PrEP users (27%, 20%, and 47% 
respectively). Lastly, participants on PrEP (27%, n=4) were more likely to report all three 
indicators compared to participants not on PrEP (20%, n=3).  
Structural, Interpersonal, and Individual Level Factors Impacting PrEP Use (RQ 1, 2) 
 
  Several facilitators and barriers emerged as factors that synergistically interact at the 
structural, interpersonal, and individual levels to impact willingness to use PrEP among 
transgender and non-binary women. The following sections present the study’s findings at each 
level. First, at the structural level, participants identified several facilitators that increased 
awareness, knowledge, and uptake, including access to PrEP messaging and information and 
active provider engagement and active provider assistance with PrEP. Further, participants 
identified two related structural barriers influencing PrEP dissemination and uptake, which 
included the conflation of TGNBW with men who have sex with men and a lack of trans-
inclusive gender affirming sexual health messaging and program.  
Next, at the interpersonal level, participants identified two important facilitators 
influencing PrEP uptake - personal relationships and community connectedness and transphobia 
and HIV-related stigma as a potential barrier. Finally, at the individual level participants 
identified having a realistic perception and understanding of personal HIV risk, reduced 
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psychological distress and increased self-esteem as facilitators to PrEP use. While participants 
discussed two interrelated barriers at the individual level, including hesitation around taking 
PrEP due to the fear that it would negatively interact with the feminizing hormones used for 
gender transition and not wanting to take any additional medication than what they are already 
being prescribed.  
Structural Level Factors Impacting PrEP Use 
PrEP Awareness and Knowledge  
Nearly all of the participants (97%, n=29) reported ever having heard of PrEP. 
Participants identified three factors that impacted willingness to take PrEP: a) types of PrEP 
information, b) how this information was received (e.g., public health campaign; doctor, friend), 
and c) trust in the information source. Key differences emerged between participants on PrEP 
and those not on PrEP with regards to willingness to take PrEP and levels of PrEP awareness and 
knowledge. For example, among non-PrEP users the majority (93%, n=14) had a high-level of 
PrEP awareness. Awareness was operationalized as: a) having ever heard of PrEP and b) 
demonstrating basic knowledge of PrEP (e.g. why PrEP is used and by whom and how effective 
it is).  
I heard about PrEP it’s like 98-99% that you don’t contract HIV. PrEP is Truvada 
when you are on PrEP it’s what you use when you are negative.  
 
- No PrEP Participant 3, 24, TW, Binary, African – American 
This participant demonstrates a basic understanding of PrEP, its effectiveness, who uses it and 
what it does. However, in addition to a basic understanding of PrEP, participants on PrEP 
illustrated greater PrEP knowledge, which included: a) how often PrEP is taken, b) potential side 
effects associated with the medication, and c) how PrEP protects against HIV. All PrEP users 
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reported knowing that PrEP is an HIV antiretroviral drug that is also used to treat individuals 
who are HIV positive.  
I know is that you take it every day, and if you take it every day it’s like 98, 99 
percent effectiveness at stopping the transmission of HIV. My understanding of 
the way that it works is that it’s basically an antiretroviral drug that is part of the 
normal course of treatment for HIV for people who actually have the infection. 
And when you build up enough of it in your blood, there’s enough of the chemical 
floating around in there such that if you come in contact and some of the viruses 
get into you they won’t survive long enough to take hold and to take over the 
white blood cells, etc. I also know that if you take it 4 times a week it’s still 
effective just not as effective so it’s good to take it every day.  
 
– On PrEP Participant 15, 38, Binary TW White 
In the statement above, the participant demonstrates a high-level of PrEP knowledge, including 
the drug’s efficacy if taken every day and how PrEP works to prevent HIV infection. She also 
shares her understanding of PrEP research, which has found that PrEP is still effective if taken 
four times a week (Grant et al., 2010; Grohskopf et al., 2013). Thus, demonstrating how access 
to more specific PrEP information may positively assist in the decision-making process around 
whether to take PrEP (i.e., participant taking PrEP has more information).  
 Next, these results indicate that sources of PrEP information differed between groups. 
The majority of participants not on PrEP (73%, n=11) attributed their PrEP awareness to a recent 
New York City public health campaign, which included subway ads and health information 
pamphlets about PrEP.  
I learned about PrEP from the ads on the subway. I heard two things: one is PrEP, 
and one is PEP. PrEP is something you can take to stop you from getting HIV, 
PEP is something to take after you have been exposed to HIV. That’s all I know 
about PrEP. I don’t know if there are side effects, or where to get it if I want to 
take it.  
- No PrEP Participant 9, 38, Non-Binary, Asian/Pacific Islander 
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Despite a high-level of awareness, this participant demonstrates how basic PrEP information 
does not include two key factors associated with the potential use of PrEP: a) where to get PrEP 
from and b) information on side effects. Further, several participants not on PrEP (60%, n=9) 
echoed the above quotation by reporting that they did not know where to get PrEP and wanted 
more information about the potential side effects associated with PrEP. These results 
demonstrate a major structural barrier to PrEP access and uptake, if participants are interested in 
PrEP but need more information (e.g., potential side effects) yet are unable to access that 
information because they do not know where to get PrEP, potential uptake may not occur.  
Among the small percentage of participants not on PrEP that had not learned about PrEP 
from a public health campaign (27%, n=4), their PrEP awareness was attributed to a one-time 
conversation (often a quick mention of PrEP) where their health care provider talked to them 
about PrEP.  
He (doctor) smoothed it in there. He said, I know you’re a wild card and you be 
out there doing your thing, if you want to try it (PrEP) or get on it just let me 
know. I told him that now I know it’s an option I’ll let him know.  
 
- No PrEP Participant 6 – 28, Binary TW, African-American 
She acknowledges that while her provider made her aware of PrEP it did not increase her 
willingness to take it despite her provider’s implication that she is high-risk. It is possible that the 
providers explicit judgement (i.e., you’re a wild card) about the participant’s sexual activity 
negatively influenced her willingness to take PrEP. Further, the providers approach also 
illustrates the lack of training providers receive in conducting sexual health assessments overall, 
and specifically with TGNBW.  
  In contrast, participants on PrEP learned about PrEP from a number of different sources, 
crediting their knowledge to: a) the internet and social media, b) working in the HIV prevention 
field, c) word of mouth from friends, and d) interactions with health care providers. Several PrEP 
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users (53%, n=8) mentioned a series of YouTube videos on PrEP starring Bob the Drag Queen 
from Rupaul’s Drag Race as one of their first introductions to PrEP.  
I heard about PrEP through the RuPaul’s Drag Race and stuff like when I watch 
them on YouTube and they were talking about PrEP and I was like what are they 
talking about.  
- On PrEP Participant 1, 27, TW, Binary, African- American 
Twenty (20%, n=3) percent of PrEP users reported that working as an HIV prevention 
outreach worker or PrEP navigator gave them access to providers and information that greatly 
increased their knowledge of and willingness to take PrEP.  
I heard about it [PrEP], I feel like mostly just word of mouth, so I knew there was 
this thing called PrEP. But it wasn’t until I started working at an LGBT health 
center and I started learning a lot more about PrEP and I was like oh my god not 
only do I want to get on PrEP ASAP, but I want everyone to know the things that 
I’ve just learned because I felt that they were really game changing.  
 
- On PrEP Participant 2, 29, Non-Binary, Latinx 
This participant talks about how being exposed to more information about PrEP increased their 
willingness to use it as well as their desire to educate others. Furthermore, they indicate that there 
is important information that is not being made accessible to all persons who might benefit from 
PrEP, thus highlighting a barrier to how PrEP information is generated and disseminated.  
 Lastly, all of the participants on PrEP discussed three factors that worked together to 
increase PrEP knowledge and uptake, this included having: a) a friend talk to them about PrEP, 
b) knowing someone on PrEP (especially other TGNBW), and c) a provider who actively 
engaged them around taking PrEP.  
When I first heard about it I wasn’t sure what it was and then maybe a year or two 
ago one of my friends brought it up and said there was PEP and PrEP and I was 
like what’s PEP and PrEP.  So, I asked more questions and she told me about it 
and that’s when I got curious and did some research myself and then my provider 
told me about it too and then I got on it about a year ago.  
 
- On PrEP Participant 4, 28, TW, Binary, API 
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Her quotation illustrates how having a personal connection to the source of PrEP information and 
a friend on PrEP sparked her interest and willingness to seek out more information about PrEP. 
In addition to her connection to others on PrEP and a motivation to learn more about PrEP, 
active provider engagement also aided in her PrEP uptake.    
These results demonstrate that PrEP messaging may be working but awareness is not the 
sole indicator of PrEP uptake.  Despite a high-level of PrEP awareness only 20% (n=3) of 
participants not on PrEP stated that they want to take or would consider taking PrEP. While the 
majority of non-PrEP users (93%, n=14) had heard of PrEP, these results demonstrate a 
disconnect between having heard of PrEP and possessing information on PrEP that is integral to 
the decision-making process around whether to take it or not. Among participants on PrEP, 
awareness was an important facilitator to PrEP uptake, however it was the source of PrEP 
information coupled with the types of information that influenced willingness to take PrEP.  
Active Provider Engagement and Assistance  
Overall, less than half of the total sample (40%, PrEP n=7, No PrEP n=5) reported that a 
provider had ever initiated a conversation with them about PrEP. In contrast, participants on 
PrEP (60%, n=8) who reported not having a provider start a conversation about PrEP indicated 
that they had initially asked their provider about starting PrEP. Participants who had a provider 
actively discuss and/or help with accessing PrEP said that these interactions increased their 
knowledge, access, and uptake. Providers, who had an ongoing dialogue with patients about 
PrEP rather than a one-time discussion, appear to positively influence participant’s willingness to 
use PrEP. Participants on PrEP reported that active provider engagement entailed ongoing 
conversations about PrEP, which included information about the medication’s efficacy and side 
effects as well as how to pay for PrEP. These ongoing conversations provided participants with 
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the opportunity to ask questions and integrate PrEP knowledge, which assisted in the decision-
making process around PrEP uptake.  
He (doctor) brought it (PrEP) up almost every other time we would meet. He 
would say hey this is available to you it’s covered by your insurance in case you 
want to go on it. 
 
- On PrEP Participant 4 – 28, Binary TW, Asian Pacific Islander 
 
This participant illustrates that having her provider talk about PrEP at almost every appointment 
and emphasizing that it is covered by was an important facilitator to her PrEP use.  
Further, a third of participants on PrEP (33%, n=5) identified active provider engagement and 
active assistance as two major facilitators to PrEP uptake at the structural level.  
PrEP was offered to me so frequently in the few interactions I had with my health 
clinic initially they made it so easy to get on. Plus, they helped me get on 
insurance that covered PrEP, that’s exactly the way to do it.  
 
- On PrEP Participant 7 – 29, Binary TW, White 
Active provider assistance included not only educating and offering PrEP but navigating the 
process of insurance and payment assistance for obtaining PrEP.  
They (health center) have a person, a case organizer almost. They’ll make sure 
everything you’re doing with the social worker, the doctor – they also double as 
the PrEP coordinator to get people on PrEP.  
 
- On PrEP Participant 9 – 25, Binary TW, White 
She indicates that having a dedicated staff member within a health center whose role is to assist 
patients in facilitating a range of health care services, including PrEP, encourages PrEP uptake 
by integrating this practice into overall health care.  
Conflation of Transgender Women with MSM 
 Another theme that emerged is the extent to which the conflation of TGNBW with men 
who have sex with men (MSM) is a barrier to PrEP access and uptake. Forty (40%, n=6) percent 
of PrEP users expressed frustration with being categorized as MSM within HIV and other STI 
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prevention services. Participants identified this as a barrier to not only PrEP uptake but also HIV 
and STI testing.  
Yeah, like when you put man or trans woman, then you're already off the bat 
saying that these two things are comparable. But if you just say do you have sex 
with a person with a penis or a vagina then it's more open to interpretation, I think 
they'll have a lot more luck with getting the answers that they need from people. 
And I feel they'll make a lot more people comfortable. 
 
- On PrEP Participant 12 – 26, Binary TW, Latina 
This participant expresses her frustration with being compared to a man and how this practice 
both renders TGNBW invisible and affects the types of information a provider might need to 
accurately assess a person’s sexual behavior and risk. She also recommends that during a sexual 
health risk assessment, providers separate a person’s gender from their anatomy (i.e., asking if 
you have sex with a person with a penis or vagina), which acknowledges that TGNBW have sex 
with partners of multiple genders with varying genitalia. The conflation of transgender and non-
binary women with MSM reinforces the societal belief that natal sex and gender identity are 
immutable by refusing to acknowledge and support TGNBW and accurately describe the factors 
associated with HIV risk among this community.  
Lack of Trans/Gender Affirming Sexual Health Messaging and Programs 
As discussed above the categorization of TGNBW with cisgender gay men renders 
TGNBW and the HIV disparities among this population invisible. Participants stated that the 
practice of lumping TGNBW with MSM contributes to a lack of transgender-inclusive and 
gender-affirming sexual health messaging and programs (which include PrEP). This off-putting 
PrEP messaging, which lacked a transgender inclusive and gender affirming lens was identified 
as a major barrier to PrEP uptake. Ninety (90%, No PrEP = 12, PrEP=15) percent of the total 
sample said that low PrEP uptake among TGNBW was due in part to a lack of trans- 
inclusive/gender affirming messaging. Participants felt that this factor directly contributed to the 
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community’s belief that PrEP was not right for them. Overall, participants stated that current 
PrEP messaging did not reflect their lives as transgender and non-binary individuals.  
I don’t ever see any information that is about trans women or sex workers, if 
you’re putting yourself at risk every day, is it a benefit to take it, will it help you? 
The pamphlets I see are really specific to lovers or partners but what if that’s not 
who you’re having sex with.  
- No PrEP Participant 1 – 37, Binary TW, Latina 
As this participant highlights, the confusion around whether PrEP was for TGNBW is not a 
byproduct of poor risk perception but rather a structural barrier perpetuated throughout PrEP 
messaging and programs that refuse to acknowledge and address the socio-cultural experiences 
of TGNBW. This participant states that PrEP messaging and programs need to be more specific 
and not gloss over the unique needs of the TGNBW community.  
Another issue raised by all participants not on PrEP was whether PrEP protects against 
HIV with multiple partners. The following participant echoes the previous statement, 
highlighting a specific high-risk context in which PrEP would be beneficial for TGNBW.  
I’ve basically heard it protects you if you have one partner. But in the trans 
community there are a lot of trans women who are sex workers, and we don’t 
know if it (PrEP) protects with multiple partners. Because we get paid more if we 
don’t use condoms. So most of the girls don’t use condoms. So, I don’t know if 
it’s true that PrEP will protect us against HIV with multiple partners.  
 
- No PrEP Participant 3 – 24, Binary TW, African-American 
 
This participant identified engagement in survival sex work as a potential risk for HIV. However, 
due to the terminology used in PrEP messaging, which emphasizes sexual partner(s) and does 
not address sex with multiple partners, participants expressed hesitation as to whether PrEP was 
right for them because they did not consider their clients sexual partners. 
 Participants also articulated a need for PrEP messaging campaigns to include images of 
the diverse gender presentations within the TGNBW community. A common thread throughout 
interviews was that many of the transgender women pictured in PrEP and HIV prevention 
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marketing campaigns do not represent the range of gender identities and expressions within the 
TGNBW community. Furthermore, the majority of participants (83%, n=25) stated that unless 
you had some personal connection to the transgender women in PrEP marketing ads you would 
otherwise never know that they were TGNBW.  
A lot of the trans people that they’ve been using in a lot of these campaigns and 
stuff have been… Quote, unquote, for lack of a better term, more passable. And 
that’s not always the reality with our community, and that’s not always what our 
community looks like. So, you need people out there to show the diversity, and 
diversity of presentations.  
- On PrEP Participant 6 – 34, Binary TW, Multiracial 
 
She implies that prioritizing TGNBW who “pass” both sends an explicit message that this is the 
group that would most benefit from and are appropriate candidates for PrEP, while at the same 
time devaluing those who do not.  
Lastly, participants discussed a lack of provider engagement around their overall sexual 
health. Almost everyone, (90%, n=27) stated that their health care provider rarely engaged them 
in discussions around their sexual health outside of standard risk assessment questions (i.e., are 
you currently sexually active? Have you had unprotected anal sex in the past 6 months?)  
Participants discussed how current sexual risk questions, “do you have sex with men, women or 
both?” do not accurately reflect their sexual activity.  
Like no doctor has ever really asked me if my dick still worked or if I could top with it, 
unless I brought something up about it.  
- On PrEP Participant 8, 22, TW, Binary, White  
In the event that a provider did discuss a participant’s genitals with them it surrounded whether 
or not they wanted to get them removed.  
 He’s only asked if I ever want to cut it off. I told him I don’t know if I want that. 
He’s never asked me anything else about it. This is fine with me, but I can see where it 
would be good for him to ask more questions.  
 
- No PrEP Participant 3, 24, TW, Binary, African - American 
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As these two quotations indicate, if providers are not having conversations about the types of 
sexual activity TGNBW are engaging in or asking how this has or has not changed since starting 
hormones they are not adequately assessing risk, fully addressing the sexual health needs, or the 
sexual well-being or satisfaction of this community.  
Overall, participants felt that providers perpetuated the belief that every TGNBW wanted 
to have bottom surgery and that genital health was unimportant because providers only 
acknowledged their genitalia when discussing surgery. Furthermore, participants identified a lack 
of diverse representation of TGNBW in PrEP messaging campaigns coupled with a lack of 
specific information for TGNBW sex workers around why PrEP would be beneficial and the 
dearth of providers willing to engage TGNBW in conversations about their overall sexual health 
created multiple structural barriers to PrEP uptake.  
Interpersonal Level Factors Impacting PrEP Use 
Personal Relationships and Community Connectedness 
Themes of personal relationships and community connectedness emerged as important 
resiliency factors that participants on PrEP said impacted their willingness to integrate PrEP into 
their lives. On the one hand, the fact that few TGNBW are on PrEP was viewed as a vicious 
cycle – TGNBW don’t see/know others on PrEP, so they don’t go on PrEP themselves.  
A lot of my trans friends are positive the vast majority of them, very few of them 
are negative and even fewer are negative and on PrEP.  
 
- On PrEP Participant 6 – 34, Binary TW, Multiracial 
In contrast, 60% (n=9) of women who did go on PrEP often reported that they had people in their 
social network who paved the way. 
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Within my friend group PrEP is something that people are often on. I definitely 
remember some of my friends being on Twitter and not just saying that they were on it 
but also saying that you should consider being on it too. Or at least you should consider if 
it’s right for you to get on it. 
  
- On PrEP Participant 8 – 22, Binary TW, White 
 
Further, close to 50% (n=7) of participants on PrEP talked about a societal responsibility to 
increase social norms around PrEP use in the transgender and non-binary community, viewing 
their PrEP use as not only an individual level protection but a contribution to the safety of the 
trans feminine community, their sexual partners, and society. PrEP users were not ashamed of 
their use, at times proselytizing the benefits and importance of being on PrEP to friends and sex 
partners.  
I want my friends to be on PrEP too. I think it’s important that people are on it 
because it helps reduce and control HIV within, not only our community, but also 
every persons that are having sex. I talk to my sexual partners about it too because 
I want them to be safe as well and also know that they are safe with me as well.  
 
- On PrEP Participant 4 – 28, Binary TW, Asian/Pacific Islander 
Lastly, a third (33%, n=5) of women on PrEP reported that a key aspect to their PrEP 
uptake was a sense of altruism and the chance to be a part of history.  
This is revolutionary I want to be one of the first people to do this. It took time, 
but I pretty much educated myself. To be a part of it is a big thing for me not just 
for myself, for future generations. Part of it is just for the history of it, just to be 
part of making the world a better place, for people, or a little bit of a safer place, 
for folks.  
- On PrEP 6 Participant – 34, Binary TW, Multiracial    
In this quotation, the participant attributes her motivation to use PrEP with the opportunity to 
participate in a movement that will have a lasting impact on HIV infection among future 
generations of transgender women. She acknowledges that her PrEP use is not only benefiting 
her individually but also the community and society as a whole.  
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 Transphobia and HIV Related Stigma 
Over a quarter (27%, No PrEP=3, PrEP=5) of the total sample discussed how societal shame 
and stigmatization around being seen as HIV positive coupled with societal messaging 
describing transgender women as unclean, unsafe, or promiscuous may hinder PrEP uptake. A 
common example articulated by both groups dealt with the public shame and stigmatization 
associated with disclosure of PrEP status.  
The worst thing about being on PrEP is actually letting people know you’re on 
PrEP because people assume that you have HIV.  
 
- On PrEP Participant 14- 27, Binary TW, Latina 
As highlighted in this quotation, several participants stated that the worst part of being on PrEP 
is having someone think that you are HIV positive because you are taking PrEP. Participants 
stated that disclosing their PrEP status whether by choice or being found out (i.e., someone 
seeing a medication bottle for PrEP) was a barrier and negative aspect to PrEP use. 
  Additionally, participants were concerned that disclosing one’s PrEP use implied that 
they were whores or had a crazy sex life.  
Like on BGC (sex/dating website), people will put negative on PrEP and then 
people start asking you got HIV, you HIV positive, that’s the first thing that 
comes even though you are saying PrEP. So, a lot of people don’t want to put that 
because that’s almost spooking, cause if you don’t have it, that’s almost like 
saying you have it. It’s like saying to who you want to have an encounter with 
that you have a crazy sex life.  
 
- No PrEP Participant 3 – 24, Binary TW, African-American 
In this quotation, PrEP use disclosure is viewed as an open invitation for people in the 
community to judge your sex life. Rather than a personal choice that promotes positive sexual 
health care and agency over TGNBW’s HIV risk.  
 A final barrier related to transphobia and HIV stigma deals with the negative stereotypes 
and representation of transgender women in the media.  
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It’s just this past knowledge, seeing transwomen on TV. So, they get freaked out. 
But then I’ll be like, no; actually, things are a lot safer, and that’s not me. So, it’s 
just this reeducation, reeducating people about our experience. It’s good. I enjoy 
doing it. It’s not a thing that we have to do, but for me it’s important. I don’t like 
being misunderstood.  
 
- On PrEP Participant 9 – 25, Binary TW, White 
To combat negative stereotypes of TGNBW this participant uses her PrEP use as a conversation 
starter with potential sex partners in an attempt to dismantle the preconceived notions that 
transgender women are unsafe or dirty. Actively disclosing her PrEP use to others acts as a 
buffer against the negative effects of stigma and discrimination.  
Individual Level Factors Impacting PrEP Use 
Risk Perception  
The role of risk perception in women’s willingness to utilize PrEP as a prevention tool is 
a complicated one, sometimes acting as a facilitator and at other times acting as a barrier. On the 
one hand, risk perception is a facilitator, because women who perceive themselves to be at risk 
want PrEP. But on the other hand, it can be a barrier, if PrEP is not seen as addressing the type of 
risk that is most important to participants or in the event that they are not engaged in high-risk 
activity.  
For all of the participants on PrEP, risk perception was a facilitator to PrEP uptake.  
Since I’m having sex with a lot of people I think it would be different if I was in a 
monogamous committed relationship with someone else who is negative it would 
be a very different thought process about whether I wanted to take it or not.  
 
- On PrEP Participant 8 – 22, Binary TW, White 
 
In this quotation, the participant clearly articulates why they are on PrEP and how their use is 
associated with their actual risk. Furthermore, highlighted in this statement is the understanding 
that if her risk level changed she would reevaluate whether or not to continue to take PrEP.  
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 Current engagement in transactional sex was identified as a motivating factor for taking 
PrEP among 60% (n=9) women on PrEP. Participants viewed HIV risk was an occupational 
hazard associated with transactional sex.  
Sex work is something that I do because I’m unemployed. I don’t know the 
histories of any of  these men I’m having sex with, so…this is why I 
considered and ended up taking PrEP.  
 
- On PrEP Participant 13, 24, TW, Binary, White 
-  
In this quotation, PrEP is used to minimize the risk associated with having sex with individuals 
whose sexual histories are unknown. She is clear that this risk is not just associated with her 
behavior but the contextual factors (e.g., unemployment and sex work) that increase her HIV 
risk.  
 Close to 50% (n=7) of participants on PrEP reported that a major driver for taking PrEP 
was previous scares and experiences where potential exposure to HIV had occurred.  
I had a scare and took PEP. After that I realized, maybe I should get on PrEP 
because it’s just preventative measures and just to keep me safe because what if I 
didn’t have access to something within those 72 hours. That's what really 
motivated me to get on PrEP and hopefully prevent any future mistakes. 
 
- On PrEP Participant 5 – 24, Binary TW, Asian/Pacific Islander 
 
This participant speaks to how PrEP is viewed as a form of harm reduction that is preventative 
especially in the event that PEP is not available. PrEP provides her the peace of mind that if a 
“mistake” happens again she safe and protected. With PrEP HIV is one less thing she has to 
worry about.  
In contrast, for women not on PrEP risk perception was a barrier to PrEP uptake, 40% 
(n=6) of participants not on PrEP talked about being low-risk and how this impacted their 
willingness to use PrEP.  
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It might differ depending on the type of sexual life I have.  Like I said my sexual 
life is very poor so in that way I don’t have to think about it (being on PrEP) but 
somebody who is having multiple partners or doing sex work.  Their thoughts and 
perspectives would be different compared to mine.  
 
-  No PrEP Participant 13 – 37, Binary TW, Asian/Pacific Islander 
This participant both understands why someone may use PrEP (i.e., having an active sex life) 
and why PrEP is not appropriate for her right now. She acknowledges that if she was having sex 
with multiple partners her thoughts and action about PrEP would be different.  
Additionally, women not on PrEP viewed their risk on a continuum, for them current 
low-risk behavior was not an indicator of future need for or use of PrEP.  
If I go back to my old ways being a hot mess and going outside of my boyfriend, 
that’s why I would do it [use PrEP].   
 
- No PrEP Participant 6, 28, TW, Binary, African-American 
This participant acknowledges that while her current risk level does not call for PrEP. She 
realizes that if her risk level were to change she would reevaluate whether to take PrEP. This 
example highlights that risk can change overtime, which speaks to the importance of having 
ongoing conversations about PrEP regardless of current risk.  
  A final barrier to PrEP uptake among participants not on PrEP (53%, n=8) is that it does 
not protect against other STIs.  
It (PrEP) would help me if I was to be on it but at the end of the day HIV is not  
the only thing you can get.  
 
        - No PrEP Participant 3 – 24, Binary TW, African American  
 
This participant knows that PrEP protects against HIV infection and that she would benefit from 
using it. However, this benefit is not enough of a motivation for her to take PrEP because it does 
not protect against other STIs, thus warranting the continued use of condoms.  
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Reduced Psychological Distress and Increased Self-Esteem 
Participants identified increased psychological well-being and sexual enjoyment as a 
major facilitator to PrEP uptake. Forty-three (43%, n=13) percent of the total sample discussed 
how PrEP reduces anxiety and worry around contracting HIV. 
The good part is that you are safer, so you do not have too much stress when you 
are having sex and you can be more open about sex and live a more freer life. 
Psychologically you are more-steady. You don’t have to worry all the time at 
every sexual encounter, OMG do I have HIV.  
 
- No PrEP Participant 9 – 38, Non-Binary, Asian Pacific Islander 
This participant speaks to the psychological and sexual impact associated with HIV rumination. 
Without PrEP sex can be stressful and not enjoyable. With PrEP sex might be/was more 
enjoyable without the constant worry around whether this encounter would be the one where you 
would get HIV. Fifty-three (53%, n=8) percent of the women on PrEP provided concrete 
examples of the stress-reducing effects associated with their PrEP use.  
Actually, I think about it (HIV) less now that I’m on PrEP. Beforehand there were 
condoms involved, but you never know. Whereas now I feel like even if I get 
some sort of weird accidental exposure, it’s probably not going to take. So, I think 
about it (HIV) less.  
 
- On PrEP Participant 15 – 38, TW Binary, White 
For this participant, using PrEP has reduced her worry about HIV by offering a level of 
protection that condoms do not provide. In her statement there is both an acknowledgement that 
condoms are an important part of her HIV prevention practice and that there are situations where 
accidental exposure may occur. It is within this gray area that she no longer has to worry about 
HIV or blame herself if an accidental exposure occurs because she is on PrEP.  
 Finally, an overarching theme among women on PrEP was how their PrEP use is a form 
of resiliency against the stigma and discrimination TGNBW routinely experience. Among PrEP 
users, 60% (n=9) said that using PrEP reduced their sense of fatality around sex.  
 90 
I consider it (being on PrEP) to be very positive because it is making people 
actually think about living and understanding ways of fighting for their lives and 
making them feel a lot more important.  
- On PrEP Participant 14, 27, Binary TW, Latina 
Rather than giving in to the constant messaging that TGNBW are high-risk, thus doomed to get 
HIV, PrEP is viewed as a strategy for increasing self-esteem and self-worth among TGNBW.  
I was obsessed with the idea of not being another number. Like if I’m going to get 
some sort of disease or something, I’d rather it be… Whatever else, like cancer or 
something like that. Like let me not do HIV. 
 
- On PrEP Participant 6, 34, TW, Binary, Multiracial 
Her resolve to not be another number contributes to her motivation to ensure that she does all 
that she can to protect herself from contracting HIV, which includes taking PrEP. Becoming 
HIV-positive is no longer inevitable because these participants take PrEP. PrEP is a tool to fight 
for their life and control over her bodies. Within this context, PrEP is a buffer against ongoing 
experiences of stigma and discrimination faced by TGNBW. 
Lack of Information on Interactions between PrEP and Feminizing Hormone and 
Managing Multiple Medications 
 A common theme expressed by participants was whether PrEP would negatively interact 
with their existing cross-gender hormone regimen by limiting the hormones effectiveness. For 
the vast majority of the women the number one health care priority was their gender transition. 
Any medication that would interfere with this process as well as add more physical burden to 
their bodies was viewed as a barrier to PrEP uptake.  
I wanted to know if it was going to affect my hormones because I was also taking 
all these pills at the time and I was like what is my body going through all of this 
just to be who I am. I wanted to know if it was going to affect my body physically 
in anyway.  
 
- On PrEP Participant 5 – 24, Binary TW, API 
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As the following non-PrEP user states, prior to PrEP initiation it would be important for her to 
know what if any impact PrEP would have on her gender transition.  
If I was to take that (PrEP) I would want to know how it would react to my 
hormones would I be to take my hormones while I take this medication. 
 
- No PrEP Participant 11, 34, TW, Binary, Multiracial 
Both participants speak to the prioritization of their gender transition and the concern that PrEP 
would negatively affect this process. While both groups of participants had similar concerns 
about potential drug-to-drug interactions between PrEP and hormone interactions, additional 
information is needed to understand the types of information PrEP users received which 
positively influenced their willingness to take PrEP.  
Another common barrier was not wanting to take additional medications. Sixty-seven 
(67%, n=10) of participants not on PrEP indicated that they did not want to add PrEP to their 
existing medication regimen.  
I take so many pills, I take spironolactone, estrogen, plus my psych meds. I’m anti 
taking a pill it’s like popping tic tacs. I just don’t want to pop another pill which is 
why I wouldn’t take PrEP.  
 
- No PrEP Participant 12 – 35, Binary TW, Multiracial 
Another non-PrEP user reiterates the sentiment above.  
 
I’m taking all this medication, pills to go to sleep, my hormone medication, and 
my antidepressant pills. That’s too much. My body is being through hell with all 
the medications I’m taking.  
 
- No PrEP Participant 3 – 24, Binary TW, African-American 
-  
These women highlight that participants not on PrEP may prioritize their gender transition and 
mental health over HIV prevention, thus highlighting the need for PrEP to be integrated into 
overall health care for TGNBW. In addition, not wanting to take too many medications may also 
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be associated with pill fatigue. These participants may be more likely to take PrEP if it was 
available in other forms.  
Finally, to address the potential barrier posed by taking an additional medication, a 
possible facilitator to PrEP uptake may be a new form of PrEP that is currently in Phase 3 
clinical trials. Long-acting injectionable PrEP would potentially require users to receive a shot 
every 8 weeks, limiting the need for daily oral PrEP over time, thus, counteracting the barrier of 
managing multiple daily medications. Twenty-seven (27%, n=4) percent of participants not on 
PrEP stated that they would be interested in taking PrEP if it was in a long-acting injectable 
form.  
I like shots they can last up to a month. That would be a lot easier because I’m not 
very consistent with taking pills. Shots are much better.  
 
- No PrEP Participant 4 – 22, Binary TW, African-American 
-  
Long-acting injectable PrEP for some would be similar to their hormone shots, which was 
viewed as more favorable than a daily pill and would assist with adherence. For those taking 
hormone shots every week getting an injection was familiar and not seen as a burden. These 
participants preferred an injectable form of medication because it was perceived to have less 
physical impact on the body compared to a daily oral pill. In addition, participants felt that not 
having to remember to take a pill every day coupled with the length of the dosage would 
positively affect adherence.  
Summary 
 The results above demonstrate key elements impacting TGNBW’s willingness to use and 
adhere to PrEP at the structural, interpersonal, and individual levels. The structural factors 
identified highlight areas in which institutional policies and practice impact willingness to use 
PrEP among TGNBW. Access to consistent PrEP information from a variety of different sources 
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indicated a high-level of PrEP knowledge and greater PrEP uptake among participants. PrEP 
users had more access to PrEP information from a variety of sources compared to non-PrEP 
users. Participants on PrEP identified active provider engagement and assistance with accessing 
PrEP as a major structural facilitator to PrEP uptake. Providers who had ongoing conversations 
with their patients about PrEP were credited with increasing participant’s PrEP knowledge and 
uptake. Furthermore, PrEP users who had help from a provider navigating insurance and 
payment for PrEP acknowledged the influence this practice had on their PrEP use. Two 
structural barriers to PrEP uptake emerged, the conflation of TGNBW with MSM and a lack of 
transgender/gender affirming sexual health messaging and programs. Participants across both 
groups stated that being categorized as a man/MSM in HIV prevention programming and 
policies rendered TGNBW invisible and inaccurately portrays HIV risk factors as solely due to 
individual behavior. Participants also identified how a lack of transgender and gender affirming 
messaging and programming specific to the HIV risk environments TGNBW are forced to 
engage in reinforces the conflation of TGNBW with MSM and erases the HIV prevention needs 
of this high-priority community.  
 At the interpersonal level, personal relationships and community connectedness 
represented facilitators to PrEP uptake. Participants stated that knowing friends who were on 
PrEP increased their PrEP awareness and uptake. Participants on PrEP expressed a sense of 
responsibility to affect social and cultural norms around PrEP use and the TGNBW community. 
PrEP was also viewed as a game changer in the fight against HIV and the majority of 
participants on PrEP felt that taking PrEP was an important step in the fight against HIV and 
offered the chance to be a part of this historical moment.  
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 Finally, at the individual level participants identified several factors associated with PrEP 
uptake. Perception of HIV risk was both a facilitator and barrier to PrEP uptake, participants who 
perceived themselves to be at risk wanted PrEP. However, risk perception was a barrier to PrEP 
uptake for participants whose HIV risk was low or for whom PrEP did not address the type of 
risk most important to them. Participants in both groups identified increased psychological 
wellbeing and sexual enjoyment as major facilitators to PrEP uptake. Taking PrEP increased 
participants’ self-esteem by reducing the sense of fatalism around HIV commonly found within 
the TGNBW community. Two final individual level barriers were a lack of information on drug-
to-drug interactions between PrEP and commonly used feminizing hormone treatment and 
managing multiple medications.  
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CHAPTER 7: SUGGESTIONS FOR BEST PRACTICE TO INCREASE  
PREP UPTAKE (RQ 3) 
Participants in both groups were asked to provide suggestions for best practice to increase 
PrEP access, uptake, and adherence among TGNBW. Each section below addresses an important 
facet to providing transgender inclusive and gender affirming sexual health, which includes 
PrEP. Participants identified three main shifts in programming to increase willingness to take 
PrEP among TGNBW: a) transgender inclusive and gender affirming sexual health messaging 
and programs, 2) ongoing active provider engagement and assistance with PrEP, and 3) 
strategies which support community mobilization/activism around PrEP.  
Transgender Inclusive and Gender Affirming Sexual Health Programs 
 
As discussed above (see section on structural-level factors), participants across both 
groups identified the need for transgender inclusive and gender affirming HIV prevention and 
sexual health education literature and messaging. Participants consistently said that by conflating 
TGNBW and MSM HIV prevention policies and practice ignored the specific sociocultural 
experiences of their community.  
We are human, so we need to have our own organization. I feel like we are 
entitled to a lot of things. But I feel like they single us out because they can’t tell 
if we’re part of the heterosexual community or men-fucking-men community and 
everything. They just want to place us in a community that’s just gay, and that’s 
not even the actual. 
- On PrEP Participant 14, 27, TW, Binary, Latina 
Here she implies that by categorizing TGNBW with MSM, HIV prevention policies and practice 
have ignored the specific HIV prevention needs of this community. She suggests that to best 
serve the community there is a need for transgender specific organizations that view TGNBW as 
people rather than trying to force them into a community they are not a part of.  
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Women in both groups indicated that messaging and programs must include images of 
diverse gender presentations, and not prioritize TGNBW who “pass”.  
You put it out there front and center, so nobody’s mistaking it whatsoever. You 
need somebody that – I mean, for lack of a better term – isn’t afraid of getting 
spooked by the general public. Somebody who’s not afraid to come out and say, 
“I’m trans. Hi.” On the side of a bus. And I think it’d be great to show people at 
different stages of transition, and different presentations. I think that’d be a good 
thing to see.  
- On PrEP Participant 6, 34, TW, Binary, Multiracial 
This participant indicates that in order to reach all TGNBW, HIV prevention campaigns must 
include images of the range of gender presentations found within the community, including 
images of TGNBW at different stages of transition.  
Another theme that emerged is the need for the development and design of sexual health 
assessment tools and health education literature that is transgender inclusive and gender 
affirming. Participants suggested that these assessment tools and literature must accurately 
represent the various genders and genitalia TGNBW are having sex with, openly address sex 
work, assess for experiences of sexual violence, and discuss the limited data about whether PrEP 
interferes with hormones.  
 Participants said that PrEP messaging for TGNBW must include language around sex 
with multiple partners and sex with clients/dates. Non-PrEP users who engaged in survival sex 
unequivocally said that they did not know if PrEP was right for them due to the language in PrEP 
health education pamphlets, which does not address engagement in transactional sex.  
I don’t ever see any information that is about trans women or sex workers, if 
you’re putting yourself at risk every day, is it a benefit to take it, will it help you? 
The pamphlets I see are really specific to lovers or partners but what if that’s not 
who you’re having sex with. 
 
- No PrEP Participant 1, 37, TW, Binary, Latina 
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This participant illustrates how messaging campaigns and health education literature, which 
neglects to directly discuss issues pertaining to TGNBW are ineffective at reaching those who 
would most benefit from PrEP.  
Another area that needs to be addressed in assessment tools and health education 
literature are experiences of sexual violence. Overall, the majority of participants reported 
multiple experiences of sexual violence. Participants expressed the need for providers to address 
these experiences.  
It’s absolutely astonishing. I don’t know a single trans woman who hasn’t been 
raped – myself included. It just kind of happens, and you just kind of have to deal 
with it, and that’s it. It’s amazing. So just right there – you’re going to be the 
victim of violence. You’re going to be discriminated against. You just kind of 
have to mentally get there, figure out ways of coping before it happens. And the 
doctor should be talking to trans patients about this, period. If a doctor’s not 
talking to them about this stuff, the doctor is not doing the job, in my opinion. 
 
- On PrEP Participant 15, 38, TW, Binary, White 
This participant identifies the stark reality of sexual violence experienced by TGNBW. Given the 
disproportionate rates of sexual violence experienced by this community, PrEP is viewed as an 
important protective factor. However, if health care providers are not addressing this with their 
TGNBW patients they are missing a critical point of contact to discuss HIV prevention and 
PrEP.  
 Finally, the following quotation outlines some of the main points PrEP messaging and 
health information campaigns should highlight to other TGNBW, including the creation of PrEP 
literature that emphasizes how and why PrEP is important.  
I just need for them to really explain to people how this can really help you, 
especially if you’re doing sex work and stuff. I feel like they should emphasize 
how important this is and tell people that it’s not going to affect your hormones in 
any way.  
- On PrEP Participant 5, 24, TW, Binary, API 
This participant talks about reaching groups that are most likely to benefit from PrEP, such as 
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TGNBW sex workers. She emphasizes the importance of educating TGNBW about PrEP’s 
benefits overall as well as how it is specifically helpful and necessary within the context of sex 
work. Finally, she acknowledges that it is important for providers to address the drug-to-drug 
interactions between PrEP and feminizing hormones given that the gender transition process is 
often a top priority for TGNBW.  
Active Provider Engagement and Assistance 
 
 Active provider engagement and assistance around PrEP emerged as key factors to 
increasing PrEP awareness, access, and uptake among the TGNBW community. Active 
engagement by health care providers referred to having an ongoing dialogue about PrEP rather 
than a one-time discussion. It is important to reiterate that 60% (PrEP=8, No PrEP=10) of the 
total sample had never had a provider discuss or offer PrEP, highlighting a missed opportunity to 
directly impact the HIV incidence rates among TGNBW. Active assistance was identified as 
PrEP navigation services that included help with obtaining insurance and/or other payment 
options.  
I think it just should be proactively offered in whatever way possible. With as 
little cost as possible. And I know that there are… Even if you don’t qualify for 
Medicaid or something for whatever reason, or if… Like some people are still on 
their parents’ insurance, and their parents’ insurance doesn’t cover it, there are 
programs to relieve the financial burden of getting on PrEP for people who are at 
highest risk.  
On PrEP Participant 7, 29, TW, Binary, White 
This participant highlights that reducing the structural barrier of cost and payment coupled with 
ongoing offers for PrEP were important facilitators to both her willingness to take PrEP and 
actual PrEP uptake. Participants also identified specific suggestions to reach those deemed most 
at risk for HIV, which included PrEP-related outreach services to sex workers to increase 
awareness, knowledge, and uptake.  
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By going out and doing education, educate people, educate us girls. Educate, 
educate, educate. Even if you have to go out to the stroll. And ask you ever heard 
about this?  
- No PrEP Participant 1 – 37, Binary TW, Latina 
The following quotation echoes the sentiment above.  
I really like seeing the outreach to cars in the areas, like in the village when they 
come by. Especially homeless trans women and they hang out on the pier and 
stuff, they’re not taking the time to get checkups. They’re focused on surviving 
first. So, going out to them and doing that outreach I think is an amazing way, 
because then they’re right there. 
 
- On PrEP Participant 5 – 24, Binary TW, API 
These participants explain that active engagement means going to street-based sex workers to 
provide PrEP education. As the participant above suggests, when surviving is your first priority 
TGNBW may not be access health care on a regular basis. Providers need to go out and literally 
ask have you heard of PrEP, instead of waiting for these women to come and ask for it. Both 
participants highlight the importance of low threshold services such as outreach teams and vans 
to increase awareness and acceptability towards PrEP, specifically among TGNBW engaging in 
survival sex. 
Finally, active provider engagement is not just asking someone if they are interested in 
PrEP. Participants suggested that providers must actively engage in conversations around PrEP 
by explaining what PrEP is, how it works, dosage and adherence information, and potential side 
effects. 
Encouraging doctors or medical providers to specifically ask about PrEP, and 
maybe even ask it with some information about what PrEP is. When I was asked – 
I mean I knew what PrEP was, I’d heard of it, but I was just asked if I was 
interested in PrEP. And so, if I didn’t know what it was, I would’ve just said no, 
not really knowing what I was being asked.  
 
- On PrEP Participant 8 – 22, Binary TW, White 
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This participant talks about how a lack of provider engagement (i.e., providing PrEP 
information) was a potential barrier to PrEP uptake for her. She highlights the importance of 
providing PrEP information in conjunction with asking patients if they want PrEP. This suggests 
that providers move away from assessing sexual risk using closed ended questions to having 
more open-ended conversations about sexual health.  
Community Mobilization and Activism 
Strategies that explore community mobilization/activism emerged as important 
facilitators to increasing awareness and trust around PrEP. Participants talked about a need for 
role models within the community who were willing to openly discussed their PrEP use.  
While I was considering if I wanted to take it or not – I was seeing people who 
were on it talk about it. Like friends of mine who were on it. So, encouraging 
people to talk about being on it [PrEP] is important.  
 
- On PrEP Participant 8 – 22, Binary TW, White 
For this participant an influential factor to her PrEP use was having friends and others in her 
community openly talk about their use.  
Furthermore, participants on PrEP acknowledged that in many cases their first 
information about PrEP came from friends and not a provider.  
My friend told me about it. She used to do sex education classes for us [her 
friends]. She taught me about it. She was like, girl, you know, they’ve got that 
new PrEP. So, I did some research on it and started taking it from there.  
 
- On PrEP Participant 11, 28, TW, Binary, African-American 
She talks about the impact her friend had on her willingness to use PrEP. She acknowledges the 
trust that comes from an established relationship with someone who is like you and how this 
opened the door for her seek out more information and ultimately get on PrEP.  
Conversely, PrEP users also discussed a sense of responsibility to educate their friends 
about PrEP.  
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I tell my friends about PrEP, because I want them to know about it. I don’t want 
my friends to be walking around here, and they have the opportunity to be 
prevented from getting HIV – I want them to know about the PrEP, so it can 
prevent them, especially when you like to do it raw. You need to be on the PrEP. 
But I encourage them to use protection. But I prefer them to use the PrEP, 
because they can protect themselves from the HIV. 
 
- On PrEP Participant 11, 28, TW, Binary, African-American 
Regardless of whether they decide to take PrEP or not, she emphasizes the importance of 
providing her friends with the knowledge to make informed decisions around whether to take 
PrEP. This participant expresses a fear around not sharing this life saving information with 
friends. She feels that it is important to educate her friends because she does not want her friends 
to be at risk for HIV and potentially seroconvert because they did not know about PrEP.  
Summary 
 
 Participants gave concrete examples for best practice to increase TGNBW’s willingness 
to use PrEP. To increase PrEP awareness and uptake, HIV prevention and sexual health 
programs need to be transgender inclusive and gender affirming. Participants said that stopping 
the practice of categorizing TGNBW with MSM was the first step to creating affirming HIV 
prevention programs. Sexual health campaigns must include images of people with diverse 
gender presentations and at different stages of gender transition, rather than prioritize TGNBW 
that “pass”. Participants stated that HIV prevention and PrEP programs need to develop 
transgender inclusive and gender affirming sexual health assessment tools and health education 
literature that accurately represent the persons TGNBW are having sex with, the high-risk 
contexts they are having sex in, and information on drug to drug interactions between PrEP and 
cross-gender hormones.   
 Participants also identified active provider engagement around PrEP and active assistance 
with getting insurance or payment for PrEP as key factors associated with willingness to take 
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PrEP and PrEP uptake. Participants stated that active provider engagement included giving 
patients information about PrEP when offering it to them and having ongoing conversations with 
patients about PrEP rather than mentioning it one-time. In addition, several women said that 
active provider engagement was about creating PrEP-related outreach services to reach TGNBW 
who would most benefit from PrEP, such as street-based sex workers.  
Finally, participants on PrEP shared community mobilization/activism strategies to 
increase PrEP knowledge and uptake among TGNBW. Participants talked about the importance 
of having community members openly talk about their PrEP use. They also highlighted the need 
for providers to acknowledge and support the role of friends in the dissemination of PrEP 
information. Participants said that seeing and talking to friends on PrEP was instrumental to their 
willingness to take PrEP. Participants on PrEP also reported a sense of responsibility to share 
their PrEP knowledge with other friends and community members to increase knowledge and 
uptake.  
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CHAPTER 8: GENDER AFFIRMATION AND HIV RISK (RQ 4) 
 
Themes of gender affirmation and high-risk contexts emerged as important factors 
associated with HIV risk among transgender and non-binary women. Participants discussed the 
community’s HIV risk in general, and their own risk specifically, as byproducts of societal 
oppression where a high need for and low access to gender affirmation led TGNBW to seek out 
gender affirmation in high-risk contexts where HIV transmission is more likely to occur, such as 
survival sex work and sexual encounters under the influence of drugs and/or alcohol. Embedded 
in participant’s narratives was the belief that systemic factors such as racism, transphobia and 
sexism were driving HIV risk among transgender women, not solely individual sexual behavior. 
For example, participants discussed how systemic racism, transphobia, and sexism were 
associated with housing and employment discrimination among TGNBW. The lack of housing 
and employment opportunities forced TGNBW into situations (e.g., survival sex work) where 
survival is intrinsically linked to HIV risk.  
Participants stressed the relationship between needing to survive, sex work as a means for 
survival, experiences of sexual violence, and HIV risk. Several rejected the common narrative 
that health care, social service providers, researchers, and public health officials perpetuate, 
which asserts that TGNBW chose to put themselves in risky situations. Thus, placing blame on 
the individual rather than acknowledging the structural factors contributing to HIV risk. 
A lot of us trans women of color are forced to do survival sex work. I’m not going 
to say we put ourselves in a risky life, but we’re forced to do this. It’s survival. 
PrEP is really important because it’s helping us minimize our risk when we do 
what we do to survive in this cruel world.  
 
- On PrEP Participant 5, 24, TW, Binary, API 
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This participant sees HIV risk as something that is forced upon transgender women, rather than 
resulting from behavioral choice or agency. PrEP is seen as a type of harm reduction, minimizing 
the negative effects of behavior that is necessary for survival. 
One participant spoke to the specific risk of sexual violence transgender and non-binary 
women face in order to survive. This 26-year-old participant on PrEP shares that when she first 
moved to New York City she was homeless, in an attempt to find a place to stay, she met up with 
a cisgender man on Grindr who offered her a place to stay for the night with no strings attached. 
However, once at his place the participant was sexually assaulted and ended up naked running 
through the streets in the middle of the night in search of help. It was after this experience that 
she got on PrEP.  
There’s a lot of risk involved [in living/surviving]. A lot of risk. So, PrEP was 
basically a necessity, especially after what happened to me (being raped), is when 
I got it prescribed. It was like, you have to be on this, especially being so 
vulnerable, this can happen again, and if you’re going to survive you might have 
to do those things that you don’t like, and you don’t like to do, and they might not 
be as safe as you’d like them to be, you know? 
 
- On PrEP Participant 12, 26, TW, Binary, Latina 
This participant discusses the choices she is forced to make to survive. Risk is an ongoing part of 
survival for transgender and non-binary women and PrEP is viewed as necessary for survival.  
 Participants used the word vulnerable to describe both their physical and emotional state 
during sexual encounters, often stating they had to be careful or safe because they did not want to 
find themselves in dangerous situations when meeting up with a potential sexual partner or 
client.  
Trans women are naturally vulnerable. A lot of us are rejected by our families and 
we are forced into situations where we are exposed to certain situations and 
clients who disregard our lives or our existence.  
  
- No PrEP Participant 7, 26, TW, Binary, White 
 105 
Vulnerability is attributed to a social and economic positioning, which comes from being 
rejected by friends, family, and society as a whole. The threat of danger associated with being 
forced into high-risk situations to survive and being regarded as less than human is viewed as 
larger than HIV risk or other threats.  
  Overall, participants mentioned personal experiences with sex work due to economic 
disenfranchisement, contextualizing HIV risk as an occupational hazard rather than a moral 
failure or behavioral issue. Several participants talked about how clients offered financial 
incentives for condomless sex.  
I just feel like it’s (PrEP) a good safety tool. I’m gonna be honest with you, I have 
my routine base, I have my procedures it’s always safe, safe, safe, but even in my 
work there are guys that request or they are offering something that would benefit 
me in exchange for something raw. It’s more of a safety thing to have.  
 
- No PrEP Participant 7, 26, TW, Binary, White 
In this way, PrEP is viewed as a life-saving precaution that should be available to all TGNBW. 
Again, HIV risk is talked about as something that is forced on transgender and non-binary 
women in order to survive, rather than individual sexual behavior or poor risk perception.  
Experiences of sexual violence/sexual assault emerged as another high-risk context in 
which HIV risk is externally generated for transgender and non-binary women. Participants said 
that experiences of sexual assault were not an if but a when. Seventy percent (70%, n=21) of the 
total sample, stated that they had been sexually assaulted or raped.  
Not every time I have had sex have a been a willing participant. I’ve been 
sexually assaulted a few times. I mean, definitely when it happened, one of the 
first things I worried about was HIV. Now, at least I’m taking PrEP, if, god 
forbid, it [being sexually assaulted] were to happen again, at least it’s one less 
thing for me to really worry about. You know, because the chance is so miniscule 
[of getting HIV], if you’re taking your PrEP.  
 
- On PrEP Participant 6, 34, TW, Binary, Multiracial 
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This participant expresses a relief in knowing that she is protected and does not have to 
worry about HIV if she is ever in another situation where she is forced to have sex. PrEP is seen 
once again as a form of harm reduction in a context where HIV risk is not a result of individual 
behavior or a lack of agency.  
While research has consistently documented the increased rates of sexual and physical 
violence among TGNBW, the conflation of TGNBW and MSM within HIV prevention and PrEP 
related literature has neglected to examine the relationship between experiences of sexual 
violence among women and HIV risk. The following participant not on PrEP expresses how 
women cannot trust men when it comes to their sexual health.  
I have a girlfriend who trusted a guy to come over and he raped her. She went to a 
clinic because she was scared that she had caught something. PrEP definitely 
needs to be readily available because any woman could have some guy be like no 
I don’t want to use a condom or he could put something in my drink.  
 
- No PrEP Participant 7, 26, TW, Binary, White 
This participant does not distinguish or separate out transgender and non-binary women from 
cisgender women, acknowledging that sexual violence and assault is a women’s issue. By saying 
“any woman” this participant is affirming her own gender as a woman, while also 
acknowledging that sexism puts her at risk from men. Within this context, PrEP can be a means 
for women to have agency over their sexual health and bodies in a world that views them as 
objects to be used and assaulted for men’s pleasure.  
Lastly, sexual experiences under the influence of drugs and/or alcohol emerged as a final 
high-risk context in which PrEP would be beneficial for transgender and non-binary women. 
Research has consistently documented that TGNBW are more likely to engage in condomless 
anal sex when using drugs and/or alcohol (Nemoto, et al., 2004; 2011; Operario, et al., 2014; 
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Risser, et al., 2005) thus increasing their risk for HIV. Participants stated that PrEP would be or 
was beneficial in situations where someone got too drunk or risked being drugged.  
Like when I get too drunk I’ll do stupid things and when I wake up in the morning 
and I feel better because at least I know that this (PrEP) is protecting me. Because 
before I would be like shit I have to worry about this. 
 
- On PrEP Participant 9, 25, TW, Binary, White  
This participant highlights her understanding of the factors which increase her risk for HIV and 
the role PrEP plays within this context. PrEP becomes a strategy for safety, reducing both risk 
for HIV and the psychological distress around potential HIV exposure due to having condomless 
sex when intoxicated.  
Finally, the following participant touches on the various social, psychological, and 
structural factors associated with gender affirmation and HIV risk among TGBNW.  
Trans women are treated as non-people and fetish objects (emphasis added 
throughout). If you’re going to try to date a guy, which if you don’t pass, or 
you’re not quite full-time yet, there’s no guys that are dating you. They’re coming 
over to have sex with you and leave. And if you have a thing for straight guys on 
top of that, you’re entering a world of bad things. So basically, you’re being 
treated like a disposable sex toy. So, people just … they might just not wear a 
condom even if you want them to. And there are definitely plenty of trans girls 
out there who just don’t have the – whatever it is – that you need to kick a guy off 
of you or tell them no way even before they get there. Because you need to be 
validated and you need to feel like you’re attractive and all that stuff. So, I mean 
there’s that much that goes on. And then also economic opportunities for women 
like myself are limited. And there’s plenty of women from all backgrounds that 
just wind up homeless and addicted to methamphetamine or heroin and need 
money for that. They just wind up in a bad spot fast, so fast. There’s a lot of 
women who don’t want to be sex workers who are because of their circumstances. 
And then your customers … you may think that your clients deserve whatever 
they want for the money. You feel like you don’t have it (agency over your 
circumstances) because society looks down on you. You’re at the lowest rung 
now. So, you have no right to ask for anything. You’re lucky you don’t get killed 
walking down the street. 
 
- On PrEP Participant 15, 38, TW, Binary, White  
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She articulates the relationship between HIV risk, gender affirmation, and high-risk contexts. 
She talks about the extreme marginalization TGNBW experience due to transphobia and how 
stigma and discrimination force this community into environments where HIV risk is associated 
with sexual violence, engagement in sex work, and drug and/or alcohol use. She goes on to talk 
about the psychological and behavioral impact consistent messaging of worthlessness have on 
TGNBW. And how these messages silence TGNBW and reinforce a sense of gratitude TGNBW 
must express for being allowed to live in the world and not killed because they are viewed as less 
than human.  
Summary 
Throughout each interview, participants consistently discussed various high-risk contexts 
(e.g., survival sex work) where HIV risk is associated with racism, sexism, and transphobia (e.g., 
housing and employment discrimination). Participants viewed their HIV risk as a complex 
multilayer process driven by stigma and discrimination at the structural, interpersonal, and 
individual levels. Participants highlighted the relationship between sex work as a means for 
survival, experiences of sexual violence, and HIV risk. Participants discussed the high-risk 
situations they are forced to engage in to survive. Risk is seen as an ongoing part of survival for 
transgender and non-binary women and PrEP is a form of harm reduction that minimizes the risk 
associated with survival. Across both groups, HIV risk was seen as an occupational hazard 
associated with engagement in sex work due to the pervasive economic disenfranchisement 
experienced by TGNBW. PrEP is viewed as a life-saving precaution that mitigates HIV risk 
associated with survival, rather than individual sexual behavior or poor risk perception. 
Participants identified experiences of sexual violence and sexual assault as another high-risk 
context in which HIV risk is externally generated for transgender and non-binary women. PrEP 
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gives women agency over their sexual health and bodies. Finally, sexual experiences under the 
influence of drugs and/or alcohol also emerged as a high-risk context in which PrEP would be 
beneficial for transgender and non-binary women. Within this context, PrEP becomes a strategy 
for safety, reducing both risk for HIV and the psychological distress around potential HIV 
exposure due to having condomless sex when intoxicated. Highlighted throughout these 
examples is that TGNBW understand that HIV risk and survival are not mutually exclusive. Yet, 
public health and HIV prevention programs for TGNBW do not acknowledge the relationship 
between survival and HIV risk. Messaging and programs around HIV risk and PrEP do not talk 
about sex work, sexual violence, or drug and/or alcohol use, opting to solely focus on the sexual 
act itself instead of the larger context in which sexual activity is taking place.  
Conclusion 
 
These data illustrate the structural, interpersonal, and individual level factors associated 
with PrEP acceptability, uptake, and access. All study participants met multiple eligibility 
criteria for PrEP, thus are deemed most in need of and likely to benefit from PrEP. Demonstrated 
throughout each thematic area, is the missing component that context matters in HIV prevention 
and that missed opportunities to reduce HIV infection occur by solely focusing on sexual 
behavior. Labeling and targeting certain groups as high-risk with one size fits all HIV prevention 
messaging and programming renders invisible the social, psychological, and behavioral factors 
associated with stigma and discrimination at the intersection of racism, transphobia, and sexism. 
The next chapter will discussion the study’s findings and implications for HIV prevention policy 
and social work practice.  
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CHAPTER 9: DISCUSSION 
Introduction 
In the United States, transgender and non-binary women (TGNBW) are a highly 
vulnerable and marginalized community disproportionately affected by HIV (Baral et al., 2013; 
Herbst et al., 2008). HIV prevalence among TGNBW is estimated at 27.7%, higher than the 19% 
prevalence among cisgender men who have sex with men and STI prevalence among TGNBW is 
estimated at 21% (Herbst et al., 2008). The highest HIV prevalence is found among African 
American transgender women, averaging 56.3%.(Herbst et al., 2008). Additionally, a recent 
analysis of data from the Center for Disease Control (CDC) found that between 2009-2014, of 
the transgender people with newly diagnosed HIV infection in the US, 84% were transgender 
women with 80% representing women of color (50.8% African American, 29.3% Latinx) (Clark 
et al., 2016). 
A growing body of evidence demonstrates that TGNBW face numerous challenges which 
negatively influence their quality of life including, poverty, violence, incarceration and routine 
discrimination in housing, employment, educational, health care and social service settings 
(Grant, et al., 2011; James, et al., 2016; Khan, 2011; Lombardi, Wilchins, Priesing, & Malouf, 
2001; Nemoto, Bödeker, & Iwamoto, 2011; Reisner, Bailey, & Sevelius, 2014; Testa et al., 
2012).  In addition to experiencing disparate rates of HIV infection, TGNBW are also at high 
risk for a host of adverse health outcomes, including substance misuse, depression, anxiety, and 
suicide (Baral et al., 2013; Benotsch et al., 2013; Clements-Nolle, Marx, Guzman, & Katz, 2001; 
Clements-Nolle, Marx, & Katz, 2006; Goldblum et al., 2012; Haas & Rodgers, 2014; Herbst et 
al., 2007; Neilands, & Sevelius, 2013; James, et al., 2016; Keuroghlian, Reisner, White, & 
Weiss, 2015; Reisner, Gamarel, Nemoto, & Operario, 2014; Reisner, Pardo, Gameral, Pardee, 
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Keo-Meier, 2015). For example, the 2015 United States Transgender Survey (USTS) (James, et 
al., 2016) found that transgender adults were more likely to use drugs (29%) and alcohol (63%) 
compared to the US general population (10% and 56% respectively) (Center for Behavioral 
Health and Statistics, 2015; 2016). Further, 82% of the USTS' respondents reported having 
serious thoughts about suicide, and 40% had attempted suicide at some point in their life 
compared to 4.6% of the US general population (James et al., 2016). Research has consistently 
documented how the many risks to the physical, emotional, and social health of TGNBW results 
from social stigma and negative societal response towards gender non-conformity at the 
structural, interpersonal, and individual level (Bradford, Reisner, Honnold, & Xavier, 2013; 
Clements-Nolle, Marx, Guzman, & Katz, 2001; Clements-Nolle, Marx, & Katz, 2006; Grant et 
al., 2011; Herbst et al., 2007; Lennon and Mistler, 2014; Lombardi, 2007; Nuttbrock et al., 2012; 
Testa et al., 2012; Wilson et al., 2009; Xavier, Bobbin, Singer, & Budd, 2008). The results of this 
dissertation support and add to the growing body of literature on the relationship between stigma, 
discrimination, decreased quality of life, and adverse health outcomes among the TGNBW 
community in three ways. First, the study findings provide evidence that supports the existing 
literature on the negative impact of stigma and discrimination at the structural, interpersonal, and 
individual level. Next, these results contribute much-needed data on how stigma and 
discrimination influence HIV risk. Finally, study findings present several resiliency factors at the 
structural, interpersonal, and individual level that mitigate HIV risk among this community.  
  Despite their disparate rates of HIV infection, the unique HIV risk and prevention needs 
of TGNBW have largely been ignored in HIV surveillance data and research because they are 
categorized as cisgender men who have sex with men (MSM). Most recently, the mis-
categorization of TGNBW as cisgender MSM has contributed to a striking lack of research on 
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pre-exposure prophylaxis (PrEP) (the newest and most efficacious biomedical HIV prevention 
intervention) use among TGNBW. This lack of research is particularly striking in the field of 
PrEP for two reasons: 1) PrEP is a highly effective method of HIV prevention and 2) TGNBW 
are a priority population for which no efficacious HIV prevention intervention exists. In fact, 
when TGNBW are discussed or included in PrEP research or programs, often they are lumped 
together with cisgender MSM. By disregarding self-identified gender identity, PrEP research 
does not address the specific sociocultural and contextual factors that contribute to HIV risk 
among this community, thus creating barriers to PrEP uptake at the structural, interpersonal, and 
individual level. This dissertation was designed to identify the facilitators and barriers to PrEP 
access, uptake, and adherence among TGNBW at risk for HIV. In doing so, this study addressed 
four key research questions: 1) what are the individual, community, and structural level factors 
impacting transgender women’s willingness to utilize PrEP as an HIV prevention tool? 2) To 
what extent do these factors impede the integration of PrEP into the lives of transgender women? 
3) What are best practices for integrating PrEP into health care for transgender women? And, 4) 
to what extent does need for and access to gender affirmation influence engagement in HIV risk 
behaviors among transgender women?  
 The results of this dissertation suggest that to increase PrEP access, uptake, and 
adherence there is a need for the development and design of strategies and programs that 
contextualize HIV risk among TGNBW as a social and psychological process rather than solely a 
byproduct of behavior. Situating HIV risk as a social and psychological process acknowledges 
that for TGNBW, risk factors are associated with multiple levels of social oppression (i.e., 
racism, transphobia, and sexism) (Sevelius, 2013; 2016). By recognizing that HIV risk is driven 
by social oppression, we begin to reframe the HIV prevention discussion to focus on the 
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intersection of the structural, interpersonal, and individual level factors contributing to HIV risk, 
rather than focusing solely on individual behaviors. To do otherwise may contribute to the 
alarming rates of HIV infection among this community by creating barriers to PrEP. This 
analysis views gender identity as an integral part of understanding the factors associated with 
HIV risk within the TGNBW community. It argues that categorizing TGNBW as cisgender 
MSM conveys and reinforces several beliefs including, a) TGNBW are in fact men, b) self-
identified gender identity is not important to understanding sexual health and risk, and c) the 
sexual practices and experiences of TGNBW are inherently the same as cisgender men who have 
sex with men (Fiereck, 2013; Sevelius et al., 2016). Furthermore, it is possible that devaluing and 
ignoring self-identified gender identity within HIV research exacerbates the HIV disparities 
experienced by TGNBW.  
  The discussion and analysis of study results integrate theories of stigma and 
discrimination (Link and Phelan, 2001) as well as the Gender Affirmation Framework (Sevelius, 
2013).  First, theories of stigma and discrimination are applied to a socio-ecological model (Baral 
et al., 2013; Link and Phelan, 2001) conceptualizing structural, interpersonal, and individual 
level barriers to health care access and utilization for TGNBW as a consequence of transgender-
related stigma and discrimination. Within this model, access to gender-affirming healthcare is 
necessary to facilitate PrEP access, uptake, and adherence. Further, to understand the contextual 
factors contributing to HIV risk among TGNBW, the Gender Affirmation Framework is utilized 
(Sevelius, 2013), which hypothesizes HIV risk among TGNBW as a negative outcome of social 
oppression. The Gender Affirmation Framework (Sevelius, 2013) proposes that TGNBW are 
forced into high-risk contexts where HIV risk increases due to the social and emotional impact of 
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stigma and discrimination. To understand TGNBW’s willingness to take PrEP it was imperative 
to identify the contextual factors that contribute to HIV risk for this community.  
 First, the structural, interpersonal, and individual level factors associated with PrEP uptake 
among the sample will be discussed. Next, how gender affirmation influences HIV risk for 
TGNBW will be considered. Then, implications for best practice in the field of PrEP will be 
explored. Finally, the last three sections will discuss implications for social work practice, study 
limitations, and directions for future research.  
  Structural Factors  
 Structural stigma is the manifestation of stigma (i.e., negative attitudes and beliefs 
attached to individuals or groups who differ from social or cultural norms) within the institutions 
of society (Link & Phelan, 2001). Structural stigma can occur in the absence of individual 
prejudice or discrimination (Link & Phelan, 2001). Examples of structural stigma against TGNB 
individuals include the lack federal anti-discrimination legislation protecting the civil rights of 
TGNB people against employment, educational, and housing discrimination (NCTE, 2016) as 
well as legislation mandating that TGNB individuals use the bathroom associated with their sex 
assigned at birth. For transgender and non-binary individuals, structural stigma manifests as 
cisgenderism (Ansara and Hegarty, 2012; Ansara and Hegarty, 2014; Lennon and Mistler, 2014), 
which is the institutional practice that refuses to acknowledge and support self-identified gender 
identity. Within the health care system, cisgenderism is enacted through a two-gender medical 
system that is based on the assumption that gender and biological sex are connected and 
unchangeable. For example, sex-specific eligibility criteria for procedures, screening tests, or 
treatments create structural barriers that make it challenging for providers to order or receive 
payment for a test or treatment for a patient who is considered ineligible based on sex-specific 
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eligibility criteria (GLBT Health Access, 2000; Khan, 2011; Sanchez et al., 2009; Snelgrove et 
al., 2012; White-Hughto, Reisner, & Pachankis, 2015). Results from this dissertation illustrate 
how institutional policies and practice shaped by cisgenderism influence TGNBW’s willingness 
to use PrEP. 
At the structural level, a lack of consistent PrEP information specific to the HIV risk and 
sexual health needs of TGBW greatly affected the sample’s PrEP knowledge and willingness to 
use PrEP. Failing to create and disseminate PrEP information that is specific to and inclusive of 
TGNBW creates barriers to PrEP uptake by requiring providers and TGNBW to interpret and 
apply information that does not acknowledge why PrEP is important for this population. Among 
the TGNBW in this sample, access to PrEP information was both a facilitator and barrier to PrEP 
uptake. Differences in willingness to take PrEP were based on types of PrEP information, 
source(s) of information, and level of trust in the information source. Overall, there was a high-
level of PrEP awareness (e.g., why PrEP is used and by whom and how effective it is) among the 
sample. However, awareness alone was not sufficient to result in a willingness to take PrEP. 
Most TGNBW not on PrEP attributed their PrEP awareness to a single source - a recent public 
health PrEP campaign that included ads on public transportation and health education literature. 
In contrast to awareness, PrEP knowledge was associated with access to greater PrEP 
information from a variety of sources, which in addition to a basic understanding of PrEP, 
included frequency of medication administration, potential side effects, and how PrEP works to 
protect against HIV. PrEP users also identified three factors which increased willingness to take 
PrEP: a) having a personal connection (i.e., close friend) to the source of PrEP information b) a 
willingness to seek out more information to decide whether PrEP was right for them, and c) 
active engagement from a provider around PrEP.  These findings highlight the way structural 
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stigma (i.e., lack of consistent information) creates barriers to health care for TGNBW (GLBT 
Health Access, 2000; Khan, 2011; Sanchez et al., 2009; Snelgrove et al., 2012, White-Hughto, 
Reisner, & Pachankis, 2015). Simply put, because specific PrEP information for TGNBW does 
not exist potential PrEP uptake may not occur.  Further, study results also underscore how 
cisgenderism results in TGNBW not being reached by the same information and social networks 
as MSM. Thus, demonstrating the need for structural interventions that create transgender 
inclusive and gender-affirming PrEP information and messaging to reach TGNBW through their 
social networks (Sevelius, 2016).  
Two additional facilitators to PrEP uptake were active provider engagement around and 
payment assistance with PrEP. Active engagement entailed health care providers who had 
ongoing conversations with their patients about PrEP as opposed to a one-time discussion. For 
example, a participant on PrEP described how her provider both consistently and in a casual 
manner discussed PrEP each time she had an appointment. She attributed her provider's 
persistence with offering PrEP and non-judgmental attitude towards whether she took it as a 
significant facilitator to PrEP uptake. Further, providers who actively assisted participants with 
either getting on health insurance that covered PrEP or a PrEP payment assistance program were 
identified as critical facilitators to PrEP uptake. These findings illustrate how providers that 
actively helped with navigating insurance coverage and payment for PrEP increased both PrEP 
access and uptake. These results suggest that to affect PrEP access and uptake positively it is 
imperative for health centers to have PrEP navigation programs to reach TGNBW. These 
findings are consistent with existing literature that suggest if programs integrate HIV prevention 
into the broader health concerns of TGNBW (e.g., hormone therapy) they are more likely to 
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retain patients and have better health outcomes (Garofalo et al., 2012; Melendez & Pinto, 2009; 
Poteat, Reisner, & Radix, 2013; Sevelius et al., 2009; Sevelius, 2013).  
   Lastly, study findings suggest that willingness to take PrEP is negatively influenced by 
policies that categorize transgender women and MSM together, which fails to describe the HIV 
disparities among this population (Clements-Nolle et al., 2006; Goldblum et al., 2012; Haas & 
Rodgers, 2014; Keuroghlian,Reisner, White, & Weiss, 2015; Moody & Smith, 2013; Operario et 
al., 2014; Reisner, Gamarel, Nemoto, & Operario, 2014; Testa, Jimenez, & Rankin, 2014; Xavier 
et al., 2008). Among the sample, the conflation of TGNBW with cisgender MSM was identified 
as a significant barrier to PrEP uptake. Participants expressed frustration and anger at being 
compared to cisgender gay men because it both refuses to acknowledge and support who they are 
and accurately reflect the experiences that place them at risk for HIV. Relatedly, the sample 
stated that the categorization of TGNBW with cisgender MSM was another barrier to 
transgender-inclusive and gender-affirming PrEP programs. Participants echoed the need for 
PrEP and HIV prevention programming to mention and address the needs of TGNBW 
specifically. Further, participants felt that a lack of TGNBW specific programming explicitly 
tells the community that they do not matter or exist.  
Several examples emerged demonstrating how structural stigma manifests within PrEP 
programming, including the absence of a) PrEP information specific to contextual factors (e.g., 
survival sex work) associated with HIV risk for TGNBW, b) diverse gender presentations in 
PrEP public health campaigns, and c) sexual health and risk assessment tools that accurately 
reflect the sexual health needs of TGNBW. These results suggest that because current HIV 
prevention programming is developed for cisgender MSM there is a lack of attention to and 
interest in the specific sociocultural and syndemic factors associated with HIV risk among 
 118 
TGNBW (Bradford et al., 2013; Lombardi et al., 2001; Operario et al., 2014; Nemoto et al., 
2011; Testa et al., 2012; Sevelius, et al., 2009; Sevelius, 2013). For example, participants 
stressed that pervasive economic disenfranchisement forced TGNBW into survival sex work 
(Nadal, Davidoff, & Fujii-Doe, 2014; Sevelius, et al., 2016), thus increasing HIV risk. However, 
despite research consistently documenting that TGNBW sex workers have higher rates of HIV 
than cisgender male sex workers (Operario, Soma, & Underhill, 2008) PrEP programming for 
TGNBW does not address sex work.  
These findings illustrate how structural stigma (Link and Phelan, 2001) influences 
TGNBW’s willingness to use PrEP. Study results are consistent with existing literature that 
suggests TGNBW do not benefit from HIV prevention programming designed for cisgender 
MSM (Garofalo et al., 2012; Poteat, Reisner, & Radix, 2013; Reisner et al., 2016; Sevelius, et 
al., 2016). Within PrEP related healthcare structural stigma perpetuates a binary two-gender (i.e., 
male or female only according to sex assigned at birth) health care system (Lombardi, 2009; 
Poteat, 2013; Snelgrove, 2012; White, Reisner, & Pachankis, 2015) that assumes gender and 
biological sex are connected, binary, and immutable and that gender determination is based on 
external genitalia. This practice reinforces cultural and institutional beliefs, and practice that 
deny, pathologize, and delegitimize gender diversity by refusing to acknowledge or accept that 
natal sex can differ from social and psychological gender (Ansara and Hegarty, 2012; Ansara 
and Hegarty, 2014; Lennon and Mistler, 2014). Thus, resulting in the development and design of 
PrEP interventions and strategies that target cisgender MSM and ignore the specific HIV 
prevention needs of TGNBW. 
 Consistent with Link and Phelan’s (2001) theory of stigma and discrimination and the 
theory of cisgenderism (Ansara and Hegarty, 2012; Ansara and Hegarty, 2014; Lennon and 
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Mistler, 2014), these findings suggest that a two-gender health care system creates systemic 
barriers to transgender-inclusive and gender-affirming PrEP related health care. Study findings 
also support the extensive literature on healthcare access among the TGNB community, which 
demonstrates how structural stigma impacts healthcare access in three ways: 1) a lack of 
consistent information on the social, emotional and physical health needs of TGNBW, 2) 
difficulty locating a knowledgeable provider, and 3) institutional policies and procedures that do 
not accommodate and acknowledge transgender identities and bodies (GLBT Health Access, 
2000; Khan, 2011; Sanchez et al., 2009; Snelgrove et al., 2012, White-Hughto, Reisner, & 
Pachankis, 2015). In the sample, a lack of consistent PrEP information and the absence of 
programs that are specific to and inclusive of TGNBW influenced willingness to take PrEP and 
access to PrEP related health care. Despite disproportionate rates of HIV infection within this 
community, evidence-based PrEP information for TGNBW still does not exist. A lack of PrEP 
information impacts uptake and access in two ways. The lack transgender inclusive PrEP 
information effects provider’s ability to receive training and education to provide PrEP related 
care that is gender affirming. Which in turn impacts TGNBW’s ability to find a knowledgeable 
PrEP provider. Furthermore, the absence of transgender-inclusive and gender-affirming PrEP 
programs perpetuates the policies and procedures (i.e., categorization of TGNBW with MSM) 
that do not acknowledge or care for transgender identities and bodies. A lack of transgender-
specific and inclusive PrEP programming ignores the specific HIV risk and sexual health needs 
of this population and forces TGNBW to seek out PrEP within a system, which by design is not 
affirming of self-identified gender identity. 
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Interpersonal Factors 
At the interpersonal level, stigma manifests as both enacted and felt stigma (Herek, 2007; 
Scambler & Hopkins, 1986). Enacted stigma refers to overt acts of discrimination (i.e., racism, 
transphobia, sexism) through slurs, rejection, ostracism or explicit forms of discrimination and 
violence (Scambler & Hopkins, 1986). Felt stigma is the fear of enacted stigma, in addition to 
feelings of shame associated with being a member of a marginalized group (Scambler & 
Hopkins, 1986).  Within the health care system, interpersonal stigma reflects the attitudes, 
beliefs, and behaviors of both providers and patients (IOM, 2010). Direct and indirect forms of 
interpersonal stigma against transgender and non-binary individuals creates significant barriers to 
accessing health care. Examples of enacted interpersonal stigma in healthcare settings include, 
outright denial of services, to refusing to use a person's name or gender pronoun, to providers 
appearing shocked or in disbelief when a person discloses being transgender or non-binary 
(GLBT, 2000; Grant, et al., 2011; James, et al., 2016). Furthermore, there is also an increased 
likelihood for transgender and non-binary individuals to experience enacted stigma due to the 
multiple people patients interact with healthcare settings. Previous negative experiences and fear 
of stigmatization affect health seeking behaviors leading transgender and non-binary individuals 
to postpone or forgo preventative and emergency health care (Grant et al., 2011; James et al., 
2016). 
The results from this dissertation highlight two factors at the interpersonal level 
influencing TGNBW’s willingness to take PrEP. First, study findings illustrate how societal 
stigma towards the transgender and non-binary community and the fear of being stigmatized as 
HIV positive were potential barriers to PrEP uptake. The fear of being judged for using PrEP due 
to lack of awareness among potential sexual partners and the general public was identified as a 
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deterrent to PrEP uptake. For example, participants not on PrEP expressed apprehension towards 
openly disclosing their PrEP use because it implied sexual promiscuity and perpetuated societal 
stereotypes that portray TGNBW as hypersexualized (Garofalo et al. 2006; Sevelius, 2013). 
Another concern surrounded having their PrEP use discovered (e.g., someone else seeing their 
medication bottle) rather than personally disclosed. Participants worried that sexual partners 
would think they were HIV positive because PrEP is also a commonly used medication for HIV 
treatment. In contrast, for participants on PrEP, the disclosure of PrEP use was an opportunity to 
combat the negative stereotypes about TGNBW and HIV risk. To understand these results, it is 
vital to situate them within the existing literature on stigma and discrimination among TGNBW, 
which has found that at the interpersonal level TGNBW experience rejection from family and 
friends (Koken, et al., 2009; Mallon and De Crescenzo, 2006) and high rates of sexual violence 
and physical assault (Lombardi et al., 2001; Nemoto et al., 2011; Testa et al., 2012) and both 
have been associated with HIV risk (Clements-Nolle, Marx, & Katz, 2006; Kenagy & Bostwick, 
2005; Lombardi, 1999; Lombardi & van Servellen, 2000; Lombardi et al., 2001; Nemoto, et al., 
1999; Nemoto, et al., 2004; Xavier, Bobbin, Singer, & Budd, 2005 ). Within this context, it is 
possible that previous experiences of enacted interpersonal stigma shape some participants 
response towards PrEP. For example, participants may believe that the consequences (i.e., 
rejection, violence) associated with disclosure or being found out far outweigh the benefits of 
using PrEP. Fears around disclosure and the extreme violence associated with it are also rooted 
in historical and contemporary perspectives of TGNB identities that criminalize gender non-
conformity (Capers, 2007; Meyerwitz, 2002; Mogul, Ritchie, & Whitlock, 2011; NCTE, 2016; 
Stryker, 2007), whereby the disclosure or presumption that an individual is transgender or non-
binary is punishable by imprisonment.  
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A second factor emerged that may mitigate the negative consequences of interpersonal 
stigma and positively impact willingness to use PrEP among TGNBW. Study findings suggest 
that having personal relationships and a sense of community connectedness were facilitators to 
PrEP and uptake. Having friends, (especially other TGNBW) openly talk about their PrEP use 
and actively encourage their friends to go on PrEP increased awareness and also reduced PrEP 
related stigma. The ability to talk to other TGNBW about their motivations for taking and 
experiences on PrEP provided an invaluable resource. A personal connection to someone on 
PrEP offered first-hand information about side effects, efficacy, and adherence. Seeing other 
TGNBW on PrEP, gave participants the chance to envision that PrEP might be something right 
for them.  
These findings also speak to participant’s overwhelming sense of community 
responsibility to change the social and cultural norms around HIV risk and PrEP use among 
TGNBW. PrEP was viewed as a game-changing, life-saving HIV prevention tool. To use PrEP 
was the chance to be a part of a historical moment in the fight against HIV. Participants saw their 
use of PrEP as an opportunity to affect the lives of future generations of TGNBW by actively 
participating in reducing the disproportionate rates of HIV among this community. These results 
are not surprising given the long history of community activism among the TGNB community 
and in particular TGNBW (Meyerwitz, 2002; Stryker, 2007; Wilchins, 1997). In the absence of 
social, legal, and medical recognition and support, the TGNB community has been forced to 
develop and disseminate their own information and strategies to provide support and get 
services. As the results of this dissertation indicate this practice has continued with regards to 
PrEP and is an essential component to PrEP uptake. 
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 The findings from this dissertation illustrate specific examples of interpersonal stigma 
(i.e., enacted and felt stigma) that influence willingness to take PrEP and the potential resiliency 
factors that increase PrEP uptake. Enacted stigma refers to instances of discrimination against 
individuals due to their perceived unacceptability or inferiority (Scrambler & Hopkins, 1986). 
Persistent messaging and actions that dehumanize TGNBW as sexually promiscuous and sexual 
objects encourage HIV related stigma and transphobia at the interpersonal level to occur. For 
example, open hostility and judgment towards TGNBW on PrEP from potential sexual partners 
and other community members may impact willingness to take PrEP due to the desire to protect 
against experiences of stigma and discrimination.  
Study findings demonstrate that willingness to take PrEP may be influenced in part by the 
fear of stigmatization and the shame associated with being seen as an HIV-positive TGNBW. To 
avoid being targets of enacted stigma, felt stigma often affects behavior. TGNBW modify or 
adapt their behavior in a variety of ways to avoid stigma in various aspects of their lives. For 
example, TGNBW may choose not to disclose their TGNB identity to their medical provider or 
may change their appearance to match their biological sex. It is possible that participants view 
not taking PrEP as a form of protection against HIV related stigma and transphobia and prioritize 
preventing further experiences of stigma over HIV prevention. 
 The present study extends the literature on interpersonal stigma and HIV risk among 
TGNBW individuals (Operario et al., 2014; Sevelius, Reznick, Hart, & Schwarcz, 2009; 
Sevelius, 2013) by identifying strategies that increase PrEP uptake as well as mitigate the 
adverse health outcomes associated with transphobia and HIV related stigma. Current literature 
on stigma and HIV risk among TGNBW consistently documents the role stigma and 
discrimination play in HIV risk (Bradford et al., 2013; Lombardi et al., 2001; Nemoto et al., 
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2011; Operario et al., 2014; Sevelius, et al., 2009; Sevelius, 2013; Testa et al., 2012). However, 
few studies have examined the protective factors and strategies employed by the TGNBW 
community that decrease HIV incidence and increase positive health outcomes. The findings 
from this dissertation illustrate the importance of social support and community connectedness in 
combating the negative health impact (i.e., HIV risk) associated with interpersonal stigma. If 
TGNBW see themselves/know someone on PrEP, they may be more willing to use PrEP. Having 
a connection to people in the TGNBW community on PrEP not only destigmatizes the use of 
PrEP but increases a sense of belonging and shared commitment to promoting positive health 
and well-being among TGNBW. Within this context, social support and community 
connectedness may act as a buffer to PrEP (HIV) related stigma and transphobia.  
Individual Factors  
At the individual level stigma manifests as the acceptance of society's negative regard for 
the stigmatized group (Scrambler & Hopkins, 1986). Individual stigma towards TGNB 
individuals is referred to as transphobia or the acceptance that those who transgress societal 
gender norms need to be feared and shunned (Herek, 2007). Internalized transphobia or self-
stigma may cause TGNB individuals to feel that they do not deserve respect from family, 
friends, coworkers, sexual partners, and non-close others. In medical settings, TGNB individuals 
may think that they do not deserve respect from their health care provider or access to health care 
that is affirming and supportive (Grant et al., 2011; James et al., 2016; IOM, 2010). For example, 
participants not on PrEP expressed uncertainty around whether PrEP was right for them often 
citing the lack of PrEP information specific to transgender women. It is possible that participants 
belief that they are not appropriate (or deserving) of PrEP is a form of internalized transphobia. 
If the information and services do not exist, then I must not need them. Also, because of 
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internalized transphobia, TGNBW may not disclose key information to their health care 
provider; avoid seeking treatment, or refrain from challenging discrimination and other forms of 
enacted stigma (Dewey, 2008; Grant et al., 2011; James, et al., 2016). For example, TGNBW 
may be unwilling to disclose engagement in survival sex work to health care providers due to the 
pervasive stigma associated with participation in sex work as well as not wanting to further 
perpetuate the stereotype that all TGNBW are sex workers.  
This study illustrates several factors at the individual level impacting willingness to take 
PrEP. Perception of HIV risk was both a facilitator and barrier to PrEP uptake. Participants who 
perceived themselves to be at risk wanted PrEP. Engagement in transactional sex and previous 
experiences where potential HIV exposure occurred were motivating factors, which positively 
influenced willingness to use PrEP. For participants whose HIV risk was low or for whom PrEP 
did not address the type of risk most important to them, risk perception was a barrier to PrEP 
uptake. For example, participants who reported low sexual activity or having a monogamous 
sexual partner felt their current sexual activity did not warrant the use of PrEP. However, for 
these participants, current low-risk behavior and perception did not impact their willingness to 
consider PrEP in the future. Participants discussed how if their risk level for HIV changed (e.g., 
engaging in sex work, having multiple sex partners), they would reconsider taking PrEP. Thus, 
demonstrating an understanding that risk can change over time and that the behaviors and 
contexts a person engages in exist on a continuum, a person is not just high-risk or low-risk. In 
contrast to previous research, which found that TGNBW underestimate their risk for HIV 
(Herbst et al., 2008), these findings demonstrate a nuanced understanding of HIV risk and the 
contexts in which risk occurs.  
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Another key finding demonstrates that increased psychological well-being and sexual 
satisfaction due to reduced HIV worry were benefits to PrEP uptake. Taking PrEP increased self-
esteem by reducing the sense of fatalism around HIV that is common among TGNBW. PrEP was 
seen as a protective factor against the ongoing stigma and discrimination TGNBW face in their 
daily lives. Because of PrEP, becoming HIV-positive was no longer inevitable.This finding 
provides a striking counterpoint to existing studies, which have found that low self-esteem, 
depression, anxiety, substance use, victimization related to gender identity and expression, and 
intimate partner violence have been associated with HIV infection and sexual risk behavior 
among TGNBW (Brennan et al., 2012; Jefferson et al., 2013; Nuttbrock et al., 2009; Operario et 
al., 2014; Sevelius, et al., 2009; Sevelius, 2013).  PrEP use gave participants the belief that they 
were worth living, a tool to fight for their lives and control over their bodies. Sex became more 
enjoyable because of PrEP. Participants expressed a sense of relief knowing that with PrEP they 
no longer always worried about getting HIV during each sexual encounter. If accidental exposure 
to HIV occurred, participants felt confident that PrEP provided an extra layer of protection that 
condoms did not. 
 A potential barrier to PrEP uptake was the fear that PrEP would negatively interact with 
participants’ feminizing hormone regimen, thereby limiting its effectiveness. Not surprising, for 
the majority of participants, the number one health care priority was their gender transition. 
These findings are consistent with existing literature on the importance of hormone therapy 
among TGNBW (Melendez and Pinto, 2007; Nuttbrock et al., 2009). Participants expressed 
hesitation about taking a medication that could slow down or stop their gender transition. 
Findings indicate that both groups expressed similar concerns about potential drug-to-drug 
interactions between PrEP and feminizing hormones. However, PrEP users were able to 
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overcome this barrier once they received information about what is currently known about drug-
to-drug interactions, indicating that with targeted, evidence-based information this barrier may 
be easily overcome.  
Study results also indicate that taking multiple medications was a barrier to PrEP use 
among participants not on PrEP. A common theme that emerged was not wanting to add another 
medication to an existing medication regimen. Participants felt that they were already on too 
many medications. In addition to feminizing hormones, participants mentioned taking psychiatric 
medications for depression, anxiety, and sleep. It is possible that PrEP is not prioritized because 
unlike taking feminizing hormones (e.g., feminization of secondary sex characteristics) or 
psychiatric medications (e.g., relief from depression, anxiety, and insomnia symptoms) it is used 
to prevent potential exposure as opposed to treating symptoms (i.e., prevention vs. 
treatment/intervention). Finally, participants expressed a willingness to take PrEP if available in 
a long-acting injectable form. For several participants not on PrEP getting an injection was more 
favorable than taking a daily oral pill and was equated with the potential for better PrEP 
adherence. Indicating that the availability of long-acting injectable PrEP may be a potential 
facilitator to future PrEP use among TGNBW who might otherwise not be on oral PrEP.  
 These findings provide preliminary support for the Gender Affirmation Framework 
(Sevelius, 2013) by demonstrating how PrEP use can mitigate the negative health consequences 
of stigma, social oppression, and psychological distress. The Gender Affirmation Framework 
(Sevelius, 2013) contextualizes HIV risk among transgender and non-binary women as a social 
and psychological process rather than solely a result of individual sexual behavior. Study 
findings suggest that PrEP use both reduces the psychological distress (e.g., HIV worry, anxiety, 
low self-esteem, internalized transphobia) linked to stigma and social oppression and the 
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increased risk for HIV associated with the high-risk contexts (e.g., sex work) TGNBW are forced 
into because of social oppression and psychological distress. For example, the use of PrEP 
promoted a sense of agency over participant's health and body. By taking PrEP, participants were 
actively taking control of their physical, emotional, and sexual health.  
Finally, these results illustrate how individual-level barriers to PrEP uptake (e.g., 
prioritization of gender transition) are influenced by structural level factors. As highlighted 
throughout this discussion, study findings suggest that a lack of transgender-inclusive and 
gender-affirming PrEP information and programs (i.e., structural) contributes negatively to PrEP 
uptake (i.e., individual). A discussed above, the lack of information on drug-to-drug interactions 
between PrEP and feminizing hormones was identified as an individual-level barrier to PrEP 
uptake. At the structural level, HIV prevention and public health programs create unnecessary 
barriers to PrEP uptake by failing to acknowledge and support the prioritization of hormone use 
for gender transition.  Important opportunities to reduce HIV infection rates among TGNBW are 
missed by the structural practice of viewing HIV prevention as a separate process from gender 
transition. These findings are similar to existing research on increasing access to HIV treatment 
for HIV positive TGNBW, which calls for the integration of HIV treatment into over gender-
affirming healthcare (Melendez and Pinto, 2007; Nuttbrock et al., 2009). The results of this 
dissertation speak to the current state of HIV prevention for TGNBW, providing preliminary 
evidence to support a systemic change to PrEP implementation and dissemination for this high-
priority community. To continue to ignore how factors at the structural, interpersonal, and 
individual levels work together to influence willingness to take PrEP, PrEP uptake, and access 
further contribute to and exacerbate the HIV disparities among TGNBW. 
  
 129 
Gender Affirmation and HIV Risk  
As discussed throughout this dissertation, gender affirmation is the social process that 
recognizes and supports TGNB individual’s gender identity and expression (Bockting et al. 
2006; Melendez and Pinto, 2007; Nuttbrock et al., 2009; Sevelius, 2013). While the need for 
gender affirmation is not unique to the TGNB community, it often takes on a more prominent 
role given TGNB individuals gender minority status. For TGNB individuals, gender affirmation 
is a vital component of their sense of self and a validation of their gender identity and expression 
(Melendez and Pinto, 2007; Nuttbrock et al., 2009). Gender affirmation can include the use of 
TGNB individuals correct name and pronouns, to the development of gender-affirming health 
care programs, to the payment (from insurance) of gender transition health care, to the active 
acceptance of the range of gender expressions these communities claim. Despite the importance 
of gender affirmation among TGNB individuals, the relationship between the need for gender 
affirmation and HIV risk has not been thoroughly investigated (Reisner, et al., 2015; Sevelius, 
2013). 
Results from this dissertation illustrate how extreme marginalization (due to multiple and 
intersecting forms of oppression) and a high need for and decreased access to gender affirmation 
contributes to HIV risk among TGNBW (Sevelius, 2013). Study findings illustrate how a lack of 
access to gender affirmation (i.e., explicit and implicit rejection of self-identified gender identity 
and expression) at the structural (society and institutions) (Grant, et al., 2011; James, et al., 2017) 
and interpersonal (family, friends, community) level (Lombardi et al., 2001; Klein & Golub, 
2013; Nemoto et al., 2011; Nuttbrock, et al., 2013; Testa et al., 2012; Wilson, et al., 2012) 
contributes to adverse social, psychological, and behavioral health outcomes among TGNBW. 
For example, rejection from family members (for being TGNB) was associated with 
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homelessness, while broader societal rejection of TGNBW made it challenging to find housing, 
employment, or obtain an education (Cochran et al., 2002; Koken, et al., 2009; Mallon and De 
Crescenzo, 2006; Reisner et al., 2015; Wilson, et al., 2009). Results also inferred that 
employment, housing, and education were only accessible to TGNBW who “passed” (i.e., 
looked/viewed as cisgender women). Participants expressed anger at being discriminated against 
when trying to get a job because they were either perceived to be transgender or did not have 
legal documents that matched their gender identity. These findings are consistent with previous 
research on stigma and discrimination and quality of life for TGBNW (Bradford et al., 2013; 
Grant et al., 2011; James, et al., 2017; Khan, 2011; Nemoto et al., 2011; Sevelius et al., 2009; 
Sevelius, 2013; Strousma, 2014).  
Overall, participants expressed the belief that systemic factors such as racism, 
transphobia, and sexism were more strongly linked to HIV risk, than their individual sexual 
behavior. The majority of participants rejected the belief that TGNBW chose to put themselves 
in risky situations and agreed that this frame places blame on the individual rather than 
acknowledging the structural factors contributing to HIV risk. In an attempt to reduce the 
consequences of stigma and social oppression participants reported that they are forced into 
high-risk contexts. It is within these high-risk contexts that HIV risk behaviors (e.g., condomless 
sex) occur (Herbst, et al., 2008; Kenagy, 2002; Kenagy, 2005; Nemoto et al., 2006; Reback & 
Simon, 2004; Simon, Reback, & Bemis, 2000).   
 Participants highlighted the relationship between HIV risk and survival. For example, 
participants talked about being forced to engage in survival sex work due to social and economic 
disenfranchisement (Baral et al., 2013; Poteat, Reisner, & Radix, 2013; Sevelius, et al., 2009; 
Sevelius, 2013). Participants shared experiences of having condomless anal sex in exchange for 
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greater financial incentives from clients, thus having to decide between survival and HIV risk. 
HIV risk is something that is forced upon TGNBW, rather than a result of behavioral choice or 
agency. Within this context, PrEP is a form of harm reduction that can minimize the negative 
effects of behaviors that are necessary for survival.  
 Experiences of sexual violence and sexual assault were also identified as high-risk 
situations where HIV risk is externally generated for TGNBW (Clements-Nolle et al., 2001; 
Herbst et al., 2008; Lombardi et al., 2001; Nemoto et al., 2011; Testa et al., 2012).  The vast 
majority of participants reported multiple occurrences of sexual assault. Participants stated that 
TGNBW were forced into situations (e.g., survival sex, sex to obtain gender affirmation, sexual 
relationships with unequal power) where they were exposed to sexual violence due to rejection 
from family, friends, and society (Nuttbrock, et al., 2013; Wilson, 2012). Participants saw PrEP 
as a necessity given the disparate rates of sexual violence among TGNBW.  
Sexual experiences under the influence of drugs and alcohol (Nemoto et al., 2011; 
Nemoto, et al., 2004; Operario, et al., 2014; Risser, et al., 2005) emerged as another high-risk 
context where PrEP is beneficial for TGNBW. For example, participants identified instances 
where they either engaged knowingly in condomless sex while intoxicated or were forced to use 
drugs during sex work. In both contexts (i.e., experiences of sexual violence and sex under the 
influence of drugs and alcohol) PrEP is a strategy for safety, reducing both risks for HIV and the 
psychological distress around potential exposure to HIV.  
Research has extensively documented that HIV risk for TGNBW is associated with 
individual sexual risk behaviors (Bockting et al., 1998; Herbst, et al., 2008; Kenagy, 2002; 
Melendez and Pinto, 2007; Nemoto et al., 2004; Operario et al., 2011; Reisner et al., 2009; 
Rodriguez-Madera and Toro-Alfonso, 2005; Sausa et al., 2007; Sugano et al., 2006). In contrast, 
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the results from this dissertation suggest that HIV risk among this community is intrinsically 
linked to survival. Study findings consistently provide evidence to support the Gender 
Affirmation Framework (Sevelius, 2013) by demonstrating the relationship between multiple 
levels of stigma, discrimination, oppression, and HIV risk. Further, without recognition or 
support for gender identity and expression TGNBW must navigate within a world that on a 
fundamental level does not value them as people. Within this context TGNBW must fight for 
survival while simultaneously being exposed to HIV risk. The data presented in this dissertation 
ask that public health and HIV prevention policies and programs no longer view the structural, 
interpersonal, and individual level factors associated with stigma and oppression as separate 
from HIV risk. The next section presents concrete examples for best practice to increase PrEP 
knowledge, access, and uptake to TGNBW.  
Best Practices  
The findings from this study provide several suggestions for best practice to increase 
TGNBW’s willingness to use PrEP. First, to increase PrEP awareness and uptake, HIV 
prevention and sexual health information, messaging, and programs must be transgender 
inclusive and gender-affirming. Study findings indicate that the first step to making HIV 
prevention policies and programs more inclusive is eliminating the practice of categorizing 
TGNBW with cisgender MSM (Fiereck, 2015; Sevelius, 2013, 2016). Another important aspect 
to creating inclusive and affirming HIV prevention information and messaging is to include 
transgender and non-binary women with diverse gender presentations in PrEP advertising and 
health information campaigns, rather than prioritizing TGNBW who “pass.” Participants stated 
that to increase willingness to take PrEP, TGNBW should be able to see themselves reflected in 
current messaging campaigns. Without diverse representation, TGNBW may not know that PrEP 
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is right for them. Furthermore, findings suggest that inclusive and affirming HIV prevention 
programs must include sexual health assessment tools and health education literature that 
accurately reflects: a) the sexual and gender identities of TGNBW and their sexual partners, b) 
the sexual activity TGNBW are engaging in, c) the high-risk contexts where HIV risk increases, 
d) information on whether there are drug-to-drug interactions between feminizing hormones and 
PrEP and e) information on new forms of PrEP that are being developed.   
These findings also illustrate how active provider engagement around PrEP and active 
payment assistance for PrEP are integral to increasing PrEP uptake among TGNBW. Active 
provider engagement included not only the act of telling patients about PrEP but giving health 
education information (e.g., efficacy, dosage/frequency, side effects, drug-to-drug interactions) 
to help make informed decisions about whether to take PrEP. For patients who were hesitant 
about taking PrEP, active provider engagement included having ongoing conversations with 
them about PrEP availability and benefits. An important factor to active provider engagement is 
that conversations about PrEP were built into participant’s ongoing gender affirming health care 
rather than requiring TGNBW to separately seek out PrEP related care. Another aspect of active 
engagement is the creation of PrEP-related outreach services to reach TGNBW who would most 
benefit from PrEP (e.g., street-based sex workers, homeless youth, and young adults). This low-
threshold service is a way to leverage PrEP to increase access to and utilization of health care 
and other support services to TGNBW that must prioritize survival over attending regular 
medical appointments. Study findings highlight that active payment assistance includes helping 
patients understand whether current health insurance covers PrEP, assistance with signing up for 
health insurance that will cover PrEP or apply for a medication payment assistance program 
associated with a pharmaceutical company. 
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Finally, the study findings indicate that community mobilization/activism strategies are 
important facilitators to increase PrEP knowledge and uptake among transgender and non-binary 
women. Having community members openly talk about their PrEP use and knowing friends on 
PrEP were critical factors to a willingness to take PrEP. Once on PrEP participants expressed a 
sense of responsibility to help reduce HIV infection rates among TGNBW by sharing their PrEP 
knowledge with friends and other community members to increase PrEP uptake. To support 
these strategies, providers must acknowledge and support the role of friends and community in 
the dissemination of PrEP information.  
 The findings from the present study have several implications for biomedical HIV 
prevention. PrEP is the newest and most promising biomedical HIV prevention intervention to 
date, yet those who would most benefit continue to have differential uptake and access compared 
to White cisgender MSM (CDC, 2018). In the United States, transgender and non-binary women 
have been identified as the group with the highest rates of new HIV diagnoses compared to 
cisgender men and women (CDC, 2011, Baral, et al., 2013; Herbst, et al., 2008). However, 
despite disparate rates of HIV infection, there are currently no guidelines providing specific 
recommendations for PrEP dissemination to this population (Escudero, et al., 2014; Sevelius, et 
al., 2016). The lack of TGNBW specific PrEP guidelines is largely a result of the historical 
practice of including TGNBW under the behavioral risk group cisgender MSM in HIV 
surveillance data and research. Aggregating TGNBW with cisgender MSM ignores this 
population’s specific HIV risk and prevention needs and allows funding for HIV prevention to be 
funneled solely to the development and design of programs and prevention strategies for those 
who are assigned male at birth.  
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 Study findings suggest that TGNBW have distinct sexual health and HIV prevention 
needs that are not addressed by current PrEP policies and programs. These results also suggest 
that initiatives to increase PrEP uptake among TGNBW will be hindered without specific 
guidelines for PrEP dissemination to this high-priority population. Furthermore, these findings 
indicate that to increase PrEP knowledge, uptake, and access, HIV prevention funding must be 
allocated to the development and design of programs and prevention strategies specific to and 
inclusive of TGNBW.  
Implications for Social Work Practice  
Over 35 years into the HIV epidemic, PrEP is currently the most promising biomedical 
HIV prevention intervention to emerge with the greatest potential for eradicating new HIV 
infections. Despite an increase in PrEP uptake across the United States, those most at risk for 
HIV continue to be left behind. The history of HIV in the United States epitomizes social 
inequality and social injustice and demonstrates how large segments of the population have been 
and continue to be left behind, while others benefit from biomedical HIV prevention and 
treatment. For marginalized populations, the factors that contribute to these disparities may pose 
a greater risk for HIV than individual behavior. At a time when scientific advances are rapidly 
changing the field of HIV prevention and treatment, social workers must develop the skills to 
integrate and translate this information, while simultaneously addressing the structural factors 
that allow for disparities in access to and uptake of PrEP. To do otherwise goes against the 
professions code of ethics, which charges social workers with the primary goal of addressing 
social problems by challenging social injustice at the structural, interpersonal, and individual 
levels (NASW, 2017).  
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  From the outset of the HIV epidemic, the field of social work has played an integral role 
in providing material, social, and emotional support services to persons living with and at risk for 
HIV (Wheeler, 2007; 2011). The findings from this dissertation suggest several areas where 
social workers can help increase access, uptake, and adherence to PrEP. First, study findings 
highlight the structural factors that create contexts in which HIV risk increases and allow for 
disparities in access to and uptake of PrEP. As such it is imperative for the social work 
profession to address these structural factors through advocating, creating, and implementing 
policies (e.g., reevaluating policies, funding, and programs for HIV prevention to provide 
housing and other public benefits and services to those who are HIV negative) that affect 
systemic change rather than solely focusing on interventions that seek to change individual 
behavior.  
Second, these findings suggest that PrEP is a critical component to mitigating the 
negative health outcomes associated with these structural factors. One goal of social welfare is to 
help ameliorate the negative consequences associated with stigma and discrimination. Social 
workers interact with TGNBW within various social service contexts and are uniquely positioned 
to increase PrEP knowledge, access, and uptake through active engagement and assistance. 
Active support entails communicating the relationship between structural factors and HIV risk to 
TGNBW through providing transgender-inclusive and gender-affirming health education 
information on PrEP and navigating the process of obtaining and paying for the medication. 
Additionally, social workers play an important role in reaching TGNBW who are most at-risk for 
HIV given the multiple high-risk contexts they are forced into for survival. As such, social 
workers can both design and implement low-threshold services to increase PrEP uptake and 
adherence.  
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 Third, study findings demonstrate the importance of community mobilization/activism 
around PrEP. The social work profession has a long history of community organizing within 
marginalized communities. These findings suggest that social workers can play a crucial role in 
teaching community building and advocacy skills to both increase PrEP uptake and address the 
structural factors that increase HIV risk for this community. For example, this can include 
advocating at the federal, state, and local level to increase access to gender affirming health care 
for TGNBW, supporting community-led models and programs that increase employment and 
educational opportunities for TGNBW, and organizing with the community around the needs and 
issues they deem most important.  
Limitations  
There are several notable limitations to the present study. First, this study utilized an 
exploratory qualitative research design, which relied on a small convenience sample recruited in 
New York City where there have been considerable efforts to increase awareness and uptake of 
PrEP on both the state and city level, thus limiting the generalizability of these findings. While 
the recruitment strategy targeted TGNBW through multiple avenues (social media, in person 
flyers at CBO’s for TGNBW, and word of mouth) it is possible that TGNBW who did not know 
or had not heard of PrEP self-selected out of participation. Thus, skewing the sample towards 
TGNBW engaged in health care. Second, because all participants were insured (public or private 
health insurance) and the vast majority received gender-affirming healthcare study findings may 
not apply to TGNBW outside of a large urban area where there is access to expanded Medicaid 
and transgender-related health care. Given the disparities in access to health care and insurance 
among transgender and non-binary individuals across the United States, these findings may be 
different among a national sample of TGNBW (James, et al., 2017).  
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Third, participants not on PrEP reported a high-level of PrEP awareness. However, 75% 
stated that they did not want or would not take PrEP. Previous research on PrEP knowledge 
among transgender and non-binary women found low levels of PrEP awareness and knowledge 
and high-levels of willingness to take PrEP once provided PrEP information (Sevelius, 2016). 
Because of the lack of transgender-specific PrEP research and health education information, 
these findings must be interpreted with caution. It is possible that the sources of information 
(public health campaign vs. trained research assistant) and the context (real world vs. research 
environment) in which this information was provided influenced these results.  
Fourth, the eligibility criteria for study participation were based on the CDC's PrEP 
guidelines for MSM. As discussed throughout this dissertation, the lack of PrEP guidelines 
specific to the factors associated with HIV risk for transgender and non-binary women is a 
significant barrier to PrEP uptake and access. It is possible that by using the CDC's PrEP 
eligibility criteria for MSM, the study findings do not adequately represent the diversity of 
sexual experience and HIV risk behaviors among this community.  
Fifth, it is possible that the findings from this dissertation are limited by the research 
team's subjectivity. All members of the research team identify as TGNB and have extensive 
experience working with social service and healthcare organizations serving the TGNB 
community in New York City. While the research team's connections to the TGNB communities 
and organizations serving the community contributed to the success of this project, it is possible 
that these connections hindered the ability to recruit individuals who were not connected to one 
of these organizations or who do not openly identify as a member of the TGNB community. 
Conversely, some TGNBW may not have felt comfortable participating in a study with a 
research team connected to the community due to concerns about confidentiality. Also, the 
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increased visibility of the TGNB community has led to a burgeoning field of research with 
TGNB people. It is also possible that an oversaturation of research studies within the New York 
City area contributed to a lack of willingness to participate. With many studies simultaneously 
going on, potential participants may have felt "othered" or tired of being targeted to participate in 
research studies. 
Lastly, participating in an in-person qualitative interview with another transgender person 
may have influenced participants responses due to social desirability. Participants may have 
tailored their answers towards what they believed the research team would find more favorable. 
Conversely, participants may have withheld certain information about their experiences due to 
fear of being judged or stigmatized for their behavior from the research team. 
It is important to acknowledge that these limitations do not detract from the important 
findings generated by this dissertation. The results presented throughout provide a nuanced 
interpretation of HIV risk and PrEP use among TGNBW. Moreover, these results have the 
potential to significantly reshape the design, development, and implementation of HIV 
prevention programs and strategies, at a time when such data are needed. 
Future Directions for Research 
 To date, there have been few studies on PrEP use among transgender and non-binary 
women. The findings from this dissertation suggest several directions for future research. First, 
little to no research exists on the sexual health (distinct from risk) of transgender and non-binary 
women. As demonstrated throughout this study, transgender and non-binary women engage in a 
variety of sexual experiences within different contexts and with people of different gender 
identities and expressions. Future research is needed to develop quantitative survey measures to 
test these findings with a national sample of transgender and non-binary women. Second, these 
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findings suggest that a lack of transgender-inclusive and gender-affirming sexual health 
assessment tools and health education information create barriers to PrEP knowledge, uptake, 
and access. Research must develop and test valid and reliable sexual health and risk assessment 
tools that accurately reflect the experiences that increase HIV risk for TGNBW, to assist in the 
development of PrEP guidelines and the design of PrEP programs that are specific to TGNBW.  
 Third, these findings demonstrate a need for reliable information on whether PrEP 
negatively interacts with commonly used feminizing hormones. For the majority of participants, 
their gender transition process was identified as the number one health priority. As such, 
longitudinal studies that test drug levels (PrEP and hormones) in TGNBW on PrEP are needed as 
well as studies that investigate the pharmokentics of the medications in real-world settings. 
Fourth, new and promising forms of PrEP (e.g., long-acting injectable) are currently being tested 
in clinical trials. Participants not on PrEP indicated that they would be more willing to use PrEP 
if it was administered as an injection rather than a daily oral pill. Future studies must include 
TGNBW to ensure that implementation guidelines specific to and inclusive of transgender and 
non-binary women are developed.  
Fifth, study results highlight the need for transgender-inclusive and gender-affirming PrEP 
programs to increase access and uptake. Research studies must partner with community-based 
health centers and organizations that have existing PrEP programs and protocols for TGNBW to 
identify and examine the factors associated with PrEP access, uptake, and adherence in a real-
world setting. Further, studies should also work with organizations providing low threshold 
services (such as outreach to homeless transgender youth and young adults) to developing 
strategies that leverage engagement in PrEP towards improving the overall health of transgender 
and non-binary women. Finally, future research must stop categorizing transgender and non-
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binary women with MSM. There is a need for longitudinal studies examining HIV risk, 
prevention and treatment that are inclusive of (i.e., cisgender women and transgender women) 
and specific to transgender and non-binary women. A research agenda that addresses HIV risk 
among this community at the structural, interpersonal, and individual level has the greatest 
potential to change HIV policy and direct funding towards the development and design of 
strategies and programs that reduce the disparate rates of HIV within this community.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Demographics of Sample by Group (N=30) 
 Total No PrEP PrEP 
 N=30 
n (%) 
n=15 
n (%) 
n=15 
n (%) 
Demographics    
Age    
 Under 30 18 (60.0) 7 (46.7) 11 (73.3) 
 30 and older 12 (40.0) 8 (53.3) 4 (26.7) 
 Gender Identity    
 Binary 28 (93.3) 14 (93.3) 14 (93.3) 
 Non-Binary 2 (6.7) 1(6.7) 1 (6.7) 
 Race/Ethnicity    
 African-American/Black 9 (30.0) 6 (40.0) 3 (20.0) 
 Latina/Hispanic 6 (20.0) 3 (20.0) 3 (20.0) 
 White – Non-Hispanic 8 (26.7) 2 (13.3) 6 (40.0) 
 Asian/Pacific Islander 4 (13.3) 2 (13.3) 2 (13.3) 
 Multiracial 3 (10.0) 2 (13.3) 1 (6.7) 
Sexual Orientation    
 Heterosexual/Straight 17 (56.7) 10 (66.7) 7 (46.7) 
 Gay 2 (6.7) 2 (13.3) 0 
 Bisexual 3 (10.0) 0 3 (20.0) 
 Queer 6 (20.0) 1 (6.7) 5 (33.3) 
 Pansexual 2 (6.7) 2 (13.3) 0 
Income    
 Less than $12,000 26 (86.7) 15 (100.0) 11 (73.3) 
 $12,000 + 4 (13.3) 0 4 (13.3) 
Employment    
 In the workforce 3 (10.0) 0 3 (20.0) 
 Not in the workforce 27 (90.0) 15 (100.0) 12 (80.0) 
Health Insurance    
 Public  26 (86.7) 15 (100.0) 11 (73.3) 
 Private 4 (13.3) 0 4 (26.7) 
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Table 2. PrEP Eligibility Criteria and Indications by Group (N=30) 
 
 
 Total No PrEP PrEP 
 (N=30) n=15 n=15 
 n (%) n (%) n (%) 
CDC Eligibility    
 Condomless anal sex in the past 6 months 27 (90.0) 12 (80.0) 15 (100.0) 
 STI Diagnosis in the past 6 months 1 (3.3) 0 1 (6.6) 
 HIV-positive sex partner 6 (20.0) 2 (13.3) 4 (26.6) 
 Any CDC PrEP eligibility criteria (3 criteria above) 30 (100.0) 15 (100.0) 15 (100.0) 
PrEP Indications    
 Multiple Sex Partners 10 (33.3) 4 (26.6) 6 (40.0) 
 A partner with multiple sex partners 9 (30.0) 3 (20.0) 6 (40.0) 
 A partner who HIV status is unknown 16 (53.3) 7 (46.6) 9 (60.0) 
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Appendix A: IRB Approval Letter 
 
 
Appendix B: Recruitment Flyer 
University Integrated Institutional Review Board
205 East 42nd Street
New York, NY 10017
 http://www.cuny.edu/research/compliance.html
Approval Notice
Continuing Review
09/21/2017
Gus Klein,
Hunter College
RE: IRB File #2015-1189
Knowledge, Acceptability, and Access to Pre-Exposure Prophylaxis (PrEP) among the
Transgender Community
Dear Gus Klein,
Your Continuing Review was reviewed and approved on 09/20/2017.  You may continue the
research.
Please note the following information about your approved research protocol:
Protocol Approval Period: 09/20/2017 - 09/19/2020
Protocol Risk Determination: Minimal
Expedited Categor(ies): (6) Collection of data from voice, video, digital, or image
recordings made for research purposes.;
(7) Research on individual or group characteristics or behavior
(including, but not limited to, research on perception, cognition,
motivation, identity, language, communication, cultural beliefs
or practices, and social behavior) or research employing survey,
interview, oral history, focus group, program evaluation, human
factors evaluation, or quality assurance methodologies. (NOTE:
Some research in this category may be exempt from the HHS
regulations for the protection of human subjects. 45 CFR 46.101(b)
(2) and (b)(3). This listing refers only to research that is not
exempt.);
Documents / Materials:
Type Description Version # Date
Informed Consent/Permission
Document
Consent Form - One to One 1 09/08/2017
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Appendix C: Eligibility Screening Script and Questions 
Screening Script and Questions 
  
Hi thanks for calling. First I'm going to tell you a bit about ourselves and the study, then, if 
you're still interested, I'll ask you some questions to determine whether or not you’re eligible to 
participate. We’re a group of researchers from HART, Hunter HIV/AIDS Research Team. We're 
affiliated with Hunter College, of the City University of New York. We are conducting a study 
on PrEP knowledge, use, and access among the transgender community. As the first step to 
understanding the potential of PrEP as an HIV prevention strategy for the trans* community we 
are conducting a series of one to one and a half hour  interviews with transgender individuals 
who are either currently on PrEP or might be interested in and/or eligible for PrEP. We are 
particularly interested in opinions about what might make PrEP more or less acceptable to 
transgender individuals in NYC and about what things community-based health centers and 
social service organizations might be able to do to reduce disparities in access to gender 
affirming prevention and care services that may directly impact PrEP adoption and access.  
 
If you are interested in participating in an interview, I will ask you a series of questions to see 
whether you are eligible. The questions will be about yourself, including some demographic 
information and some information about your sexual behavior and substance use.  
 
If it seems like you’re eligible after answering these questions, you’ll have the opportunity to 
schedule an interview as soon as possible. The interview would last between an hour to an hour 
and a half and would include questions about: a) your attitudes and opinions about PrEP; b) what 
you think might make trans* individuals more or less likely to use PrEP; and c) your opinions 
about the best way to create a program that would provide PrEP to trans* folks who need it most. 
The interview will take place at our research offices at Hunter College @ 68th and Lexington 
Ave. In appreciation for your time, you would be paid $40 in cash upon completion of the 
interview.  
 
In the event that you are not eligible for the study, we will ask you if you would like to be 
contacted for future studies for which you may be eligible. If you are interested, we will ask for 
your contact information. We will use your answers to these screening questions to determine 
whether you are eligible for future studies so that we can contact you. If you do not want your 
contact information linked to your answers you do not have to provide your contact information. 
Regardless of your decision, all of your answers will be kept confidential.  
 
Do you have any questions about the study so far? 
 
If you are eligible and choose to participate, any information about you will be kept confidential 
to the extent permitted by law.  
 
VERBAL CONSENT: Do you feel comfortable answering a few personal questions right now 
so that I can determine if you’re eligible to participate? Yes / No  
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1. How did you hear about the study?  
2. What is your age? ____ 
3. What is your zip code? _____  
4. What is your race or ethnicity?  
a. Black/African American  
b. Latino/Hispanic  
c. White/Caucasian  
d. Asian/Pacific Islander  
e. Native American  
f. Multiracial  
g. Other (Specify:_____________)  
 
5. What is your sex assigned at birth?  
a. Male 
b. Female 
c. Intersex 
 
6. What is your current gender identity  
a. Male  
b. Female  
c. Transwoman (male to female)  
d. Transman (man to female)  
e. Gender Non-Conforming 
f. Genderqueer 
g. Other____________________ 
 
7. What do you consider sexual identity?  
a. Straight  
b. Gay  
c. Lesbian 
d. Bisexual  
e. Queer 
f. MSM  
g. Other (Specify:____________)  
 
8. What is your current employment status? (Check all that apply) 
a. Full-Time  
b. Part-Time 
c. More Than One Job  
d. Self-Employed, own your business  
e. Self-Employed, contract worker  
f. Unemployed But Looking  
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g. Unemployed and Stopped Looking  
h. On Disability  
i. Student  
j. Retired  
k. Homemaker or Full-time Parent  
l. Other (please specify) ____________________ 
9. What is your current gross annual household income (before taxes)? 
a. Less than $12,000  
b. $12,000-$24,999  
c. $25,000-$34,999  
d. $35,000-$49,999  
e. $50,000-$74,999  
f. $75,000-$150,000 
g.  Over $150,000  
 
10. What type of health insurance do you have? 
a. I have NO health insurance coverage  
b. Insurance through a current or former employer (employee health plan, COBRA, 
retiree benefits)  
c. Insurance through someone else’s employer (spouse, partner, parents, etc.)  
d. Insurance you or someone in your family purchased  
e. Medicare  
f. Medicaid  
g. ADAP  
h. Military health care/Champus/Veterans Administration/Tri-Care  
i. Student Insurance through College or University 
j.  Other (please specify) ____________________ 
 
11. Do you drink alcohol?  
12. Approximately how many alcoholic drinks have you had in the past 30 days?  
13. Do you have sex with: (Yes / No) 
a. Cisgender men 
b. Cisgender women 
c. Trans/GNC women 
d. Trans/GNC men 
e. Other_____________________ 
14. In the past six months have you had receptive anal/vaginal/or front hole sex with a: 
a. Cisgender man 
b. Transgender woman  
15. In the past six months how often have you had condomless sex? (always, sometimes, 
never) 
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16. In the past month have you had: 
a. An HIV positive partner 
b. Multiple sex partners 
c. A partner with multiple sex partners 
d. A partner whose HIV status is unknown 
17. Have you recently tested positive for a sexually transmitted infection? (e.g. syphilis, 
chlaymadia)? Yes/No 
18. If yes, which one?  
 
19. Are you currently taking PrEP? (Yes/No)  
20. If yes, what’s the name of the medication you are prescribed? (Truvada) 
21. How do you pay for PrEP?  
22. How much is your co-pay?  
23. What is your HIV Status?  
a. Positive  
b. Negative  
c. I don’t know  
 
Eligible = Q2 >18, Q5 and Q6=current gender identity is different from sex assigned at birth, 
Q13= cisgender men and/or transgender women, Q23=b or c, and Q13=yes, and/or Q14=yes, 
and/or Q16>1 and/or Q17=yes, and Q19=yes(to be eligible for the PrEP group).   
 
- It looks like you are eligible. Are you still interested in participating? Yes / No  
 
If Yes: Great! We would also like to send you a text or email with directions to our office and a 
reminder the day before your appointment.  Do you have a working, personal telephone number 
or email that we can use? Give me a minute to pull up our calendar and we can schedule an 
appointment for you to come to our office for an interview.   
 
Text for Contact Information:  
Name:  
Cell Number:   okay to text: Yes/No okay to leave message: Yes/No 
Email:  
Best Contact Method: email____   call_____    text_____ 
 
If No: Thank you for your time! Would you like us to contact you for any future studies? 
 
If ineligible: - Thank you for your time! Based off your answers to the screening questions, you 
are not eligible for participation in this study.  We often are recruiting for new studies, would you 
like use to contact you for any future studies?  
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IF Yes: Would you prefer to be contacted via email or phone?  
 
Text for Contact Information:  
Name:  
Cell Number:   okay to text: Yes/No okay to leave message: Yes/No 
Email:  
Best Contact Method: email____   call_____    text_____ 
 
 
IF No: Thank you again for your time!  
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Appendix D: Semi-Structured Interview Guide 
 
Increasing Access to PrEP among Transgender Women and Trans Feminine Individuals 
 
Semi-Structured Interview Guide 
 
I. Introduction (ALL PARTICIPANTS) 
• The goal of this study is to gather information about the primary care, sexual 
health care experiences and needs of the transfeminine community.  This 
interview will deal with 4 main areas, the general health care you currently 
receive, your sexual health, pre-exposure prophylaxis (PrEP ) and provider 
communication (or how you want your doctor to talk to you).    
II. QUESTIONS FOR PARTICIPANTS  
Interviewer:  The first set of questions focus on the types of health care you currently 
have access to and use, which may include primary care, sexual health, transition-related, 
non-western medicine/healing, mental health, and any other specialty care.   
 
A.  Health Care  
1. What types of health care do you currently use?  (Probe different types of health care)  
2. Of the types of health care, you just mentioned, which do you use on a regular basis?  
3. In general, how would you describe the health care you receive? (Note: distinguish 
between regular care and any other care)  
a. What are the aspects that you consider positive?  
b. What are the aspects that you consider negative?  
4. In general, when looking for a provider, what are the 3 most important things you look 
for?  
a. In thinking of these three things, have you had to compromise on any of them 
regarding the care you get now?  
5. Tell me about the best experience you’ve had with a provider about your health. 
a. What made it good or affirming? 
b. What did the provider say? 
6. Tell me about the worst experience you’ve had with a provider about your health. 
a. What made it a negative experience? 
b. What did the provider say or do? 
c. What should the provider have said or done differently? 
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7. What was it like trying to find your current primary care provider?  
a. What were some the positives about this process? 
b. What were some of the negatives about this process 
8. Can you describe the primary care that you currently receive, what does it include? 
a. How often do you see your primary care provider?  
b. How does your provider talk to you about your health, your body, your transition?  
9. Is there health care you currently need or want, but can’t get? What is it and why?  
 
Interviewer: The next set of questions deals more specifically with your sexual health Much 
of the focus on HIV and trans* people is about risk behavior and disease prevention. Little if 
any information is available on sexuality, including sexual relationships and sexual 
experiences that are pleasurable, fulfilling, and safe (and by safe we mean free from pressure, 
discrimination, or violence).  Instead of starting with a question about HIV risk, we’d first 
like you to describe your ideal sex life.   
 
B. Sexual Health 
1. Can you describe your ideal sex life?  
2. Can you talk a little bit about your current sex life and the ways in which it is or isn’t 
like your ideal.  
3. What role does HIV and other STI’s play in your sex life?  
4. When was the last time you discussed your sexual health with a provider?   
a. Who brought it up? (If the participant brought it up)  Was there a specific 
reason/issue that you wanted to address with your provider? (If provider brought 
it up) What did they say? 
b. How did that conversation go?   
5. When was the last time a provider took a sexual history? What did they say? 
6. What role do drugs and/or alcohol play in your sex life?  
7. When was the last time you discussed your drug and/or alcohol use with a provider?  
a. Who brought it up?  (If the participant brought it up)  Was there a specific 
reason/issue that you wanted to address with your provider? (If provider brought 
it up) What did they say? 
b. How did that conversation go?  
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C. PrEP (if person is on PrEP skip to section D)  
Interviewer:  The next set of questions are about pre-exposure prophylaxis, which is often called 
PrEP or Truvada?  
1. What have you heard about PrEP (pre-exposure prophylaxis or Truvada)?  
2. What have you heard about PrEP? or about how it works?  
3. Has a health care provider every talked to you about PrEP? If yes, what did they say? 
4. If you were to consider taking PrEP, what would you want to know to help you decide 
whether or not to take it?  
Potential probes: 
a. What types of things would you most want to know about PrEP? 
b. What things would be the biggest barriers to your considering PrEP? 
c. What do you think would be the ideal method or program for reaching trans* 
individuals who might want to take PrEP?  
 
5. In general, how would you describe your thoughts and attitudes toward PrEP? 
Potential probes: 
a. What are the aspects of PrEP that you consider positive?  
b. What are the aspects of PrEP that you consider negative?  
c. How do you think that your answers are similar or different from other trans* 
people you know?  
 
6. Let’s say you decided to use PrEP.  What do you think it would be like?  
Potential probes: 
a. What do you think the best things about being on PrEP would be?  
b. What would be the worst things about being on PrEP?  
 
 
7. One thing that will be really important for people who decide to take PrEP is that they 
remember to take the medication every day.  
 
Potential probes: 
 
a. What do you think would be easy or difficult about remembering to take PrEP 
pills daily?  
b.  What do you think would be most helpful in helping trans* people take PrEP 
daily?  
c. How could health care providers help with this process?  
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d. What do you think would be the biggest barrier to trans* people accessing this 
type of support?  
 
8. If PrEP was available in an injectable/gel form would you be willing to get an injection 
every month, every 3 months or use a gel? [If yes]Can you say why? [If no] Are there 
any circumstances under which you would be willing?   
D. Participants on PrEP only ask these questions if person is currently on PrEP (skip and 
go to Section E)  
 
1. How long have you been taking PrEP?  
2. How did you first hear about PrEP?  
3. What do you know about PrEP or about how it works?  
4. In general, how would you describe your thoughts and attitudes toward PrEP? 
Potential probes: 
a. What are the aspects of PrEP that you consider positive?  
b. What are the aspects of PrEP that you consider negative?  
c. How do you think that your answers are similar or different from other trans* 
folks you know?  
 
5. When did you start taking PrEP?  Why did you start?  
6. When you were considering taking PrEP, what factors entered into that decision? 
Potential probes: 
a. What types of things did you most want to know about PrEP?  
b. What things were the biggest barriers for you taking PrEP?  
c. Who do you think would be the ideal candidate for PrEP?  
d. What do you think is the ideal method or program for reaching trans* individuals 
who might want to take PrEP?  
 
7. Since you’ve started taking PrEP, what has it been like?  
Potential probes:  
a. What are the best things about being on PrEP?  
b. What are the worst things about being on PrEP?  
 
8. One thing that will be really important for trans* people who decide to take PrEP is that 
they remember to take the medication every day.  
a. What has been easy or difficult about remembering to take PrEP pills daily?  
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b.  What do you think would be most helpful in helping trans* people take PrEP 
daily?  
c. How could health care providers help with this process?  
d. What do you think would be the biggest barrier to trans* people accessing this 
type of support?  
 
9. Do you openly talk about being on PrEP with friends, sexual partners? Why? 
 
10. If PrEP was available in an injectable/gel form would you be willing to get an injection 
every month, every 3 months or use a gel? [If yes]Can you say why? [If no] Are there 
any circumstances under which you would be willing?   
E. Provider Communication 
 
Interviewer:   One of the goals of this study is to get specific suggestions from 
transfeminine/trans women about how you would like providers to talk to you about your sexual 
health and the information you would like them to provide and the types of services you’d like 
that pertain to your sexual health.  .   
1. How would you like your provider to talk to you about your body?  
a. What words do you want them to use? 
b. What questions would you want them to ask you? 
2. How would you like your provider to talk to you about your sex life?  
a. What words do you want them to use? 
b. What questions would you want them to ask you? 
3. What questions do you have about the process of transitioning that you would 
a. Ask a doctor 
b. Ask a friend 
c. Where do you currently go if you have a question? (website, support group…) 
d. Whose answers do you trust and why?  
4. What sexual health services would you want providers to offer?   
 
Interviewer:  We’re almost at the end of the interview, just a couple more questions. We would 
like your input on where future research on transfeminine health care needs.    
1. Thinking about your health care and sexual health needs right now, what are the 3 most 
important health care issues for you? 
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2. Thinking about trans fem community in general.  What do you think are the 3 most 
important health care issues facing your community?  
3. What are 3 ways you think trans women are strong given the struggles you go through.   
4. Is there anything else you think we should’ve asked that we didn’t?  
 
**Note: This interview guide is designed to provide a basic structure and outline to the interview 
process. As qualitative interviews are designed to collect in-depth insights into participants’ 
particular attitudes and experiences, interviewers may need to ask clarification, follow-up, or 
other additional questions related to these topics in any particular interview.**  
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